<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Channels (Austin)</journal-id><journal-id journal-id-type="iso-abbrev">Channels (Austin)</journal-id><journal-title-group><journal-title>Channels</journal-title></journal-title-group><issn pub-type="ppub">1933-6950</issn><issn pub-type="epub">1933-6969</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7801124</article-id><article-id pub-id-type="pmid">33258401</article-id><article-id pub-id-type="doi">10.1080/19336950.2020.1852831</article-id><article-id pub-id-type="publisher-id">1852831</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Acid-sensing ion channel 3: An analgesic target</article-title><alt-title alt-title-type="left-running-head">J. S. DULAI ET AL.</alt-title><alt-title alt-title-type="right-running-head">CHANNELS</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6784-5214</contrib-id><name><surname>Dulai</surname><given-names>Jasdip Singh</given-names></name><xref ref-type="aff" rid="aff0001"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2699-1979</contrib-id><name><surname>Smith</surname><given-names>Ewan St. John</given-names></name><xref ref-type="aff" rid="aff0001"/><xref ref-type="corresp" rid="an0001"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3830-5160</contrib-id><name><surname>Rahman</surname><given-names>Taufiq</given-names></name><xref ref-type="aff" rid="aff0001"/></contrib><aff id="aff0001">Department of Pharmacology, <institution-wrap><institution>University of Cambridge</institution></institution-wrap>, <city>Cambridge</city>, <country>UK</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT Ewan St. John Smith <email xlink:href="mailto:es336@cam.ac.uk">es336@cam.ac.uk</email>; Taufiq Rahman<email xlink:href="mailto:mtur2@cam.ac.uk">mtur2@cam.ac.uk</email> Department of Pharmacology, <institution-wrap><institution>University of Cambridge</institution></institution-wrap>, <city>Tennis Court Road, Cambridge</city>, <postal-code>CB2 1PD</postal-code>, <country>United Kingdom</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>4</day><month>1</month><year>2021</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>1</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>15</volume><issue>1</issue><fpage seq="8">94</fpage><lpage>127</lpage><permissions><copyright-statement>&#x000a9; 2021 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-01-03">http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="KCHL_15_1852831.pdf"/><abstract><title>ABSTRACT</title><p>Acid-sensing ion channel 3 (ASIC3) belongs to the epithelial sodium channel/degenerin (ENaC/DEG) superfamily. There are 7 different ASIC subunits encoded by 5 different genes. Most ASIC subunits form trimeric ion channels that upon activation by extracellular protons mediate a transient inward current inducing cellular excitability. ASIC subunits exhibit differential tissue expression and biophysical properties, and the ability of subunits to form homo- and heteromeric trimers further increases the complexity of currents measured and their pharmacological properties. ASIC3 is of particular interest, not only because it exhibits high expression in sensory neurones, but also because upon activation it does not fully inactivate: a transient current is followed by a sustained current that persists during a period of extracellular acidity, i.e. ASIC3 can encode prolonged acidosis as a nociceptive signal. Furthermore, certain mediators sensitize ASIC3 enabling smaller proton concentrations to activate it and other mediators can directly activate the channel at neutral pH. Moreover, there is a plethora of evidence using transgenic mouse models and pharmacology, which supports ASIC3 as being a potential target for development of analgesics. This review will focus on current understanding of ASIC3 function to provide an overview of how ASIC3 contributes to physiology and pathophysiology, examining the mechanisms by which it can be modulated, and highlighting gaps in current understanding and future research directions.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Acidosis</kwd><kwd>acid-Sensing Ion Channel 3</kwd><kwd>analgesia</kwd><kwd>asic3</kwd><kwd>inflammation</kwd><kwd>ion channels</kwd><kwd>nociception</kwd><kwd>pain</kwd><kwd>pH</kwd></kwd-group><counts><fig-count count="10"/><table-count count="4"/><ref-count count="238"/><page-count count="34"/></counts></article-meta></front><body><sec id="s0001" disp-level="1"><title>The epithelial sodium ion channel/degenerin superfamily</title><p>Approximately 1.5% of the human genome encodes ion channels (&#x0003e;400 in total) [<xref rid="cit0001" ref-type="bibr">1</xref>], proteins that are integral to cellular excitability in tissues throughout the body. The importance of ion channels is demonstrated by the fact that they account for 19% and 18% of human protein and small drug targets in the ChEMBL database, respectively [<xref rid="cit0002" ref-type="bibr">2</xref>]. This review will focus on an ion channel family that detects changes in extracellular pH: acid-sensing ion channels (ASICs), and more specifically ASIC3.</p><p>The epithelial sodium channel (ENaC)/Degenerin (DEG) ion channel superfamily are selective for Na<sup>+</sup>, showing preference over K<sup>+</sup> of 100-fold for ENaC and 10-fold for ASIC subunits [<xref rid="cit0003" ref-type="bibr">3&#x02013;5</xref>]. An additional characteristic of the ENaC/DEG superfamily is sensitivity to the reversible channel blocker, amiloride [<xref rid="cit0006" ref-type="bibr">6</xref>]. In mammals, there are nine ENaC/DEG genes, four encode ENaC subunits (&#x003b1;/&#x003b2;/&#x003b3;/&#x003b4;-ENaC) and five encode ASIC subunits (ASIC1-5). Although the nomenclature has been standardized for the ASIC family (<xref rid="t0001" ref-type="table">Table 1</xref>), ASIC5 is still often referred to as Bile Acid-Sensitive Ion Channel (BASIC), due to it not being modulated by extracellular acid [<xref rid="cit0007" ref-type="bibr">7</xref>] and displaying a low amino acid homogeneity of ~30% with other ASIC subunits (by contrast, ASIC1-4 share at least 50% amino homogeneity, <xref rid="t0002" ref-type="table">Table 2</xref>) [<xref rid="cit0007" ref-type="bibr">7&#x02013;11</xref>]. Due to alternative splicing, the four main ASIC genes produce six ASIC subunits: ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3 and ASIC4 and studies using x-ray crystallography [<xref rid="cit0012" ref-type="bibr">12</xref>] and atomic force microscopy [<xref rid="cit0013" ref-type="bibr">13</xref>] have demonstrated that ASICs form trimers, subunits combining to form homomeric or heteromeric ion channels. To date, a total of 18 ASIC structures are available in the Protein Data Bank (PDB), but all of these are of <italic>Gallus gallus</italic> (chicken) ASIC1a (cASIC1a). Therefore, it should be remembered that all structural information discussed on ASIC3 (<xref ref-type="fig" rid="f0001">Figure 1</xref>), both here and in the wider literature, is largely based on the structure of cASIC1a. Like BASIC, not all ASIC subunits form proton-sensitive homotrimers, ASIC2b and ASIC4 both being proton-insensitive [<xref rid="cit0014" ref-type="bibr">14</xref>,<xref rid="cit0015" ref-type="bibr">15</xref>], but able to modulate the properties of other ASICs in heteromeric configurations [<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0017" ref-type="bibr">17</xref>]. Of all ASIC subunit configurations, those containing ASIC3 are the most sensitive to protons [<xref rid="cit0018" ref-type="bibr">18</xref>], as well as producing a characteristic biphasic response: an initial transient inward current followed by a smaller magnitude-sustained phase, features that make ASIC3 of particular interest in the context of pain [<xref rid="cit0005" ref-type="bibr">5</xref>]. Human ASIC3 (hASIC3) was first located on chromosome 7q35 (6.4 cRad telomeric) in the late 1990s [<xref rid="cit0019" ref-type="bibr">19</xref>] and there have been limited subsequent studies of hASIC3, and thus, this review will encompass the broader mammalian publications from rat (rASIC3) and mouse (mASIC3) orthologues which share an 84% amino acid identity to hASIC3.
<fig id="f0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>3D Structural Model of rat ASIC3. (a) front view of rASIC3 subunit domains. (b) Side view of homotrimeric rASIC3. (c) Top view from extracellular side. Individual subunits are shown in different colors for A and B. The homology model of rASIC3 was built using the published crystal structure of chicken ASIC1a as template (PDB: 2QTS, PMID: 17,882,215); for details of rASIC3 modeling see Rahman and Smith 2014</p></caption><alternatives><graphic specific-use="web-only" content-type="color" xlink:href="KCHL_A_1852831_F0001_OC"/><graphic specific-use="print-only" content-type="black-white" xlink:href="KCHL_A_1852831_F0001_PB"/></alternatives></fig>
<table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>ASIC Family Nomenclature. Identification of further ASIC subunits has led to the evolution of their nomenclature, finally resulting in the transition to the use of alpha numerical names. NaC &#x02013; Sodium Chanel, ACCN &#x02013; Amiloride-Sensitive Cation Channel, BNaC &#x02013; Brain NaC, BASIC &#x02013; Bile ASIC, (BL)INAC &#x02013; (Brain, Liver and) Intestine NaC, DRASIC &#x02013; Dorsal Root ASIC, MDEG &#x02013; Mammalian and Degenerin Channel, SPASIC &#x02013; Spinal Cord ASIC, and TNaC &#x02013; Testis NaC</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/></colgroup><thead><tr><th align="left">Subunit Name</th><th align="center">Amiloride Gene Code</th><th align="center">Sodium Expression Code</th><th align="center">Other/Previous names</th></tr></thead><tbody><tr><td align="left">ASIC1a</td><td align="left">ACCN2</td><td align="left">BNaC2&#x003b1;</td><td align="left">ASIC&#x003b1;</td></tr><tr><td align="left">ASIC1b</td><td align="left">ACCN2</td><td align="left">BNaC2&#x003b2;</td><td align="left">ASIC&#x003b2;</td></tr><tr><td align="left">ASIC2a</td><td align="left">ACCN1</td><td align="left">BNaC1&#x003b1;</td><td align="left">MDEG1</td></tr><tr><td align="left">ASIC2b</td><td align="left">ACCN1</td><td align="left">BNaC1&#x003b2;</td><td align="left">MDEG2</td></tr><tr><td align="left">ASIC3</td><td align="left">ACCN3</td><td align="left">TNaC1</td><td align="left">DRASIC</td></tr><tr><td align="left">ASIC4</td><td align="left">ACCN4</td><td align="left">BNaC4</td><td align="left">SPASIC</td></tr><tr><td align="left">ASIC5</td><td align="left">ACCN5</td><td align="left">(BL)INaC</td><td align="left">BASIC</td></tr></tbody></table></table-wrap>
<table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Human ASIC Family Homogeneity. Calculated in Clustal Omega using UniProt amino acid sequences</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th align="center">ASIC1a</th><th align="center">ASIC1b</th><th align="center">ASIC2a</th><th align="center">ASIC2b</th><th align="center">ASIC3</th><th align="center">ASIC4</th><th align="center">ASIC5</th></tr></thead><tbody><tr><td align="left">ASIC1a</td><td align="center">-</td><td align="center">79.15</td><td align="center">67.46</td><td align="center">59.61</td><td align="center">50.59</td><td align="center">50.41</td><td align="center">28.45</td></tr><tr><td align="left">ASIC1b</td><td align="center">79.15</td><td align="center">-</td><td align="center">62.17</td><td align="center">56.80</td><td align="center">49.60</td><td align="center">49.90</td><td align="center">27.05</td></tr><tr><td align="left">ASIC2a</td><td align="center">67.46</td><td align="center">62.17</td><td align="center">-</td><td align="center">77.54</td><td align="center">50.82</td><td align="center">47.33</td><td align="center">29.50</td></tr><tr><td align="left">ASIC2b</td><td align="center">59.61</td><td align="center">56.80</td><td align="center">77.54</td><td align="center">-</td><td align="center">47.78</td><td align="center">45.40</td><td align="center">26.67</td></tr><tr><td align="left">ASIC3</td><td align="center">50.59</td><td align="center">49.60</td><td align="center">50.82</td><td align="center">47.78</td><td align="center">-</td><td align="center">46.97</td><td align="center">28.90</td></tr><tr><td align="left">ASIC4</td><td align="center">50.41</td><td align="center">49.90</td><td align="center">47.33</td><td align="center">45.40</td><td align="center">46.97</td><td align="center">-</td><td align="center">25.98</td></tr><tr><td align="left">ASIC5</td><td align="center">28.45</td><td align="center">27.05</td><td align="center">29.50</td><td align="center">26.67</td><td align="center">28.90</td><td align="center">25.98</td><td align="center">-</td></tr></tbody></table></table-wrap>
</p></sec><sec id="s0002" disp-level="1"><title>Asic structure and function</title><p>Early work by Krishtal et al., in 1980, demonstrated for the first time that application of extracellular acid could evoke inward currents in sensory neurones [<xref rid="cit0020" ref-type="bibr">20</xref>], and further work has shown that localized tissue acidification (pH &#x02264;6.0) causes pain in humans [<xref rid="cit0021" ref-type="bibr">21&#x02013;23</xref>]. Thus, there is a clear link between acidosis, acid-evoked sensory neurone activation and pain. There are a variety of ion channels and receptors that can be modulated by acid, which have been reviewed in detail elsewhere [<xref rid="cit0024" ref-type="bibr">24</xref>], but here we will concentrate on ASICs, which underlie the transient inward currents first recorded 40 years ago. With the exception of ASIC4 and ASIC5, all ASIC subunits show robust expression in sensory neurones [<xref rid="cit0025" ref-type="bibr">25</xref>,<xref rid="cit0026" ref-type="bibr">26</xref>] and their activation by extracellular acid causes transient proton-gated currents that are mainly carried by Na<sup>+</sup>, although ASIC1a homomers also show Ca<sup>2+</sup> permeability [<xref rid="cit0027" ref-type="bibr">27</xref>]. The ASIC-mediated cation influx leads to neuronal depolarization, which, if of sufficient magnitude to activate voltage-gated sodium channels, can induce action potential firing in nociceptors (sensory neurones tuned to detect noxious stimuli [<xref rid="cit0028" ref-type="bibr">28</xref>]) and ultimately evoke the sensation of pain. Whilst ASICs are gated by extracellular protons, their proton sensitivity can be modulated by other extracellular ions such as Ca<sup>2+</sup> and Zn<sup>2+</sup> (discussed in later sections). As illustrated in <xref ref-type="fig" rid="f0002">Figure 2</xref>, homomeric ASIC3 and some ASIC3 containing heteromers (especially ASIC2a/3) display a pronounced sustained current in the continued presence of acidity following partial inactivation of the initial transient inward current. This sustained current implies that in the presence of prolonged tissue acidosis, ASIC3 would remain activated, supporting a sustained inward Na<sup>+</sup> current in sensory neurones causing their membrane depolarization and ultimately prolonged action potential firing. Thus, ASIC3 can effectively transduce the prolonged tissue acidosis occurring in pathological conditions into pain.
<fig id="f0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Illustrated Example Current Traces of the pH-Sensitive ASICs. Currents are represented with their half pH maximal activation of a typical rASIC patch-clamp profile. The illustrated example traces are based off published recordings</p></caption><graphic content-type="black-white" xlink:href="KCHL_A_1852831_F0002_B"/></fig></p><p>Following initial work demonstrating that ASICs are activated by extracellular protons, much research has been dedicated to identifying the region and amino acids that detect protons [<xref rid="cit0027" ref-type="bibr">27</xref>]. In the very first crystal structure of cASIC1a, an acidic pocket situated between the finger-thumb-ball region, was proposed to be critical for proton sensing [<xref rid="cit0012" ref-type="bibr">12</xref>]. However, mutagenesis of residues within this acidic pocket did not fully abolish proton sensitivity for ASIC1a [<xref rid="cit0029" ref-type="bibr">29</xref>,<xref rid="cit0030" ref-type="bibr">30</xref>]. Additionally, rASIC2a is proton-sensitive, whereas its splice variant rASIC2b is not, yet both subunits contain the same 5/6 carboxylate residues of the acidic pocket; site-directed mutagenesis and chimera construction of rASIC2a/2b have identified that the first 87 amino acids after transmembrane domain 1 are of particular importance [<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0031" ref-type="bibr">31</xref>]. Furthermore, mutational analysis of the rASIC1a palm domain has identified it to also be an influential component to proton activation, but of less importance than the finger-thumb-ball acidic pocket region [<xref rid="cit0032" ref-type="bibr">32</xref>,<xref rid="cit0033" ref-type="bibr">33</xref>].</p><p>In whole-cell recordings of rASIC3-transfected COS-7 cells, the current measured had a half-maximal pH (pH<sub>0.5</sub>) of activation at pH 6.7, a pH<sub>0.5</sub> steady-state inactivation of pH 7.1 and amiloride inhibited the current at micromolar levels (half maximal inhibitory concentration, IC<sub>50</sub>&#x000a0;=&#x000a0;63&#x000a0;&#x000b5;M) [<xref rid="cit0034" ref-type="bibr">34</xref>]. Mouse ASIC3 (mASIC3) shows similar proton-sensitivity to rASIC3, but naked mole-rat ASIC3 (nmrASIC3), despite sharing &#x0003e;80% amino acid identity with mASIC3 and rASIC3, respectively, is not activated by extracellular protons. Much like proton-insensitive ASIC2b and ASIC4, nmrASIC3 is able to traffic to the cell membrane and modulate the properties of proton-sensitive ASIC subunits [<xref rid="cit0035" ref-type="bibr">35</xref>]. There is an 84% amino acid identity between hASIC3 and rASIC3, the 16% difference accounting for some differences in channel activity, such as hASIC3 requiring only pH 6.0 for sustained current activation, whereas rASIC3 requires a more acidic pH 4.5 [<xref rid="cit0019" ref-type="bibr">19</xref>]. Interestingly, hASIC3, but not rASIC3, has 3 splice variants resulting in differences in the C-terminal domain and one of these, hASIC3a, is activated (albeit to a lesser extent) by alkalinization [<xref rid="cit0036" ref-type="bibr">36</xref>]. Thus, contrary to the function implied by the name <italic>acid</italic>-sensing ion channel, it appears that activation is according to a change in pH, rather than acid-sensing per se. Residues Arg68 and Arg83 located within the base of the palm region of hASIC3a have been implicated in sensing alkalinization, such that if they are mutated the sustained current in high pH is significantly reduced; these residues are absent in rASIC3 which aligns with the fact that rASIC3 is activated only by pH&#x0003c;7.0 [<xref rid="cit0036" ref-type="bibr">36</xref>].</p></sec><sec id="s0003" disp-level="1"><title>Pathological tissue acidosis</title><p>Nociceptors express ASICs and other acid sensors, suggesting that the ability of the body to detect and respond to acidosis is physiologically important [<xref rid="cit0024" ref-type="bibr">24</xref>]. As will be discussed further on, ASIC3, like many sensory transduction ion channels, can be sensitized by inflammatory mediators and modulated by other proteins, all of which can alter ASIC3&#x02019;s biophysical properties, including sensitivity toward extracellular protons. Here we will first discuss how tissue acidosis itself can be generated, thus revealing the circumstances in which ASIC3 activation can occur and why it could be considered an appealing therapeutic target in analgesia.</p><p>In normal physiological conditions, blood plasma pH is pH 7.35&#x02013;7.45 and is well buffered, but during pathophysiological conditions such as metabolic acidosis there can be marked systemic acidosis due to buffering systems being overcome; a further factor affecting blood plasma pH is temperature, such that in hyperthermia (&#x02265;40&#x000b0;C) there can be a decrease by ~0.05 pH [<xref rid="cit0037" ref-type="bibr">37</xref>]. Besides metabolic disorders producing systemic pH changes, there are other conditions that result in local pH changes (<xref ref-type="fig" rid="f0003">Figure 3</xref>). For example, inflammation occurs in response to pathogens, trauma, or autoimmune diseases. As immune cells infiltrate the site of injury there is often a concomitant drop in pH, in arthritic conditions, for example, although reported pH values differ, human synovial fluid readings place this acidification for rheumatoid (RA) at &#x02206; (the difference in pH compared to healthy individuals of) 0.7 pH units [<xref rid="cit0038" ref-type="bibr">38</xref>] and osteoarthritis (OA) at &#x02206; 0.55 pH units [<xref rid="cit0039" ref-type="bibr">39</xref>]. Gout is a further form of inflammatory arthritis and is linked to uric acid levels. As the joint pH becomes more acidic, urate crystals become insoluble leading to deposition into the joints and researchers examining the urine pH levels of those with gout compared to healthy individuals identified a significant difference (&#x02206; 2.6 units) [<xref rid="cit0040" ref-type="bibr">40</xref>], but a localized pH drop of 0.24 units represents a more reflective change at the disease site [<xref rid="cit0041" ref-type="bibr">41</xref>]. However, it should be noted that not all studies of gout, OA and RA record acidosis, i.e. it has also been reported that synovial fluid from patients with gout, OA and RA can be approximately pH 7.4 [<xref rid="cit0042" ref-type="bibr">42</xref>].
<fig id="f0003" fig-type="figure" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Tissue Acidosis in Human Pathophysiology Conditions. Acidic changes from the normal physiological state to the disease states. Arthritic conditions are local readings (i.e. synovial fluid), and the respiratory conditions are obtained from breath condensate. OA &#x02013; Osteoarthritis, RA &#x02013; Rheumatoid Arthritis, TB &#x02013; Tuberculosis, ALI &#x02013; Acute Lung Injury, BE &#x02013; Bronchiectasis, COPD &#x02013; Chronic Obstructive Pulmonary Disease, and CF &#x02013; Cystic Fibrosis</p></caption><alternatives><graphic specific-use="web-only" content-type="color" xlink:href="KCHL_A_1852831_F0003_OC"/><graphic specific-use="print-only" content-type="black-white" xlink:href="KCHL_A_1852831_F0003_PB"/></alternatives></fig></p><p>The mucosal lining of the bronchi also experiences changes in pH during different pathological conditions. For example, in pulmonary tuberculosis (TB) a drop of pH 0.5 occurs [<xref rid="cit0043" ref-type="bibr">43</xref>], and airway surface liquid pH in from epithelia in cystic fibrosis (CF) patients is reduced by pH 0.2 compared to that of healthy individuals [<xref rid="cit0044" ref-type="bibr">44</xref>]. Respiratory pH can also be measured through taking breath condensate pH readings and compared to control individuals relative acidosis has been measured in asthma (&#x02206; pH 0.11), chronic obstructive pulmonary disease (COPD, &#x02206; pH 0.27), bronchiectasis (&#x02206; pH 0.30) [<xref rid="cit0045" ref-type="bibr">45</xref>] and acute lung injury (&#x02206; pH 1.61) [<xref rid="cit0046" ref-type="bibr">46</xref>]. There are other conditions in which acidosis has been measured in rodent models of human disease, e.g. in cardiac ischemia pH drops from pH 7.15 to pH 6.84 [<xref rid="cit0047" ref-type="bibr">47</xref>] and in stroke from pH 7.3 to pH 6.3 [<xref rid="cit0048" ref-type="bibr">48</xref>].</p><p>Overall, it is clear that tissue acidosis occurs in a variety of painful conditions and, as detailed previously, ASIC3 has the biophysical characteristics that suggest it can encode prolonged acidosis into nociception and pain. One key aspect of whether or not ASIC3 is able to play a role in different painful, acidic conditions is whether or not it is expressed in the appropriate location, which will now be discussed.</p></sec><sec id="s0004" disp-level="1"><title>ASIC3 expression and its pathophysiological roles</title><p>The expression pattern of a receptor anchors its function and role in both physiology and pathophysiology, here we will review what is currently understood about the expression and function of ASIC3 in mammals; a summary of ASIC3 expression is provided in <xref rid="t0003" ref-type="table">Table 3</xref>.
<table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>ASIC3 Expression in Different Species. Columns show where expression has been identified, see pathophysiology section for details and references. ASIC-like currents are current recordings which displayed an ASIC3-like profile. IHC &#x02013; Immunohistochemistry, ISH &#x02013; In Situ Hybridization, PCR &#x02013; Polymerase Chain Reaction. G &#x02013; Guinea Pig, H &#x02013; Human, M &#x02013; Mouse (<sup>0</sup> &#x02013; unspecified, <sup>1</sup> &#x02013; C57/BL6J, <sup>2</sup> &#x02013; F4, <sup>3</sup> &#x02013; CD1, <sup>4</sup> &#x02013; &#x02018;F2&#x000a0;+&#x000a0;129S2/B6&#x002b9;, <sup>5</sup>&#x02013;129S/SvPasCr, <sup>6</sup> &#x02013; BALB/c, <sup>7</sup> &#x02013; ICR) and R &#x02013; Rat (<sup>0</sup> &#x02013; unspecified, <sup>8</sup> &#x02013; Wistar, <sup>9</sup> &#x02013; Hooded Lister, <sup>10</sup> &#x02013; Sprague Dawley, <sup>11</sup> &#x02013; Spontaneously Hypertensive, <sup>12</sup> &#x02013; Wistar Kyoto)</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th align="center">Northern Blot</th><th align="center">Western Blot</th><th align="center">qPCR</th><th align="center">RT-PCR</th><th align="center">ISH</th><th align="center">IHC</th><th align="center">ASIC-like Current</th></tr></thead><tbody><tr><td align="left">Retinal Ganglion</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>9</sup></td><td align="center">&#x000a0;</td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Dorsal Root Ganglion (DRG)</td><td align="center">R<sup>8</sup>,M<sup>1,3</sup></td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>8,10</sup>,M<sup>3</sup>,H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Trigeminal Ganglion</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>7</sup>,H</td><td align="center">&#x000a0;</td><td align="center">M<sup>7</sup>,R<sup>10</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Nodose Ganglion (NG)</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>0</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>0</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Cochlear Spiral Ganglion</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Vestibular Ganglion</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>8</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Petrosal Ganglion</td><td align="center">&#x000a0;</td><td align="center">R<sup>0</sup></td><td align="center">R<sup>0</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>0</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Mesensephalic Trigeminal Ganglion</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>3,4</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Anterior Fungiform Papillae</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Tooth Pulp Neurons</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Osteoclasts</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Carotid Body</td><td align="center">&#x000a0;</td><td align="center">R<sup>11,12</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>11,12</sup>,M<sup>0</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Nucleus Pulposus</td><td align="center">&#x000a0;</td><td align="center">H,R<sup>8</sup></td><td align="center">&#x000a0;</td><td align="center">H,R<sup>8</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Femoral Articular Cartilage</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Synovium and Synoviocytes</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Skeletal Muscle</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>8</sup></td><td align="center">H</td></tr><tr><td align="left">Vascular Smooth Muscle Cells</td><td align="center">&#x000a0;</td><td align="center">R<sup>0</sup>,M<sup>1</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>0</sup>,M<sup>1</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>0</sup>,M<sup>1</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Pleura and Pulmonary DRG</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>8</sup></td></tr><tr><td align="left">White and Brown Adipose Tissue</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>5</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Peptidergic Renal Afferents</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td></tr><tr><td align="left">Testis</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Monocyte</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Dendritic Cells</td><td align="center">&#x000a0;</td><td align="center">M<sup>1,6</sup></td><td align="center">&#x000a0;</td><td align="center">M<sup>1,6</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Spinal Cord</td><td align="center">R<sup>0</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Brainstem</td><td align="center">R<sup>0</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>3,4</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Astrocytes</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Ear</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>3</sup></td><td align="center">M<sup>3</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Eye</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>3</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Organ of Corti</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>3</sup></td><td align="center">M<sup>3</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Jugular Ganglion</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">G</td><td align="center">&#x000a0;</td><td align="center">R<sup>0</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Lumbosacral and Thoracolumbar DRG</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">M<sup>1</sup></td><td align="center">R<sup>10</sup>,M<sup>1</sup></td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td></tr><tr><td align="left">Hypothalamus</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Amygdala</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Caudate Putamen</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Prefrontal Cortex</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup>,H</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Hippocampus</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Cardiac DRG</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>1</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td></tr><tr><td align="left">Venoatrium Junction NG</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>3</sup></td><td align="center">M<sup>3</sup></td></tr><tr><td align="left">Gastric DRG and NG</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">R<sup>10</sup></td></tr><tr><td align="left">Bladder Smooth Muscle Cells and Urothelium</td><td align="center">&#x000a0;</td><td align="center">R<sup>8</sup></td><td align="center">R<sup>8</sup>,H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>8</sup></td><td align="center">H</td></tr><tr><td align="left">Cutaneous DRG</td><td align="center">&#x000a0;</td><td align="center">R<sup>8</sup></td><td align="center">R<sup>8</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>8</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Gastrocnemius Muscle DRG</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Cerebellum</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Odontoblast Cell Bodies</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Taste Epithelial</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">R<sup>10</sup></td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Glomus Cells</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">M<sup>0</sup></td><td align="center">&#x000a0;</td></tr><tr><td align="left">Bronchial (16HBE14o) and Submucosal (Calu-3) Cells</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Colonic (T84) Cells</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Pancreatic (CFPAC) Cells</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Submucous and Myenteric Plexus</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr><tr><td align="left">Intestine DRG</td><td align="center">&#x000a0;</td><td align="center">H</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td><td align="center">&#x000a0;</td></tr></tbody></table></table-wrap>
</p><sec id="s0004-s2001" disp-level="2"><title>Central nervous system</title><p>All ASICs, including ASIC3, are widely expressed within the central and peripheral nervous systems (CNS and PNS, respectively) [<xref rid="cit0025" ref-type="bibr">25</xref>]. In a study involving (mice and naked mole-rats), ASIC3 appears to be most abundantly expressed in the PNS (dorsal root ganglion, DRG) and represents the predominant ASIC isoform (approximately 10-fold higher expression than ASIC1-4) whilst its expression levels in the CNS (spinal cord and various brain regions) are comparable to or lower than other ASIC subunits [<xref rid="cit0049" ref-type="bibr">49</xref>]. This is in contrast with the early observation showing rASIC3 expression being confined to the PNS [<xref rid="cit0027" ref-type="bibr">27</xref>]. However, several studies now support ASIC3 CNS expression, including in the superior cervical ganglia, spinal cord, brain stem [<xref rid="cit0050" ref-type="bibr">50</xref>] and hypothalamus [<xref rid="cit0051" ref-type="bibr">51</xref>], and recent single-cell RNA-sequencing of various mouse brain regions shows that ASIC3 is expressed in numerous brain regions, albeit higher expression being observed in sensory neurones [<xref rid="cit0025" ref-type="bibr">25</xref>]. Both the hypothalamus and hippocampus play a role in emotional behavior [<xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0053" ref-type="bibr">53</xref>], and ASIC3<sup>&#x02212;/-</sup> mice showed reduced aggression and anxiety-like behavior compared to wild-type (WT) mice [<xref rid="cit0054" ref-type="bibr">54</xref>], i.e. CNS expression of ASIC3 is important to brain function.</p><p>By contrast, hASIC3 appears to be more evenly distributed throughout the human nervous system (DRG, spinal cord and brain), with ASIC1a being the most dominant form in DRG [<xref rid="cit0036" ref-type="bibr">36</xref>]. Thus, the relative contribution of ASIC3 in humans compared to rodents with respect to CNS expression might be different. One difference of potential clinical significance is the elevated expression of hASIC3 in GABAergic interneurons of the temporal lobe identified in epileptic patients [<xref rid="cit0055" ref-type="bibr">55</xref>]. This is because inhibition of ASIC3 with the sea anemone <italic>Anthopleura elegantissima</italic> toxin 2 (APETx2), in rat models of epilepsy leads to: shortened latency to seizure, increased incidence of generalized tonic-clonic seizures and significantly decreased frequency of action potential firing in interneurons; thus, ASIC3 may play a protective role through dampening action of potential frequency in post-synaptic neurones [<xref rid="cit0055" ref-type="bibr">55</xref>].</p><p>Whereas the role of ASIC3 in epilepsy is likely linked to modulation of interneuron excitability and general CNS activity, studies in migraine models have proposed a role for ASIC3 in mediating pain, where cortical spreading depression is thought to generate ischemia and a concomitant drop in extracellular pH. Indeed, application of acid to the dura in rats produces hypersensitivity to facial stimulation, which is ameliorated by blocking ASIC3, moreover, dura-innervating sensory neurones express ASIC3 [<xref rid="cit0056" ref-type="bibr">56</xref>].</p></sec><sec id="s0004-s2002" disp-level="2"><title>Peripheral nervous system</title><p>Most ASIC3 research to date has been conducted in rodents, with channel expression predominantly in the PNS [<xref rid="cit0049" ref-type="bibr">49</xref>,<xref rid="cit0057" ref-type="bibr">57</xref>], unlike hASIC3 which is reportedly more equally distributed between CNS and PNS. Hence, most published studies have focused on peripheral ASIC3 expression and the accompanying function in pathophysiology.</p><p>In rat cutaneous sensory neurones, ~60% exhibit ASIC3-like currents (as identified by sensitivity to the ASIC3 inhibitor APETx2) and responded synergistically to mild acidification, hypertonicity, and arachidonic acid; combinatorial stimuli that also increased nociceptor excitability and produced pain [<xref rid="cit0058" ref-type="bibr">58</xref>]. The group went further to show that ASIC3 expression is increased 24&#x000a0;hours after plantar incision, with inhibition of ASIC3 significantly reducing spontaneous, thermal, and postural pain behaviors [<xref rid="cit0059" ref-type="bibr">59</xref>]. The role of ASIC3 in pain in general is further supported by ASIC3<sup>&#x02212;/-</sup> mice displaying a reduced latency to the onset of moderate to high-intensity pain stimuli, in the acetic acid-induced writhing test, hot-plate test and in mechanically induced pain [<xref rid="cit0060" ref-type="bibr">60</xref>]. Moreover, injection of acetic acid (pH ~3.5&#x02013;4.0) or SL-NH2 (a peptide that causes itch) alone to both ASIC3<sup>&#x02212;/-</sup> and WT mice produced no difference in response between genotypes, but a combination of acid and SL-NH2 caused a statistically significant increase in scratching in WT mice compared to ASIC3<sup>&#x02212;/-</sup>, which was ablated by administration of amiloride; subsequent analysis found that SL-NH2 slows the rate of pH 5.0-induced ASIC3 desensitization which may contribute to itch behavior [<xref rid="cit0061" ref-type="bibr">61</xref>]. Thus overall, these data support the role of ASIC3 in cutaneous pain and itch.</p><p>However not all studies support such a key role for ASIC3 in pain. For example, in transgenic dominant-negative ASIC3 mice, Mogil and colleagues [<xref rid="cit0062" ref-type="bibr">62</xref>] observed no difference in sensitivity to heat, but observed an increased response to a mechanical (von Frey and tail-clip test) and chemical/inflammatory (formalin and acetic acid writhing test) stimuli, compared to WT mice, the authors noted this may be attributed to a change in ASIC1a and 2a activity [<xref rid="cit0062" ref-type="bibr">62</xref>]. A further paper also found that ASIC3<sup>&#x02212;/-</sup> mice were hypersensitive to high-intensity thermal stimuli compared to WT mice [<xref rid="cit0063" ref-type="bibr">63</xref>]. One possibility for these conflicting findings is differential dysregulation of alternative ASIC subunits, or other sensory ion channels in different mouse genotypes.</p></sec><sec id="s0004-s2003" disp-level="2"><title>Musculoskeletal system</title><p>The musculoskeletal system is a common point of injury, either as a result of traumatic damage or through pathophysiological conditions (arthritis), both being accompanied by inflammation and pain [<xref rid="cit0064" ref-type="bibr">64</xref>]. As discussed previously, acid evokes pain in humans, and a proportional relationship has been shown to exist between the level of acidity and pain response measured in humans when an acidic buffer was applied to the forearm muscles [<xref rid="cit0065" ref-type="bibr">65</xref>].</p><p>With regard to specific musculoskeletal conditions, RA is an autoimmune disease often marked by intra-articular decreases in pH, aberrant hyaluronan regulation and destruction of bone and cartilage [<xref rid="cit0066" ref-type="bibr">66</xref>]. Under control conditions, it has been shown that mice express ASIC3 in knee joint synoviocytes, but not in primary afferent neurones innervating the knee joint synovium, whereas post-inflammation (induced by carrageenan), ASIC3 coexpression was observed with protein gene product (PGP) 9.5 and calcitonin gene-related peptide (CGRP) in synovium-innervating primary afferent fibers; furthermore, unlike WT mice, ASIC3<sup>&#x02212;/-</sup> mice do not develop secondary mechanical analgesia (in response to von-Frey filaments), but like WT mice do develop primary mechanical hyperalgesia (in response to response to tweezers) [<xref rid="cit0067" ref-type="bibr">67</xref>]. It should be noted that a further study using retrograde tracing has found that ~30% of knee-innervating afferents express ASIC3 under control conditions, which rises to ~50% during inflammation [<xref rid="cit0068" ref-type="bibr">68</xref>], thus afferents innervating non-synovium regions (e.g. bone, menisci, ligaments, etc.) of the knee likely express ASIC3 under control conditions with synovium-innervating neurones also expressing ASIC3 during inflammation. Considering the expression of ASIC3 in both synoviocytes and sensory neurones, development of synovial fluid acidity has the potential to modulate multiple cell types in an ASIC3-dependent manner. Indeed, in fibroblast-like synoviocyte (FLS) cultures isolated from WT mice, exposure to pH 5.5 for 1 hour increased hyaluronan release, by 1.5-fold compared to (physiological) pH 7.4, via increased intracellular calcium [Ca<sup>2+</sup>]<sub>i</sub> [<xref rid="cit0069" ref-type="bibr">69</xref>]. This could be a potential protective mechanism to compensate for the enhanced ASIC3 expression observed in these cells during inflammation. In addition to ASIC3 expressing FLS cells mediating increased [Ca<sup>2+</sup>]<sub>i</sub> in response to acidic pH, the addition of inflammatory mediators such as interleukin 1&#x003b2; (IL-1&#x003b2;) caused an ASIC3-dependent increase in the levels of phospho-extracellular signal-regulated kinase (p-ERK), IL-6 and matrix metalloproteinase mRNA, and ultimately FLS cell death, a cascade that was significantly muted in ASIC3<sup>&#x02212;/-</sup> mice [<xref rid="cit0070" ref-type="bibr">70</xref>]. This observation of IL-1&#x003b2; modulating ASIC3 function is further confirmed in studies in mice showing that induction of ischemia-related myalgia caused an increase in mechanical hypersensitivity and defensive behaviors, which were both attenuated by knock-down of ASIC3 or the IL-1 receptor 1 [<xref rid="cit0071" ref-type="bibr">71</xref>].</p><p>Unlike RA, OA is not an autoimmune condition, but rather involves biomechanical changes in the joint and low-grade inflammation with pain being a key symptom [<xref rid="cit0072" ref-type="bibr">72</xref>]. In rats, using the mono-iodoacetate induced OA model, outside the site of injection there was an increase of both ASIC3 expression in knee joint afferents and weight-bearing pain, effects that plateaued after 3&#x000a0;days, and upon co-administration with the ASIC3-specific blocker APETx2 both changes were diminished [<xref rid="cit0073" ref-type="bibr">73</xref>]. Thus, these results support the findings from RA models showing that the function of ASIC3 appears to be more important in secondary than primary hyperalgesia.</p><p>There are many models used to simulate inflammatory pain in rodents, three key acute models being: complete Freund&#x02019;s adjuvant (CFA), which produces a cell-mediated immune response [<xref rid="cit0074" ref-type="bibr">74</xref>]; carrageenan via a nonimmune-mediated response [<xref rid="cit0075" ref-type="bibr">75</xref>]; and zymosan via an innate immune response [<xref rid="cit0076" ref-type="bibr">76</xref>]. Carrageenan and CFA intra-plantar paw injections have been shown to produce similar degrees of inflammation in WT and ASIC3<sup>&#x02212;/-</sup> mice, however, the inflammation does not directly correlate to the degree of hyperalgesia. Whereas both inflammation models produced a statistically significant difference for mechanical hyperalgesia between genotypes (after 24&#x000a0;hours, i.e. ASIC3<sup>&#x02212;/-</sup> mice showed less hyperalgesia compared to WT), only carrageenan produced a statistically significant thermal hyperalgesia difference (after 24&#x000a0;hours, i.e. ASIC3<sup>&#x02212;/-</sup> mice showed less hyperalgesia compared to WT); furthermore, the ASIC3<sup>&#x02212;/-</sup> displayed a reduction in the inflammatory features (granuloma and vasculitis) of muscle compared to WT by ~65% [<xref rid="cit0077" ref-type="bibr">77</xref>], which may perpetuate differences in hyperalgesia between genotypes. In support of these findings, carrageenan-induced muscle inflammation in WT mice is associated with an increase in ASIC3 mRNA in lumbar DRG neurones, and in the same model, ASIC3<sup>&#x02212;/-</sup> mice develop only primary, but not secondary, muscle hyperalgesia [<xref rid="cit0078" ref-type="bibr">78</xref>]. In a different model of muscle pain, repeated acid injections into the gastrocnemius muscle caused mechanical hyperalgesia in WT mice, but not ASIC3<sup>&#x02212;/-</sup> mice, furthermore, ASIC3<sup>&#x02212;/-</sup> mice did not develop cutaneous mechanical hyperalgesia after muscle inflammation whilst heat hyperalgesia occurred at similar levels to in WT mice [<xref rid="cit0079" ref-type="bibr">79</xref>]. Interestingly, the importance of ASIC3 in muscle mechanical hyperalgesia was reinforced by results showing that injecting an ASIC3-encoding virus (and administration of carrageenan) into the muscle of ASIC3<sup>&#x02212;/-</sup> mice resulted in rescuing of the development of muscle mechanical hyperalgesia like that observed in WT mice, thus demonstrating a key role for ASIC3 in muscle-innervating sensory neurones in this model [<xref rid="cit0080" ref-type="bibr">80</xref>]. Mechanical hyperalgesia is also a prominent consequence of nerve injury. It has been shown that whilst ASIC3<sup>&#x02212;/-</sup> mice showed greater sensitivity to mechanical stimulation compared to WT, in post-spinal nerve ligation of ASIC3<sup>&#x02212;/-</sup> mice showed comparable development of mechanical and heat hyperalgesia to WT mice; thus, ASIC3 appears to play a limited role in neuropathic pain [<xref rid="cit0081" ref-type="bibr">81</xref>]. The role of ASIC3 in neuropathic pain has been further evaluated using the cisplatin model of chemotherapy-induced peripheral neuropathy, which causes hyperalgesia and allodynia in rodents [<xref rid="cit0082" ref-type="bibr">82</xref>], increased expression of ASIC3 being observed in DRG neurones innervating the gastrocnemius muscle, alongside mechanical hyperalgesia, which was ameliorated by the ASIC inhibitor amiloride [<xref rid="cit0083" ref-type="bibr">83</xref>].</p><p>One potential limitation of ASIC3<sup>&#x02212;/-</sup> models is the potential for compensatory upregulation of expression of other acid sensors (e.g. TRPV1 or other ASIC subunits). To address this, a study was conducted employing an artificial miRNA construct (miR-ASIC3) to knock down ASIC3 in a carrageenan-induced muscle inflammation in mice. Using this approach, it was shown that miR-ASIC3 treated mice displayed a reduction in neuronal ASIC3 expression and developed a reduced level of mechanical hyperalgesia compared to WT mice [<xref rid="cit0084" ref-type="bibr">84</xref>].</p><p>Another condition in which musculoskeletal pain plays a key component is chronic fatigue syndrome, which is exacerbated post-exercise. In an investigation of post-exercise pain in chronic fatigue syndrome (CFS) patients, there was a strong correlation between post-exercise pain and increased ASIC3 mRNA expression, additionally, baseline ASIC3 mRNA expression was higher in the CFS patients compared to control [<xref rid="cit0085" ref-type="bibr">85</xref>]. In humans, females report greater muscle pain (e.g. fibromyalgia and myofascial pain syndrome) than males, which has also been found to occur in mice, such that female mice develop hyperalgesia for longer 24-hours post-muscle fatigue and injury compared to male mice, an effect not due to estradiol as demonstrated by removal of ovaries (1 week prior to behavior testing), but it remains to be tested if this reduced hyperalgesia in males may be due to testosterone [<xref rid="cit0086" ref-type="bibr">86</xref>].</p><p>Globally, one of the leading causes of years lived with a disability (126 out of 195 countries) is lower back pain, which has increased in prevalence from 42.5 million in 1990 to 64.9 million in 2017, standardized by age and sex [<xref rid="cit0087" ref-type="bibr">87</xref>]. A theory explaining the pathophysiology in the intervertebral discs that links to the pain experienced is that of increased lactate production (due to anaerobic glycolysis in the muscle) which leads to reduced pH and ultimately neuronal death [<xref rid="cit0088" ref-type="bibr">88</xref>]. Within the inner core of the invertebrate disc is the nucleus pulposus, which sits in a mildly acidic (pH 6.8&#x02013;7.2) [<xref rid="cit0089" ref-type="bibr">89</xref>], hyperosmotic and avascular environment, and under these conditions ASIC3 (expressed by nucleus pulposus cells) serves to promote cell survival and lower the activity of the pro-apoptotic protein, caspase-3; ASIC3 was shown to be positively regulated by NGF via p75NTR and ERK signaling [<xref rid="cit0090" ref-type="bibr">90</xref>], a pathway implicated in neuronal diseases and when inhibited, suppresses neuropathic pain [<xref rid="cit0091" ref-type="bibr">91</xref>]. During degeneration of the rat nucleus pulposus tissue, ASIC3 expression is decreased and there is an elevated level of transforming growth factor beta (TGF-&#x003b2;), which has been proposed to downregulate ASIC3 through the SMAD3 pathway [<xref rid="cit0092" ref-type="bibr">92</xref>]. This protective function of ASIC3 in intervertebral disc degeneration is further supported by the observation that culturing human nucleus pulposus cells under acidic conditions leads to increased apoptosis, which can be prevented through the use of amiloride [<xref rid="cit0093" ref-type="bibr">93</xref>,<xref rid="cit0094" ref-type="bibr">94</xref>].</p><p>Why might it be that ASIC3 appears to be particularly important in mediating muscle pain? One reason could be that there is a higher expression of ASIC3 in muscle than cutaneous afferents, as has been reported in rats, for example, 83% of ASIC3-expressing muscle afferents also expressed the vasodilatory peptide calcitonin gene-related peptide (CGRP) leading to the hypothesis that these afferents may act as muscle metaboreceptors, triggering pain during insufficient oxygen supply to the muscle, such as might occur during exercise [<xref rid="cit0095" ref-type="bibr">95</xref>]. This hypothesis is supported by femoral occlusion induced by arterial ligation of rat hindlimb muscles (i.e. vascular insufficiency) leading to a significant increase in ASIC3 expression in the surrounding muscle-innervating sensory neurones, suggesting that ASIC3 might contribute to the exaggerated sympathetic and pressor responses observed during arterial occlusion due to lactic acid build up [<xref rid="cit0096" ref-type="bibr">96</xref>].</p></sec><sec id="s0004-s2004" disp-level="2"><title>Cardiovascular system</title><p>As described previously, tissue pH can decrease during periods of cardiac ischemia and humans who suffer a heart attack experience severe chest pain, as do those with angina where coronary blood flow decreases and pH is thought to drop. Studies by Sutherland and colleagues [<xref rid="cit0034" ref-type="bibr">34</xref>] demonstrated that sensory neurones innervating the heart were excited by acid and produced currents with similar biophysical properties to those of rASIC3 [<xref rid="cit0034" ref-type="bibr">34</xref>]. Whilst 90% of rat cardiac-innervating DRG neurones had ASIC-like currents, only 50% of cardiac DRG neurones do in mice, but nevertheless, cardiac innervating neurones isolated from ASIC3<sup>&#x02212;/-</sup> mice exhibited a more acidic half-maximal pH of activation compared to WT mice [<xref rid="cit0097" ref-type="bibr">97</xref>]. In rat sensory neurones, ASIC-like currents are sensitized by lactate (a by-product of anaerobic metabolism during cardiac ischemia) due to it chelating Ca<sup>2+</sup> and the same effect is observed with rASIC3 [<xref rid="cit0098" ref-type="bibr">98</xref>]. Lactate shifts the activation curve of ASIC3-like currents in rat cardiac-innervating sensory neurones, such that they display prolonged sustained currents at more basic pH in the presence of lactate [<xref rid="cit0099" ref-type="bibr">99</xref>]. In addition to lactate, it appears that adenosine triphosphate (ATP) is likely involved in sensitizing of ASIC3, activation of P2X5 by ATP resulting in ASIC3 producing larger responses to acid than acid alone [<xref rid="cit0100" ref-type="bibr">100</xref>]. Furthermore, it has been shown that a combination of acid, lactate and ATP is more effective than each individual substance alone at activating muscle-innervating sensory neurones [<xref rid="cit0101" ref-type="bibr">101</xref>]. Thus, it appears that ASIC3 acts as a coincident detector of lactate, ATP and protons to mediate cardiac and skeletal muscle pain.</p><p>At the heart of the cardiovascular system is the requirement of sensing PO<sub>2</sub> and PCO<sub>2</sub> in order to regulate breathing and heart rate and a key part of this system are the carotid bodies. ASIC3 is the highest expressed ASIC isoform in carotid body glomus cells, and is considered to be a key mediator of the carotid body response to extracellular acidosis [<xref rid="cit0102" ref-type="bibr">102</xref>], which can result during hypercapnia. Moreover, spontaneously hypertensive rats display enhanced chemoreceptor sensitivity alongside increased ASIC3 expression in carotid bodies, thus further indicating a key role for ASIC3 in carotid body function [<xref rid="cit0103" ref-type="bibr">103</xref>]. Moreover, there is evidence that ASIC3 is also involved in control of blood pressure, as well as regulating breathing rate. For example, ASIC3<sup>&#x02212;/-</sup> mice have a lower systolic and diastolic blood pressure, coupled with a slightly, but not statistically significant, higher heart rate, as a potential compensatory role, compared to WT mice [<xref rid="cit0104" ref-type="bibr">104</xref>]. The link between ASIC3 and blood pressure regulation is further supported by the human genetic polymorphism rs2288646-A found in Taiwanese individuals, which is associated with a higher frequency of higher systolic and diastolic blood pressure, allele frequency being 9.7% amongst those with hypertension [<xref rid="cit0105" ref-type="bibr">105</xref>]; however, the effect of this polymorphism on channel function or expression is yet to be determined.</p><p>ASIC3-like currents have also been detected in mouse venoatrial junctions nodose neurons, which are low-pressure baroreceptors that detect alterations in central venous pressure and induce the release of atrial natriuretic peptide; in ASIC3<sup>&#x02212;/-</sup> mice when blood volume was increased, urine outflow did not increase, thus, blood volume homeostasis is impaired in the absence of ASIC3 [<xref rid="cit0106" ref-type="bibr">106</xref>].</p><p>With regard to vascular functions of ASIC3, one contributing factor to migraine, as well as hypertension, is impaired activity of vascular smooth muscle cells (VSMC) [<xref rid="cit0107" ref-type="bibr">107</xref>]. Interestingly, VSMC isolated from cerebral arteries of mice express ASIC3 albeit to a lesser extent than other ASIC subunits [<xref rid="cit0108" ref-type="bibr">108</xref>] and thus ASIC3 is expressed in cells whose dysfunction is associated with migraine and hypertension. Additionally, VSMCs are also implicated in wound healing, a function that becomes reduced upon silencing of ASIC3 (~30% decrease after 24&#x000a0;hours) as chemotactic migration was inhibited [<xref rid="cit0109" ref-type="bibr">109</xref>], hence providing further supporting evidence for ASIC3 playing a role in the regulation of VSMC function.</p><p>Lastly, ASIC3 involvement within the vasculature extends to pressure-induced vasodilation, which can lead to ulceration as blood flow is decreased, but ASIC3<sup>&#x02212;/-</sup> mice or those treated with diclofenac/APETx2/amiloride show a reduced change (~25% from baseline) in response to local applied pressure (0 to 0.7 kPa), whilst the WT show a peak increased response by 50% at 0.2 kPa [<xref rid="cit0110" ref-type="bibr">110</xref>]; a protective mechanism of ASIC3 in the presence of pathophysiological vasodilatory effects.</p></sec><sec id="s0004-s2005" disp-level="2"><title>Gastrointestinal system</title><p>Of all bodily tissues, the gastrointestinal (GI) system probably encounters the broadest range of stimuli under healthy conditions, as well as being the site of numerous pathological conditions that disrupt bowel function and can give rise to the sensation of pain. We will now discuss the various regions of the GI tract and the diseases affecting GI function.</p><p>Furthermore, in vagal and glossopharyngeal sensory ganglia, rASIC3 was found to be coexpressed with CGRP and TRPV1 in jugular ganglia (78% and 62%, respectively), less frequent coexpression was observed in petrosal ganglia (28% and 22%, respectively), and coexpression was rare in nodose ganglia (ND, 6% and 1%, respectively) [<xref rid="cit0111" ref-type="bibr">111</xref>]. As in rat, ASIC3 is expressed in mouse vagal and DRG neurones, with ASIC3<sup>&#x02212;/-</sup> mice having a decreased sensitivity of vagal gastro-esophageal tension receptors, colonic mesenteric and colonic serosal mechanoreceptors compared to their WT counterparts [<xref rid="cit0112" ref-type="bibr">112</xref>]. In mouse thoracolumbar DRG neurones, ASIC3 was the least abundant ASIC isoform expressed, but when looking specifically at colonic sensory neurones it was the highest (by 5-fold) [<xref rid="cit0113" ref-type="bibr">113</xref>]. Guinea pigs in comparison to mice display greater levels of ASIC3 (similar to in rats) in vagal esophageal neurones that are putative cell bodies of tension mechanosensors; this interspecies differences also extends to nodose neurones, which follow the same pattern [<xref rid="cit0114" ref-type="bibr">114</xref>]. Thus, ASIC3 is expressed in those sensory neurones compatible with it playing key roles in visceral afferent function and contributing to visceral pain.</p><p>When comparing the acid-sensitivity of rat gastric sensory neurones arising from ND ganglia vs. those from DRG, it was observed that the former displayed biphasic ASIC3-like currents, but had a lower (more acidic) half-maximal pH of activation [<xref rid="cit0115" ref-type="bibr">115</xref>]. Given that ASIC3 is expressed by nociceptors, it may contribute to dyspeptic symptoms which include, abdominal pain. In support of this hypothesis, the hyperresponsiveness observed in mice following induction of increased intragastric acidity was greatly diminished in ASIC3<sup>&#x02212;/-</sup> mice, the sensory importance of ASIC3 being demonstrated by reduced brainstem activity (measured with c-Fos, a marker of neuronal excitation), and thus ASIC3 can be considered a detector of noxious gastric acid secretion [<xref rid="cit0116" ref-type="bibr">116</xref>]. As expected with ASIC3 activity, mouse ND gastric and gastroesophageal ganglia neurones displayed greater currents with increased acidity, pH 4.0 vs pH 7.0 (control); however, whereas ASIC3 appears to play a role in acid sensation, perhaps important during dyspepsia, TRPV1 appeared to play a greater role in broader chemo- and mechanosensation [<xref rid="cit0117" ref-type="bibr">117</xref>].</p><p>A possible role for ASIC3 in Crohn&#x02019;s disease patients is demonstrated by biopsy samples showing a 2.5-fold increased expression of ASIC3, which was hypothesized to contribute toward visceral hypersensitivity in chronic inflammatory pain [<xref rid="cit0118" ref-type="bibr">118</xref>]. More recently, single-cell RNA-sequencing of colonic sensory afferent neurones has identified ASIC3 to be expressed in 3/7 colonic sensory neurone subsets, thus suggesting that it has a distinct role to play in colonic sensory function [<xref rid="cit0026" ref-type="bibr">26</xref>]. Using transgenic mice to investigate a possible role for ASIC3 in gastrointestinal function and the chronic abdominal pain experienced by patients, ASIC3<sup>&#x02212;/-</sup> mice were observed to have a reduction in distention sensitivity of 50%, which would correlate with a reduction in pain [<xref rid="cit0119" ref-type="bibr">119</xref>]. Moreover, zymosan-induced colonic hypersensitivity is blunted in ASIC3<sup>&#x02212;/-</sup> mice [<xref rid="cit0120" ref-type="bibr">120</xref>].</p></sec><sec id="s0004-s2006" disp-level="2"><title>Respiratory system</title><p>In rats, 58% of DRG neurones projecting to pleural and pulmonary tissues displayed ASIC3-like currents [<xref rid="cit0121" ref-type="bibr">121</xref>] and rASIC3-like currents have also been reported in vagal pulmonary sensory neurones [<xref rid="cit0122" ref-type="bibr">122</xref>], thus, sensory neurones are well equipped to respond to tissue acidification associated with respiratory disease via ASIC3. In cystic fibrosis (CF), the cystic fibrosis transmembrane conductor regulator (CFTR) is faulty which leads to airway dysfunction leading to viscous mucous and reoccurring lung infections, and a contributory factor in this dysregulation includes a drop in pH [<xref rid="cit0044" ref-type="bibr">44</xref>]. Human lung tissues show co-expression of CFTR and ASIC3, with ASIC3 levels upregulated in CF lung sections associated with the increased inflammation compared to non-CF tissue; additionally, hASIC3 was found to be co-expressed with CFTR in the following human epithelial cell lines, airway submucosal (Calu-3), bronchial (16HBE14o), colonic (T84) and pancreatic (CFPAC) cells, all from parts of the body that have been shown to develop acidic changes in CF patients [<xref rid="cit0123" ref-type="bibr">123</xref>].</p><p>The most common chronic respiratory disease globally is chronic obstructive pulmonary disorder (COPD) (3.95% prevalence), followed by asthma (3.6% prevalence) [<xref rid="cit0124" ref-type="bibr">124</xref>], and whilst initial research centered around the involvement of muscarinic, tachykinin and bradykinin receptors, emerging data has implicated ASICs in disease pathology, with a drop in pH being associated with inflammatory airway diseases [<xref rid="cit0125" ref-type="bibr">125</xref>]. A characteristic of asthma is reversible bronchoconstriction leading to a difficulty in breathing and coughing, symptoms which can be induced using citric acid in guinea pigs [<xref rid="cit0126" ref-type="bibr">126</xref>]. In the advanced stages of COPD, there is high prevalence (&#x0003e;75%) of pain, breathlessness and fatigue [<xref rid="cit0127" ref-type="bibr">127</xref>], which can be attributed to the characteristic hypoxia associated with the condition. In rats, three days after chronic hypoxia, the petrosal ganglion has been shown to express elevated levels of ASIC3 (no change in superior cervical or sensory nodose ganglion expression); additionally, chronic hypoxia induces an inflammatory cytokine response (IL-1&#x003b2;, IL-6, and TNF-&#x003b1;) which can also increase ASIC3 expression [<xref rid="cit0128" ref-type="bibr">128</xref>]. Interestingly, the cytokine-induced increase in ASIC3 was prevented by concomitant ibuprofen administration and although ibuprofen inhibits ASIC1a, it has no effect upon ASIC3 [<xref rid="cit0129" ref-type="bibr">129</xref>], thus the effect of ibuprofen is most likely due to its disruption of cyclooxygenase mediated signaling pathways.</p></sec><sec id="s0004-s2007" disp-level="2"><title>Genitourinary system</title><p>One of the alternative names for ASIC3 is the testis sodium channel (TNaC), which came about due to its relatively high expression in the human testis and due to only showing 82% amino acid identity with rASIC3 was initially thought to be a distinct ion channel, however, it has since become clear that TNaC and hASIC3 are the same [<xref rid="cit0130" ref-type="bibr">130</xref>]. Interestingly, a case study documents a middle-aged man with testicular pain coupled with testicular ischemia [<xref rid="cit0131" ref-type="bibr">131</xref>]; and thus it is tempting to propose, considering its high testicular expression, that ASIC3 may have been involved in mediating this pain.</p><p>With regard to the excretory side of the genitourinary system, renal-innervating rat DRG neurones displayed ASIC3-like currents (transient and sustained currents at pH 5 and 6), which the authors propose play a role in the vasodilatory effects of inflammatory kidney disease such as hypertension [<xref rid="cit0132" ref-type="bibr">132</xref>]. Further down the excretory route, rat bladder-innervating DRG neurones also display ASIC3-like currents [<xref rid="cit0133" ref-type="bibr">133</xref>] and it is thought that these ASIC3-expressing neurones likely play a role in bladder function because bladder afferents in ASIC3<sup>&#x02212;/-</sup> mice no longer respond to extracellular acidification [<xref rid="cit0134" ref-type="bibr">134</xref>]. Moreover, a common form of bladder irritation is cyclophosphamide-induced cystitis and in rats this is accompanied by increased ASIC3 expression in the urothelium and suburothelia plexus, but not in the detrusor smooth muscle, thus further suggesting a role for ASIC3 in bladder function [<xref rid="cit0135" ref-type="bibr">135</xref>]. By contrast, in humans, bladder biopsies show ASIC3 to be expressed in both detrusor smooth muscle and urothelium, increased levels occurring in those presenting with bladder pain [<xref rid="cit0136" ref-type="bibr">136</xref>]. Lastly, painful urination (dysuria) is a common symptom of urinary tract infections (UTIs), where bacteria, such as <italic>Escherichia coli, Enterococcus faecalis</italic> and <italic>Klebsiella pneumoniae</italic>, increase urine pH to make it less acidic. Thus, depending upon the causative bacterium, urinary pH has been reported to rise from a more acidic range of pH 5&#x02013;7.5 [<xref rid="cit0137" ref-type="bibr">137</xref>], toward the basic range of &#x02265;6.72 in children [<xref rid="cit0138" ref-type="bibr">138</xref>] and &#x02265;6.28 in adults [<xref rid="cit0139" ref-type="bibr">139</xref>]. Considering that hASIC3a is activated by both acidification and alkalinization, and the expression of ASIC3 in bladder afferents, it could well be that hASIC3a plays a role in UTI pain, but this remains to be tested.</p></sec><sec id="s0004-s2008" disp-level="2"><title>Ears, eyes and mouth</title><p>In addition to playing a key role in the somatosensory system, ASIC3 is also expressed in certain sensory organs. For example, in mice ASIC3 is expressed in cochlear spiral ganglion neurones and the organ of Corti [<xref rid="cit0140" ref-type="bibr">140</xref>,<xref rid="cit0141" ref-type="bibr">141</xref>], as well as in the vestibular afferent neurones of rat [<xref rid="cit0142" ref-type="bibr">142</xref>]. With regard to the function of ASIC3 in hearing, ASIC3<sup>&#x02212;/-</sup> mice have normal hearing at birth, but go on to develop hearing loss (4&#x000a0;months post birth); however, the mechanism for this early-onset hearing loss and any potential role of ASIC3 is not fully understood [<xref rid="cit0141" ref-type="bibr">141</xref>]. Functioning auditory capability of mothers is essential for them to respond to vocalization of their pups. The auditory frequency of mice is reduced from 2 to 90&#x000a0;kHz measured in WT mice, to 4&#x02013;32&#x000a0;kHz in ASIC3<sup>&#x02212;/-</sup>, which was coupled with a reduction in maternal care and pup social development (e.g. reduction in anogenital sniffing, whisker to whisker and push under interactions), phenotypes that were accompanied by reduced serotonergic transmission in the hippocampus, striatum, midbrain and brainstem [<xref rid="cit0143" ref-type="bibr">143</xref>]. Lastly, ASICs may also contribute to the ototoxic action of aminoglycosides, such as neomycin and streptomycin. This is because aminoglycosides reduce the desensitization rate of the ASIC-like currents in mouse spiral ganglion neurones, i.e. Na<sup>+</sup> influx is maintained for a longer period, and a known side-effect of these drugs is ototoxicity associated with persistent Na<sup>+</sup> entry [<xref rid="cit0140" ref-type="bibr">140</xref>].</p><p>With regard to a role of ASIC3 in vision, in the mouse retina ASIC3 has been shown to be widely expressed, including the rod inner segment of photoreceptors, horizontal cells, amacrine cells, and retinal ganglion cells [<xref rid="cit0144" ref-type="bibr">144</xref>,<xref rid="cit0145" ref-type="bibr">145</xref>]. This appears to provide a protective longevity role because ASIC3<sup>&#x02212;/-</sup> mice display retinal rod dysfunction and degeneration [<xref rid="cit0144" ref-type="bibr">144</xref>]. In addition, ASIC3 is expressed by sensory neurones innervating the eye where it may act to detect pH changes, such as the acidification observed in rabbit glaucoma models, where consistent high intraocular pressure (&#x0003e;70&#x000a0;mmHg) leads to a drop in pH (7.32 to 7.03) [<xref rid="cit0146" ref-type="bibr">146</xref>].</p><p>Within the mouth, ASIC function has the potential to be involved in both taste and pain sensation. Within odontoblast soma (cells situated on the outer surface of the dental pulp), hASIC3 is expressed at low levels [<xref rid="cit0147" ref-type="bibr">147</xref>]; nevertheless, it may play a role in the transmission of tooth pain [<xref rid="cit0148" ref-type="bibr">148</xref>]. This is because rASIC3 has been observed in 33% of sensory neurones innervating tooth pulp, thus indicating a potential role in dental pain [<xref rid="cit0149" ref-type="bibr">149</xref>]. Similarly, in mice, ASIC3 is expressed in trigeminal ganglion neurones and the periodontal Ruffini, a primary mechanoreceptor, endings [<xref rid="cit0150" ref-type="bibr">150</xref>]. In humans, a case study of two patients showed that they were responsive to bitter, sweet, and salty, but not sour stimuli, an observation that was coupled with ASIC3 being one of a few receptors undetectable in the lingual fungiform papillae of the sour-ageusia patients (others included polycystic kidney disease channels and ASIC1a/1b/2a/2b) [<xref rid="cit0151" ref-type="bibr">151</xref>]. Considering that acid evokes amiloride-sensitive currents in rat vallate taste receptors [<xref rid="cit0152" ref-type="bibr">152</xref>], it can certainly be hypothesized that ASIC3 (perhaps in tandem with other ASICs) is involved in sour taste and thus lack of expression in individuals with sour-ageusia may explain their phenotype.</p></sec><sec id="s0004-s2009" disp-level="2"><title>Bone and bone marrow-derived cells</title><p>Much of the pathophysiological discussion until now has been in relation to the acidosis induced during an inflammatory response, especially in relation to musculoskeletal conditions. However, bone itself can undergo and respond to changes in pH. For example, mild drops in bone pH (pH 7.3&#x02013;6.9) affect the osteoclast&#x02013;osteoblast balance which underpins bone integrity, such that acidity shifts the equilibrium to greater bone degradation and active osteoclasts themselves produce an acidic microenvironment [<xref rid="cit0153" ref-type="bibr">153</xref>]. This adaptation to changes in pH in bone in humans has been linked to ASIC3, with expression established in osteoclasts albeit at relatively low levels in comparison to ASIC1 and ASIC2 [<xref rid="cit0154" ref-type="bibr">154</xref>]. Cancer-associated bone pain (CABP), affects &#x0003e;70% of metastatic bone cancer patients and the role osteoclasts and acidification have been implicated in the pain experienced with ASIC3 implicated being involved in transmission of CABP, such that ASIC3 expression is elevated in rat DRGs with tumor-associated CABP [<xref rid="cit0155" ref-type="bibr">155</xref>].</p><p>In mouse, ASIC3 expression has been documented in bone marrow-derived dendritic cells, with acidosis leading to upregulated expression of CD11c, MHC class II, CD80, and CD86 via ASICs; this effect was abolished the most by diclofenac which blocks ASIC3 selectively, compared to ASIC1a selective ibuprofen and the nonselective ASIC inhibitor amiloride (see modulator section for more details of inhibitors) [<xref rid="cit0156" ref-type="bibr">156</xref>]. Lastly, ASIC-like currents and expression of ASIC3 has also been documents in both microglia [<xref rid="cit0157" ref-type="bibr">157</xref>] and astrocytes [<xref rid="cit0158" ref-type="bibr">158</xref>].</p></sec><sec id="s0004-s2010" disp-level="2"><title>Endocrine system</title><p>Unlike work on the nervous and musculoskeletal systems, there has been little detailed investigation of how ASIC3 might contribute toward endocrine function. However, in an analysis of 606 Taiwanese individuals, 33 possessed the ASIC3 rs2288646A polymorphism and this was associated with a statistically significantly lower frequency of insulin resistance and lower fasting serum insulin levels [<xref rid="cit0159" ref-type="bibr">159</xref>]. With age, glucose tolerance declines and insulin resistance increases (contributing toward a high prevalence of type 2 diabetes in the elderly population) and interestingly ASIC3<sup>&#x02212;/-</sup> mice, as well as wild-type mice administered ASIC3 inhibitors displayed improved glucose intolerance with enhanced insulin sensitivity [<xref rid="cit0160" ref-type="bibr">160</xref>]. In either case, the exact mechanism by which ASIC3 (and the rs2288646A polymorphism) is involved in blood glucose regulation is unknown. Long-term diabetes is associated with diabetic neuropathy, which affects 40&#x02013;50% of diabetics in their lifetime [<xref rid="cit0161" ref-type="bibr">161</xref>,<xref rid="cit0162" ref-type="bibr">162</xref>]. Considering the role of ASIC3 in pain and that lactate levels increase in response to elevated glucose levels (i.e. after meals) [<xref rid="cit0163" ref-type="bibr">163</xref>], this may add to the potential for ASIC3 sensitization to contribute to pain in diabetic neuropathy.</p></sec></sec><sec id="s0005" disp-level="1"><title>Modulation of ASIC3</title><p>As detailed in the preceding sections, ASIC3 is not only the most highly sensitive ASIC subunit to extracellular protons, but is also implicated in a plethora of physiological and pathophysiological conditions that in many cases are directly or indirectly associated with pain. Consequently, there has been significant interest in developing subunit selective ASIC modulators. To date, 49 endogenous and exogenous (<xref rid="t0004" ref-type="table">Table 4</xref>) ASIC3 modulators have been identified that either cause a change in ASIC3 expression or function; excluding the numerous ligand-based screened synthetic Merck compounds, which are discussed in detail in the Amiloride Analogues section. For some of these modulators, the putative binding sites on ASIC3 have been suggested through in silico modeling and/or mutagenesis studies (<xref ref-type="fig" rid="f0004">Figure 4</xref>) and many have been evaluated for their analgesic activity.
<fig id="f0004" fig-type="figure" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Binding regions of ASIC3 Modulators. Proven (co-crystal structures and mutagenesis) and suspected (in silico) binding of agonists (a) and antagonists (b) to the rASIC3 binding regions. The homology model of rASIC3 was built using the published crystal structure of cASIC1a as template (PDB: 2QTS, PMID: 17,882,215); for details of rASIC3 modeling see [<xref rid="cit0200" ref-type="bibr">200</xref>]</p></caption><alternatives><graphic specific-use="web-only" content-type="color" xlink:href="KCHL_A_1852831_F0004_OC"/><graphic specific-use="print-only" content-type="black-white" xlink:href="KCHL_A_1852831_F0004_PB"/></alternatives></fig>
<table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Endogenous and Exogenous Modulators of ASIC3. Categorized into their excitatory/agonist or inhibitory/antagonist effects on the peak transient and sustained currents, data is inclusive of both human and rodent ASIC3. 4-AP &#x02013; 4-aminopyridine, 5-HT &#x02013; Serotonin, AA &#x02013; Arachidonic Acid, ATP &#x02013; Adenosine Triphosphate, DTT &#x02013; 1,4-Dithiothreitol, EGCG &#x02013; (&#x02010;)&#x02010;Epigallocatechin Gallate, GMQ &#x02013; 2-Guanidine-4-methylquinazoline, LPC &#x02013; Lysophosphatidylcholine, NPSF &#x02013; Neuropeptide SF, SNAP &#x02013; S-nitroso-N-acetylpenicillamine, SP &#x02013; Substance P, THP &#x02013; tetrahydropapaveroline, TPEN &#x02013; N,N,N&#x02019;,N&#x02019;&#x02013;tetrakis-(2-piridilmetil)-etilendiamina</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th align="center">Excitatory/Agonist</th><th align="center">Inhibitory/Antagonist</th></tr></thead><tbody><tr><td align="left">Transient</td><td align="left">ATP, DTT, Lactate, Reticuline, SNAP, THP, TPEN</td><td align="left">&#x003b1;-Dendrotoxin, 4-AP, Amiloride, APETx2, BM-21, Ca<sup>2+</sup>, Cd<sup>2+</sup>, CGA, Cu<sup>2+</sup>, Diminazene, EGCG, Gd<sup>3+</sup>, Hcr 1b-1, Ligustrazine, Mg<sup>2+</sup>, Ni<sup>2+</sup>, NS383, Pb<sup>2+</sup> [<xref ref-type="bibr" rid="cit0009">9</xref>,<xref ref-type="bibr" rid="cit0223">223</xref>,<xref ref-type="bibr" rid="cit0223">223</xref>], PhcrTx1, Propofol, Thalassiolin B, Zn<sup>2+</sup></td></tr><tr><td align="left">Sustained</td><td align="left">5-HT, Chloroquine, FMMRamide, NPFF, NPSF, Sephin1, SL-NH2, SP</td><td align="left">Aspirin, Diclofenac Acid, Gastrodin, Salicylic Acid, Tetracaine</td></tr><tr><td align="left">Both</td><td align="left">AA, GMQ, Guanabenz, Agmatine, Arcaine, Hyperosmolarity, Lindoldhamine, LPC, YPFFamide/Endomorphin-2, YPWFamide/Endomorphin-1</td><td align="left">A-317,567, Nafamostat Mesilate, Sevanol, Ugr9-1</td></tr></tbody></table></table-wrap>
</p><sec id="s0005-s2001" disp-level="2"><title>The inflammatory soup</title><p>As discussed previously, tissue acidosis commonly develops in inflammation, but protons are just one of a plethora of mediators present in the inflammatory soup that can activate and sensitize sensory neurones; sensitization being mediated by a mixture of changes in nociceptor gene expression and/or post-translational modification of receptors involved in transducing or transmitting noxious stimuli. For example, it has been shown that the following inflammatory mediators lead to increased ASIC3 transcription in DRG neurones: nerve growth factor (NGF, 7-fold alone vs control), serotonin (5-HT, 10-fold), interleukin-1 (IL-1, 5-fold) and bradykinin (BK, 4-fold) with a combined effect of an 8-fold increase [<xref rid="cit0164" ref-type="bibr">164</xref>]. With regard to post-translational modification of ASIC function, protein kinase C (PKC) stimulation by phorbol 12,13-dibutyrate (PDBu) enhanced amplitudes of rASIC3 currents, but only when co-expressed with ASIC2b, this is because only ASIC2a/b, and not ASIC3, can interact with protein interacting with C kinase-1 (PICK-1), which is necessary for PKC modulation [<xref rid="cit0165" ref-type="bibr">165</xref>]. In sensory neurones it was shown that 5-HT and BK, which activate PKC signaling, are able to potentiate ASIC3-like currents [<xref rid="cit0165" ref-type="bibr">165</xref>].</p><p>Many inflammatory mediators induce increases in [Ca<sup>2+</sup>]<sub>i</sub>, which activate phospholipase A2 (PLA<sub>2</sub>), an enzyme that cleaves membrane phospholipids to produce arachidonic acid (AA), the precursor to prostaglandin production. Although the roles of prostaglandins in nociceptor sensitization and pain are well understood, AA can itself have effects upon nociceptor function, including upon ASIC subunits, including ASIC3, i.e. 50&#x000a0;&#x000b5;M AA potentiates the pH 6.9 induced activation of the rASIC3 transient current 2-fold [<xref rid="cit0166" ref-type="bibr">166</xref>]. Hyperosmolarity (600 mOsmol kg-1) can also occur in inflammation and combined with AA (10&#x000a0;&#x000b5;M) was observed to potentiate (both transient and sustained) ASIC3 currents in DRG neurones (at pH 7.2) by 148% and 547%, respectively [<xref rid="cit0058" ref-type="bibr">58</xref>]. Lysophosphatidylcholine (LPC), like AA, is also hydrolyzed from membrane phospholipids by PLA<sub>2</sub> and activates rASIC3 currents at pH 7.4 with a half-maximal effective concentration (EC<sub>50</sub>) of 4.3 &#x000b5;M, an effect that was proposed to involve binding to the non-proton ligand binding site of ASIC3 [<xref rid="cit0167" ref-type="bibr">167</xref>]. There is also evidence for upregulation of nitric oxide (NO) during inflammation and the NO donor S-nitroso-N-acetylpenicillamine (SNAP) has been shown to potentiate the rASIC3 transient phase at 100 &#x000b5;M in pH 6.9 solution, an effect that appears to involve direct nitrosylation, rather than intracellular signaling cascades [<xref rid="cit0168" ref-type="bibr">168</xref>].</p><p>ATP is also generated during ischemia and released from cells that lyse during inflammation, and, as mentioned previously, is able to sensitize rASIC3-like currents predominantly via activation of P2X5 [<xref rid="cit0100" ref-type="bibr">100</xref>]. As well as inflammatory cells producing pro-inflammatory mediators, cell death leads to substances entering the extracellular space, including protons, ATP and the extracellular concentration of thiols (such as glutathione and sulfhydryl groups, which can be mimicked using dithiothreitol [DTT]) increase. Like AA and NO, DTT (1&#x000a0;mM at pH 6) also potentiates mASIC3 transient currents by 357%, a phenomenon that persisted upon wash out [<xref rid="cit0169" ref-type="bibr">169</xref>]. The group also observed that the metal chelator N,N,N&#x02019;,N&#x02019;-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) behaved in the similar manner, increasing transient mASIC3 currents by 164% (1&#x000a0;mM at pH 6); it was proposed that DTT and TPEN act on a redox-sensitive site on ASIC3. As reported in studies examining the effect of lactate upon ASIC3, which increases ASIC3 currents by chelating Ca<sup>2+</sup>, reducing extracellular Ca<sup>2+</sup>/Mg<sup>2+</sup> concentrations directly increase ASIC3-mediated currents [<xref rid="cit0098" ref-type="bibr">98</xref>,<xref rid="cit0099" ref-type="bibr">99</xref>]. Lactate, which is also released in ischemia, (at pH 7.0, 15&#x000a0;mM in vitro) increased the transient amplitudes of rASIC3 by 70%, this amplitude effect was replicated in the absence of lactate with dual reductions of extracellular Ca<sup>2+</sup> (&#x00394; 0.29&#x000a0;mM) and Mg<sup>2+</sup> (&#x00394; 0.12&#x000a0;mM) concentrations [<xref rid="cit0098" ref-type="bibr">98</xref>]. Given the lactate amplitude effects were negated by increasing Ca<sup>2+</sup> (&#x00394; 0.35&#x000a0;mM) and Mg<sup>2+</sup> (&#x00394; 0.12&#x000a0;mM) concentrations, it is likely that lactate&#x02019;s mechanism of action is through chelating divalent cations.</p></sec><sec id="s0005-s2002" disp-level="2"><title>Analgesics</title><p>One class of commonly taken over the counter, and also widely prescribed, analgesics are non-steroidal anti-inflammatory drugs (NSAIDs), which inhibit cyclooxygenase (COX) enzymes to reduce prostaglandin production and thus relieve pain by preventing the sensitizing effects of prostaglandins upon sensory neurones. However, it has also been shown that COX-independent mechanisms exist that contribute to the analgesic effect of NSAIDs [<xref rid="cit0170" ref-type="bibr">170</xref>]. The Lazdunski lab observed that inflammation of rat hindpaws significantly upregulated the mRNA levels of some ASIC subunits (ASIC1a, ASIC2b, and ASIC3) in rat DRG neurones and that this could largely be suppressed by corticosteroids, as well as by some NSAIDS [<xref rid="cit0129" ref-type="bibr">129</xref>]. They further investigated if there were any direct effects of NSAIDs on ASIC subunits when expressed in CHO cells and observed that certain NSAIDs, at high micromolar concentrations, could inhibit ASIC currents in a somewhat isoform-selective manner. Interestingly, salicylic acid (IC<sub>50</sub> of 260&#x000a0;&#x000b1;&#x000a0;21&#x000a0;&#x003bc;M, <xref ref-type="fig" rid="f0005">Figure 5a</xref>), aspirin (IC<sub>50</sub> not specified, <xref ref-type="fig" rid="f0005">Figure 5b</xref>), and diclofenac (IC<sub>50</sub> of 92&#x000a0;&#x000b1;&#x000a0;19&#x000a0;&#x003bc;M, <xref ref-type="fig" rid="f0005">Figure 5c</xref>) inhibited the sustained current component of ASIC3 but not the transient component, whereas the ASIC1a current was inhibited by ibuprofen (IC<sub>50</sub> not specified) and flurbiprofen (IC<sub>50</sub> of 349&#x000a0;&#x000b1;&#x000a0;40&#x000a0;&#x003bc;M) only. A range of other NSAIDs, namely piroxicam, etodolac, nimesulide, naproxen indomethacin and acetaminophen had no effect on either ASIC1a or ASIC3. However, subsequent work from Pless lab established that ibuprofen and some of its analogues could inhibit the transient currents of ASIC3 albeit with very weak potency, i.e. ibuprofen had an IC<sub>50</sub> of 51.3 mM (<xref ref-type="fig" rid="f0005">Figure 5d</xref>) at pH 6.4 [<xref rid="cit0171" ref-type="bibr">171</xref>]. Using site-directed mutagenesis, they identified a region comprising the upper of transmembrane helices and extracellular domain &#x003b2;9-&#x003b1;4 loop of rASIC1a to be the main site of ibuprofen binding. Most of the key residues identified for ibuprofen recognition are largely conserved across rASIC1a, rASIC1b, and rASIC2a, but rASIC3 has different residues in two key positions namely Thr in place of Lys76 (K76T) and has Ala in place of a critical Lys (K422A). It is intriguing to note that despite these amino acid differences, ibuprofen&#x02019;s potency for inhibiting the ASIC3 peak current was comparable to that for inhibiting ASIC1a (IC<sub>50</sub> of 29.5&#x000a0;mM), which suggests that other binding regions are likely involved.
<fig id="f0005" fig-type="figure" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Structures of Analgesics and Anesthetic Modulators of ASIC3. THP &#x02013; Tetrahydropapaveroline. Structures were produced in MarvinSketch</p></caption><graphic content-type="black-white" xlink:href="KCHL_A_1852831_F0005_B"/></fig></p><p>The structural determinants for the inhibition of ASIC3&#x02019;s sustained current by salicylic acid, aspirin, and diclofenac remain unknown. In outside-out patches, extracellular application of aspirin or salicylic acid inhibits ASIC3, thus making a direct interaction with an extracellular region of ASIC3 highly likely. In addition, the reversibility of aspirin&#x02019;s inhibition, as well as inhibition by salicylic acid, suggest that such ASIC3 inhibition by these specific NSAIDS does not involve acetylation [<xref rid="cit0129" ref-type="bibr">129</xref>]. However, employing salicylic acid or high dose salicylates to block ASIC3 and reduce pain is not a clinical option as high doses and/or chronic exposure causes tinnitus and sepsis-like disease [<xref rid="cit0172" ref-type="bibr">172</xref>].</p><p>Like NSAIDs, local anesthetics can also be prescribed to relieve pain and act primarily through inhibition of voltage-gated sodium channels, but in a similar manner to certain NSAIDs, some anesthetics inhibit ASIC3. For example, tetracaine (<xref ref-type="fig" rid="f0005">Figure 5e</xref>) inhibits ASIC3 transient currents in a pH-dependent manner with an IC<sub>50</sub> of 9.96&#x000a0;mM (at pH 4.5), with concentrations &#x02265; 3&#x000a0;mM also partially inhibiting the sustained current (at pH 4.5 and 6) [<xref rid="cit0173" ref-type="bibr">173</xref>]. The general anesthetic propofol (<xref ref-type="fig" rid="f0005">Figure 5f</xref>) also inhibits ASIC-like currents in sensory neurones, as well as the transient currents mediated by both rASIC1a and rASIC3, albeit in all cases that only ~20% inhibition was observed [<xref rid="cit0174" ref-type="bibr">174</xref>].</p><p>Unlike NSAIDs, opioids are primarily prescribed to control pain, having a very limited role on inflammation. Whereas NSAIDs inhibit ASIC3, tetrahydropapaveroline (THP, <xref ref-type="fig" rid="f0005">Figure 5g</xref>), a precursor of endogenous morphine biosynthesis, activates both hASIC3 (EC<sub>50</sub> of 24.86&#x000a0;mM) and rASIC3 (EC<sub>50</sub> of 17.23&#x000a0;mM), with another precursor, reticuline (<xref ref-type="fig" rid="f0005">Figure 5h</xref>), having a similar activating effect on hASIC3 (EC<sub>50</sub> of 0.56&#x000a0;mM), all at pH 5.5 [<xref rid="cit0175" ref-type="bibr">175</xref>]. The effect of THP on the transient component was much larger in hASIC3 vs rASIC3 (5.5-fold at pH 5.5), such interspecies variation may be due to a baseline difference in the half-maximal pH for activation of the transient current, rASIC3&#x000a0;=&#x000a0;pH 7.20 and hASIC3&#x000a0;=&#x000a0;pH 7.67 [<xref rid="cit0175" ref-type="bibr">175</xref>]. Additionally, the endogenous opioid peptides, endomorphin-1 (YPWFamide) and endmorphin-2 (YPFFamide) have been observed to potentiate (both transient and sustained phases) mASIC3 in L-cells (a &#x0fb01;broblast cell line) [<xref rid="cit0176" ref-type="bibr">176</xref>].</p><p>A non-pharmacological method of pain control is the use of cryo/heat-therapy, which is used and marketed for relief of muscle pain. Whilst temperature does not directly stimulate nor inhibit mASIC3 activity, reducing the temperature from 34&#x000b0;C to 6&#x000b0;C slowed the rate of (pH 4-induced) desensitization [<xref rid="cit0177" ref-type="bibr">177</xref>]. A similar effect was observed in rat DRG neurones where increasing the temperature (from 22&#x000b0;C to 50&#x000b0;C) accelerated the rate of desensitization [<xref rid="cit0178" ref-type="bibr">178</xref>]; given that the pH used was pH 6.8 and that a biphasic current observed, this effect is most likely attributable to rASIC3. Additionally, it has been demonstrated that the half-maximal activation pH becomes more acidic (pH 6.73 to 6.66) as temperature was increases (25&#x000b0;C to 35&#x000b0;C) [<xref rid="cit0179" ref-type="bibr">179</xref>].</p></sec><sec id="s0005-s2003" disp-level="2"><title>Amiloride</title><p>Waldmann and colleagues [<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0027" ref-type="bibr">27</xref>] first showed that ASIC3 is sensitive to amiloride (<xref ref-type="fig" rid="f0006">Figure 6a</xref>) and its derivatives benzamil and ethylisopropylamiloride (EIPA), all of which are nonselective blockers of ion channels in the ENaC/DEG superfamily; interestingly, these compounds strongly inhibit the transient component of ASIC3 current whilst mildly potentiating the sustained component. Clinically, amiloride is prescribed as an antihypertensive medication with classification as a K<sup>+</sup> sparing diuretic due to its effects upon ENaC in the nephron [<xref rid="cit0180" ref-type="bibr">180</xref>], thus, amiloride has limited potential as an analgesic due to diuresis being an unwanted side effect. A further disadvantage is that amiloride can cross the blood&#x02013;brain barrier (BBB) and hence there is also potential for side effects resulting from central inhibition of centrally expressed ASICs. Lastly, the lack of selectivity across ASIC isoforms at comparable concentrations to those that inhibit other ion channels and transporters limits the potential of amiloride directly being used to target ASICs to relieve pain [<xref rid="cit0181" ref-type="bibr">181&#x02013;183</xref>].
<fig id="f0006" fig-type="figure" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Structures of Amiloride and Other Synthetic Inhibitors of ASIC3. &#x0201c;Compounds&#x0201d; are developed by Merck Research Laboratories. Structures were produced in MarvinSketch</p></caption><graphic content-type="black-white" xlink:href="KCHL_A_1852831_F0006_B"/></fig></p><p>To try and further determine how amiloride interacts with ASICs, Gouaux and colleagues saturated cASIC1a with mitotoxin A (MitTx, PDB 4NTX, see <italic>Toxins and peptides</italic> section) and identified two different locations for amiloride binding: the acidic pocket of the extracellular domain and the fenestration between adjacent subunits, partially occluding the pore region [<xref rid="cit0184" ref-type="bibr">184</xref>]. These sites are conserved between ASIC1a and ASIC3 and are likely to represent the binding sites for amiloride on ASIC3 too. Interestingly, attenuation of ASIC3 currents was observed with a high amiloride concentration (200&#x000a0;&#x003bc;M) at highly acidic pH (pH 4) [<xref rid="cit0005" ref-type="bibr">5</xref>], but the same concentration paradoxically enhanced currents at neutral pH (pH 7) [<xref rid="cit0099" ref-type="bibr">99</xref>]. The structural basis of such enhancement of ASIC3 current by amiloride remains unclear but Xu and Colleges have suggested, using site-directed mutagenesis, that the observed effect was dependent on the integrity of the non-proton ligand-sensing domain in ASIC3 [<xref rid="cit0185" ref-type="bibr">185</xref>].</p></sec><sec id="s0005-s2004" disp-level="2"><title>Synthetic non-amiloride inhibitors</title><p>Abbott Laboratories reported A-317,567 (<xref ref-type="fig" rid="f0006">Figure 6b</xref>) as the first small molecule blocker of native and recombinant ASICs, including ASIC3 [<xref rid="cit0186" ref-type="bibr">186</xref>]. This molecule is peripherally active and ~4 times more potent against ASIC3 than amiloride with an in vitro IC<sub>50</sub> of 9.5&#x000a0;&#x000b5;M (at pH 4.5) and an in vivo analgesic effect from 9&#x000a0;&#x000b5;mol/kg (in rats). Importantly, A-317,567 showed potent analgesic effects in rat models of inflammatory and post-operative pain without affecting the urine output (at concentrations up to 30&#x000a0;&#x000b5;mol/kg), as well as crossing the BBB (&#x0003c;20-fold concentration vs periphery) [<xref rid="cit0186" ref-type="bibr">186</xref>]. Abbott however did not disclose any detailed evolution including the chemical starting point and structure-activity relationship (SAR). The CNS penetration and thus potential for therapeutic and/or side effects was further evaluated, specifically the anxiolytic effect with mixed effects being observed [<xref rid="cit0187" ref-type="bibr">187</xref>].</p><p>Several years later, a group of scientists from Merck modified A-317,567 in the region that links the amidine moiety which is found to be critical for inhibition of ASIC3, and an evaluation of a series of indole amidines modified at the 2-position of the indole ring led to the discovery of a potent ASIC3 blocker, &#x0201c;compound 9g&#x0201d; (IC<sub>50</sub>&#x000a0;=&#x000a0;490&#x000a0;nM, <xref ref-type="fig" rid="f0006">Figure 6c</xref>), which at 10&#x02013;30 mg/kg produced similar analgesic effects to naproxen (20 mg/kg) in CFA-induced mechanical hyperalgesia [<xref rid="cit0188" ref-type="bibr">188</xref>]. The same group continued to explore the SAR around A-317,567 and linked the 2-napththimidamide and tetrahydroisoquinoline moieties and produced several derivatives. The compound with an acetylenic linkage (&#x0201c;compound 10b&#x0201d;, <xref ref-type="fig" rid="f0006">Figure 6d</xref>) was also highly potent (IC<sub>50</sub>&#x000a0;=&#x000a0;356&#x000a0;nM) ASIC3 channel blocker, which was also found to reverse mechanical hypersensitivity in the rat iodoacetate model of OA, although sedation was noted [<xref rid="cit0189" ref-type="bibr">189</xref>]. Sedation was also observed in ASIC3<sup>&#x02212;/-</sup> mice, suggesting that sedation (and thus possibly also analgesia) are mediated independent of ASIC3 inhibition [<xref rid="cit0189" ref-type="bibr">189</xref>]. To identify novel chemical scaffolds against ASIC3, Merck also carried out a high-throughput electrophysiological screening of their proprietary fragment library. From the initial hits, subsequent optimization led to significant improvement of potency (0.7&#x000a0;mM to 3&#x000a0;&#x003bc;M) with retention of good ligand efficiency and incorporation of reasonable physicochemical properties, off-target profile, and pharmacokinetics in rats [<xref rid="cit0190" ref-type="bibr">190</xref>]. The best lead compound (&#x02018;compound 24&#x02019;, <xref ref-type="fig" rid="f0006">Figure 6e</xref>) from this fragment-based approach had an IC<sub>50</sub> of 3.1&#x000a0;&#x003bc;M when measured in vitro, but to date there has been no evaluation of this or other compounds from this (late 2010) report against pain in in vivo models.</p><p>Whilst the work from Abbott and Merck has led to the development of small-molecule inhibitors of ASIC3, they have lacked selectivity. Since then, the availability of cASIC1a crystal structures, which were not available at the time of conducted research, could aide a structure-based approach, as opposed to the ligand-based approach employed so far, to develop a selective inhibitor.</p></sec><sec id="s0005-s2005" disp-level="2"><title>Non-proton ligand activation</title><p>As its name indicates, the primary activator of ASIC3 is protons, but both endogenous and exogenous compounds have been identified that can modulate ASIC3 independently of protons. The first of these to be identified was 2-guanidine-4-methylquinazoline (GMQ, <xref ref-type="fig" rid="f0007">Figure 7a</xref>), a small, nitrogen-rich compound, which activates homomeric rASIC3 at 100&#x000a0;&#x000b5;M at neutral pH 7.4 by binding to the non-proton ligand sensing domain encompassing Glu79 and Glu423 [<xref rid="cit0191" ref-type="bibr">191</xref>]. GMQ has an EC<sub>50</sub> of 680&#x000a0;&#x000b5;M (in rASIC3 at pH 7.4), compounds with related structures guanabenz and sephin1 having an EC<sub>50</sub> for activation at neutral pH of 67.5&#x000a0;&#x000b5;M and 1220&#x000a0;&#x000b5;M, respectively; in addition, GMQ and guanabenz enhanced transient and sustained phases of acid-activation of ASIC3 [<xref rid="cit0192" ref-type="bibr">192</xref>]. Another guanidine-based compound is 4-chlorophenylguanidine (4-CPG, <xref ref-type="fig" rid="f0007">Figure 7b</xref>), which has been shown to increase the ASIC3 half-maximal pH activation from 6.79 to 7.12; but only at a very high concentration of 1&#x000a0;mM [<xref rid="cit0193" ref-type="bibr">193</xref>]. Lastly, a structure similar to GMQ, is chloroquine (CQ, <xref ref-type="fig" rid="f0007">Figure 7c</xref>), which has also been shown to increase only the sustained rASIC3 currents at pH 7 (EC<sub>50</sub> 435.2&#x000a0;&#x000b5;M), an effect largely abolished if Glu79 is mutated and completely abolished if Glu423 is mutated; excitingly, CQ-induced itching behavior in mice was ablated by the ASIC3 blocker APETx2 [<xref rid="cit0194" ref-type="bibr">194</xref>].</p><p>Agmatine, (an arginine metabolite, structurally similar to GMQ) and arcaine (an analogue of agmatine) have also been shown to activate ASIC3 at pH 7.4 through interaction with the non-proton sensing domain, also referred to as the palm domain region of the receptor [<xref rid="cit0195" ref-type="bibr">195</xref>]. However, both arcaine (<xref ref-type="fig" rid="f0007">Figure 7d</xref>) and agmatine (<xref ref-type="fig" rid="f0007">Figure 7e</xref>) had the greatest effect (on both transient and sustain phase currents) at pH 5.0, increasing currents by 20% (EC<sub>50</sub>&#x000a0;=&#x000a0;1.2&#x000a0;mM) and 7% (EC<sub>50</sub>&#x000a0;=&#x000a0;9.7&#x000a0;mM), respectively. Given that inflammation increases both ASIC3 and agmatine expression [<xref rid="cit0196" ref-type="bibr">196</xref>], these in vitro results demonstrate that interaction between agmatine and ASIC3 could have in vivo significance in relation to pain.</p><p>Lastly, the non-proton sensing domain has also been recognized as the binding region for 5-HT (<xref ref-type="fig" rid="f0007">Figure 7f</xref>), which enhances the sustained current under acidic conditions with an EC<sub>50</sub> of 41.2&#x000a0;&#x000b5;M at pH 5.0 [<xref rid="cit0197" ref-type="bibr">197</xref>], an effect independent of any signaling through 5-HT receptors.
<fig id="f0007" fig-type="figure" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Structures of Non-Proton Ligand Activating Modulators of ASIC3. GMQ &#x02013; 2-guanidine-4-methylquinazoline, 4-CPG &#x02013; 4-chlorophenylguanidine. Structures were produced in MarvinSketch</p></caption><graphic content-type="black-white" xlink:href="KCHL_A_1852831_F0007_B"/></fig></p></sec><sec id="s0005-s2006" disp-level="2"><title>Toxins and peptides</title><p>In addition to endogenous modulators, a range of exogenous poisons and toxins have been identified as modulators of ASIC3. To date, the sea anemone <italic>Anthopleura elegantissima</italic>-derived toxin APETx2 (<xref ref-type="fig" rid="f0008">Figure 8a</xref>), is the most potent rASIC3 inhibitor with an IC<sub>50</sub> of 63&#x000a0;nM; although less potent against hASIC3 with an IC<sub>50</sub> of 175&#x000a0;nM [<xref rid="cit0198" ref-type="bibr">198</xref>]. Although APETx2 has been used in various animal studies, e.g. subcutaneous administration reduced acid-evoked paw flinching [<xref rid="cit0058" ref-type="bibr">58</xref>] and intraarticular administration ameliorated OA pain [<xref rid="cit0073" ref-type="bibr">73</xref>], being a 42 amino acid peptide makes it inappropriate for systemic use due to it being prone to rapid degradation. Moreover, it is also not selective for ASIC3 homomers, but rather also inhibits certain ASIC3 containing heteromers (1a/1b/2b), as well as inhibiting the voltage-gated sodium channel NaV1.8 [<xref rid="cit0198" ref-type="bibr">198</xref>,<xref rid="cit0199" ref-type="bibr">199</xref>]. Through in silico methods, there have been two predicted sites of interaction, the base of the thumb and the base of the palm [<xref rid="cit0200" ref-type="bibr">200</xref>], but this has not yet been functionally proven.</p><p>The sea anemone toxin polypeptide &#x003c0;-AnmTX Hcr 1b-1 (<xref ref-type="fig" rid="f0008">Figure 8b</xref>), can be extracted from <italic>Heteractis crispa</italic> and has a similar amino acid identity to APETx2 (49%), also being found to inhibit the transient phase with an IC<sub>50</sub> of 5.5&#x000a0;&#x000b5;M at pH 4 [<xref rid="cit0201" ref-type="bibr">201</xref>]. Another sea anemone toxin is PhcrTx1 (<xref ref-type="fig" rid="f0008">Figure 8c</xref>), extracted from <italic>Phymanthus crucifer</italic>, which partially inhibits acid-evoked currents (&#x02264;44%) with an IC<sub>50</sub> of 100&#x000a0;nM, however, this was conducted in DRG neurones and thus the effect may not be specific to only inhibition of homomeric ASIC3 [<xref rid="cit0202" ref-type="bibr">202</xref>]. Lastly, Ugr9-1 (<xref ref-type="fig" rid="f0008">Figure 8d</xref>) is a further sea anemone toxin extracted from <italic>Urticina grebelnyi</italic> and completely inhibited the transient component of hASIC3 currents, at pH 5.5 (IC<sub>50</sub> of 10&#x000a0;&#x003bc;M), as well as partially inhibiting the amplitude of the sustained component (IC<sub>50</sub> of 1.44&#x000a0;&#x003bc;M); however, whilst APETx2 inhibits NaV1.8 and PhcrTx1 inhibits voltage-gated K<sup>+</sup> channels, such inhibition was not observed with Ugr9-1 [<xref rid="cit0203" ref-type="bibr">203</xref>,<xref rid="cit0204" ref-type="bibr">204</xref>].</p><p>Conversely, unlike sea anemone toxins, venom from the Texas coral snake (<italic>Micrurus tener</italic>, MitTx, <xref ref-type="fig" rid="f0008">Figure 8e</xref>), potentiates ASIC3 (EC<sub>50</sub>&#x000a0;=&#x000a0;830&#x000a0;nM), although this effect was weaker than that observed with other ASIC subunits, ASIC1a and ASIC1b requiring a &#x0223c;100-fold lower concentration of MitTx for potentiation [<xref rid="cit0205" ref-type="bibr">205</xref>]; the combined effects of MitTx on multiple ASICs makes interpreting data from neuronal recordings and behavioral studies complicated. cASIC1a crystal structures (PDB Identifiers 4NTW, 4NTX and 4NTY) were made in complex with MitTx (and amiloride), showing that the binding region was similar to that predicted by Rahman and Smith (2014) for APETx2, which is interesting considering the opposing effects of APETx2 and MitTx [<xref rid="cit0184" ref-type="bibr">184</xref>]. Interestingly, &#x003b1;-Dendrotoxin (&#x003b1;-DTx, <xref ref-type="fig" rid="f0008">figure 8f</xref>), which comes from the eastern green mamba snake <italic>Dendroaspis angusticeps</italic>, inhibits acid-gated currents in DRG neurones (IC<sub>50</sub> of 0.8&#x000a0;&#x000b5;M, at pH 6.1) and although the currents were characteristic of ASIC3, this effect should be considered as nonselective ASIC inhibition before further characterization of effects against ASIC3 in a recombinant expression system; there is also evidence that &#x003b1;-DTx inhibits certain voltage-gated K<sup>+</sup> channels (1.1, 1.2 and 1.6), thus the toxin has nonselective actions [<xref rid="cit0206" ref-type="bibr">206</xref>].
<fig id="f0008" fig-type="figure" orientation="portrait" position="float"><label>Figure 8.</label><caption><p>Structures of Toxin Peptide Modulators of ASIC3. &#x003b1;-DTx &#x02013; alpha-Dendrotoxin. APETx2 obtained from PDB 1WXN, Ugr9-1 obtained from PDB 2LZO, and &#x003b1;-DTx obtained from PDB 1DTX. Hcr 1b-1 (Uniprot: P0DL87), PhcrTx1 (Uniprot: C0HJB1) and MitTx (Uniprot: G9I929) 3D homology models were developed in SWISS-MODEL using the nearest sequence template. Structures were previewed in UCSF Chimera</p></caption><alternatives><graphic specific-use="web-only" content-type="color" xlink:href="KCHL_A_1852831_F0008_OC"/><graphic specific-use="print-only" content-type="black-white" xlink:href="KCHL_A_1852831_F0008_PB"/></alternatives></fig></p><p>In addition to peptide toxins, certain neuropeptides have also been established as ASIC3 potentiators, but not direct activators. For example, the invertebrate abundant FMRF-amide and mammalian related neuropeptide (NP) FF (NPFF), slowed the inactivation time constant of the pH 4-evoked rASIC3 transient current, but increased the amplitude of the sustained current when applied at 50&#x000a0;&#x000b5;M [<xref rid="cit0207" ref-type="bibr">207</xref>]. A further mammalian peptide, neuropeptide SF (NPSF) displays similar potency to NPFF, again effects only being significant upon the sustained current [<xref rid="cit0208" ref-type="bibr">208</xref>]. A further peptide, RPRFamide (RPRFa), isolated from the venom of the cone snail <italic>Conus textile</italic>, showed similar characteristics to NPFF and NPSF, slowing desensitization of rASIC3 with an EC<sub>50</sub> of 4.23&#x000a0;&#x000b5;M (pH 6.3), as well as enhancing acid-induced pain [<xref rid="cit0209" ref-type="bibr">209</xref>]. Through site-directed mutagenesis of ASIC3, RPRFa was shown to interact with the lower palm domain (the non-proton sensing domain) of ASIC3 [<xref rid="cit0210" ref-type="bibr">210</xref>] and extensive analysis identified numerous beta sheet regions of the palm domain to be involved in rASIC3 current kinetics: Leu77, Glu79, Gln269, Gln271, Arg376, Ala378, Glu380 and Glu423.</p><p>Lastly, the anti-nociceptive peptide nocistatin, which is produced by neuronal cells and neutrophils, has been shown to reduce the speed of activation (49%), amplitude (18%) and the rate of desensitization (32%) of the rASIC3 transient current [<xref rid="cit0211" ref-type="bibr">211</xref>]. Therefore, it is possible that at least some of the anti-nociceptive effect of nocistatin is through inhibition of ASIC function.</p></sec><sec id="s0005-s2007" disp-level="2"><title>Natural products</title><p>There is a growing public interest and endorsement for the use of complementary and alternative medicines for disease management [<xref rid="cit0212" ref-type="bibr">212</xref>]. Commonly prescribed plant-based derivatives include opiates (e.g. morphine from <italic>Papaver somniferum</italic>) for pain relief, digoxin (<italic>Digitalis lanata</italic>) for atrial fibrillation/flutter, and quinine (Cinchona) for malaria/muscle cramps. There are doubtless other pharmacological actions awaiting to be discovered from studying plant-derivatives and the question is, for the purpose of this review at least, do any modulate ASIC3?</p><p>The first such compound to be identified is lignan sevanol (<xref ref-type="fig" rid="f0009">Figure 9a</xref>), extracted from thyme (<italic>Thymus armeniacus</italic>), which is a reversible blocker of hASIC3, acting independently of the pH stimulus used (from 5.5 to 6.5), and completely blocks the transient component (IC<sub>50</sub> of 353&#x000a0;&#x000b5;M), as well as partially inhibiting the amplitude of the sustained component (IC<sub>50</sub> of 234&#x000a0;&#x000b5;M) [<xref rid="cit0213" ref-type="bibr">213</xref>]. In addition to the effects of sevanol on hASIC3, a synthetic analogue, a stereoisomer, and a precursor compound that represents half of the sevanol molecule were tested, all of which showed a marked reduction in inhibition of hASIC3 [<xref rid="cit0214" ref-type="bibr">214</xref>].</p><p>Ligustrazine (<xref ref-type="fig" rid="f0009">Figure 9b</xref>), is a Chinese traditional medicine used to promote blood flow (menstruation and headaches) and treat inflammatory conditions (boils and carbuncles), which is extracted from the roots of <italic>Ligusticum striatum</italic>. With regard to modulation of ASIC function, ligustrazine decreases ASIC3-like transient currents, at pH 5&#x02013;6.5 with an IC<sub>50</sub> of 239.5 m&#x0039c;, but had a greater potency against ASIC1a/1b/2a (IC<sub>50</sub> of 60&#x02013;130&#x000a0;&#x000b5;M) [<xref rid="cit0215" ref-type="bibr">215</xref>]. By contrast, the natural tea flavonoid (-)-epigallocatechin gallate (EGCG, <xref ref-type="fig" rid="f0009">Figure 9c</xref>) is more potent and selectively inhibits ASIC3 with an IC<sub>50</sub> of 13.2&#x000a0;&#x000b5;M at pH 5; injection of 100&#x000a0;&#x000b5;mol/L also significantly attenuated acid-induced pain responses in mice [<xref rid="cit0216" ref-type="bibr">216</xref>]. Another herbal medicine used for headaches is gastrodin (<xref ref-type="fig" rid="f0009">Figure 9d</xref>), a constituent of <italic>Gastrodia elata</italic>, which inhibits the amplitude of ASIC-like currents in DRG neurones (IC<sub>50</sub> 21&#x000a0;&#x000b5;M, at pH 5.5) and attenuates acetic acid evoked pain [<xref rid="cit0217" ref-type="bibr">217</xref>]. Another Chinese medicine is paeoniflorin (PF), extracted from <italic>Paeoniae alba</italic> and used to treat conditions associated with neuronal damage (i.e. stroke and Parkinson&#x02019;s disease), which has been shown to reduce the expression of rASIC3 in PC12 cells (a DRG-like cell line) [<xref rid="cit0218" ref-type="bibr">218</xref>].</p><p>Furthermore, the extract BM-21, from sea grass <italic>Thalassia testudinum</italic>, and thalassiolin B (a pheloic component of the extract, <xref ref-type="fig" rid="f0009">Figure 9e</xref>) are both able to inhibit peak amplitudes of rASIC currents in DRG neurons (at pH 6.1 IC<sub>50</sub> values were 720&#x000a0;&#x003bc;g/mL and 27&#x000a0;&#x003bc;M, respectively), as well as attenuating mouse pain behavior induced by acetic acid or formalin [<xref rid="cit0219" ref-type="bibr">219</xref>]. In a similar manner, chlorogenic acid (CGA, a natural organic structure common in plants, <xref ref-type="fig" rid="f0009">Figure 9f</xref>), inhibits transient acid-evoked currents in DRG neurones with an IC<sub>50</sub> of 23.5&#x000a0;&#x000b5;M, given rASIC3 is predominant in rat DRG neurone and the nature of the biphasic currents measured, the inhibition observed with CGA is likely due to ASIC3 inhibition; localized injections (1&#x02013;10&#x000a0;&#x000b5;M) also attenuated acetic-acid-induced pain behavior [<xref rid="cit0220" ref-type="bibr">220</xref>]. In a prior neuropathic behavior study in rats, 200 mg/kg IP injections of CGA produced a similar effect to the analgesic gabapentin (100 mg/kg) [<xref rid="cit0221" ref-type="bibr">221</xref>]; however, the effect of CGA reduced rapidly over time, which may be due to fast metabolism and/or a significant degree of excretion compared to the synthetic compound gabapentin; albeit direct ASIC involvement was not tested.</p><p>So far all herbal compounds described are inhibitors, but lindoldhamine (<xref ref-type="fig" rid="f0009">Figure 9g</xref>), a bisbenzylisoquinoline alkaloid extracted from <italic>Laurus nobilis</italic>, has been shown to generate sustained currents in both rASIC3 (EC<sub>50</sub> of 3.2&#x000a0;mM) and hASIC3 (EC<sub>50</sub> of 3.77&#x000a0;&#x000b5;M) expressing cells at pH 7.8, as well as greatly potentiating acid-evoked transient currents at pH 5.5 and 5.0, for rASIC3 and hASIC3, respectively [<xref rid="cit0222" ref-type="bibr">222</xref>]. Additionally, it was shown that potentiation of hASIC3 transient amplitudes by lindoldhamine (1&#x000a0;mM) was greater under basic conditions (pH 8.5 compared to 7.4).
<fig id="f0009" fig-type="figure" orientation="portrait" position="float"><label>Figure 9.</label><caption><p>Structures of Natural Product Modulators of ASIC3. EGCG &#x02013; (-)-Epigallocatechin gallate. Structures were produced in MarvinSketch</p></caption><graphic content-type="black-white" xlink:href="KCHL_A_1852831_F0009_B"/></fig></p></sec><sec id="s0005-s2008" disp-level="2"><title>Miscellaneous</title><p>A variety of cations are present endogenously within the body, as well as used as experimental tools, and thus it is important to understand how ASIC3 is modulated by cations, for example, the inhibitory effects of Ca<sup>2+</sup> have already been discussed. In addition, the following cations have also been shown to inhibit ASIC3 (and/or ASIC3-like currents): Gd<sup>3+</sup> with an IC<sub>50</sub> of &#x0223c;2.5&#x000a0;mM [<xref rid="cit0009" ref-type="bibr">9</xref>], Pb<sup>2+</sup> with an IC<sub>50</sub> of 8.7&#x000a0;&#x000b5;M [<xref rid="cit0223" ref-type="bibr">223</xref>], high concentration (1&#x000a0;mM) Cd<sup>2+</sup> and Ni<sup>2+</sup> [<xref rid="cit0224" ref-type="bibr">224</xref>], Cu<sup>2+</sup> with an IC<sub>50</sub> of 14.4&#x000a0;&#x000b5;M [<xref rid="cit0225" ref-type="bibr">225</xref>], and Zn<sup>2+</sup> with an IC<sub>50</sub> of 61&#x000a0;&#x000b5;M [<xref rid="cit0226" ref-type="bibr">226</xref>]. Obviously, many of these cations will also modulate the function of other ion channels expressed by sensory neurones and thus interpreting any in vivo activity is complex.</p><p>Much like aspirin and diclofenac acid which have their primary action as COX inhibitors, but also directly modulate ASIC3, further potential such re-purposing of medically licensed drugs has been investigated. For example, diminazene (<xref ref-type="fig" rid="f0010">Figure 10A</xref>), an anti-protozoan diarylamidine, is a nonselective inhibitor of ASICs with greatest potency against ASIC1b, in silico docking models suggesting that binding occurs at the base of the palm region [<xref rid="cit0227" ref-type="bibr">227</xref>]. In addition, nafamostat mesilate (NM, <xref ref-type="fig" rid="f0010">Figure 10B</xref>), is a protease inhibitor licensed for acute pancreatitis also inhibits hASIC3 transient currents (IC<sub>50</sub> of &#x0223c;2.5&#x000a0;&#x000b5;M) and sustained currents (IC<sub>50</sub> not determined due to current instabilities), but is not selective, also inhibiting ASIC1a and 2a, albeit at 4 and 20 fold higher concentrations, respectively [<xref rid="cit0228" ref-type="bibr">228</xref>]. Moreover, 4-aminopyridine (4-AP, <xref ref-type="fig" rid="f0010">Figure 10C</xref>), which can be used to treat multiple sclerosis via blockade of voltage-gated K<sup>+</sup> channels, also nonselectively inhibits the transient phase of ASIC-mediated currents, with the least effect on rASIC3, reducing amplitude by ~25% (10&#x000a0;mM at pH 5) [<xref rid="cit0229" ref-type="bibr">229</xref>].</p><p>Although not used therapeutically, the small compound NS383 [(3E)-8-ethyl-3-(hydroxyimino)-5-phenyl-1 H,2 ;H,3 H,6 H,7 H,8&#x000a0;H,9 H-pyrrolo[3,2-h]isoquinolin-2-one-3-hydroxy-4-mycinide] (<xref ref-type="fig" rid="f0010">Figure 10D</xref>) was observed to inhibit acid-evoked rASIC3 transient currents with an IC<sub>50</sub> of 2.1&#x000a0;&#x000b5;M (pH 5), the inhibition being pH dependent and greater (&#x00394;40%) at pH 6.8; it should be noted that hASIC3 was not inhibited by NS383 and that the inhibitory effect on rASIC1a currents was more pronounced [<xref rid="cit0230" ref-type="bibr">230</xref>]. Interestingly, the in vivo doses of NS383 which produced analgesia (10&#x02013;60 mg/kg) were not much higher than morphine (3&#x02013;10 mg/kg, a centrally acting opioid), but much more potent than amiloride (50&#x02013;200 mg/kg) and acetaminophen (also known as paracetamol, 100&#x02013;400 mg/kg). Again, NS383, much like NM and Merck&#x02019;s compound 7d, provides an interesting lead to develop a selective and more potent inhibitor of ASIC3.
<fig id="f0010" fig-type="figure" orientation="portrait" position="float"><label>Figure 10.</label><caption><p>Structures of &#x0201c;Miscellaneous&#x0201d; Modulators of ASIC3. Structures were produced in MarvinSketch</p></caption><graphic content-type="black-white" xlink:href="KCHL_A_1852831_F0010_B"/></fig></p><p>In addition to small molecules and various endogenous and exogenous mediators, it has also been demonstrated that other proteins present in the plasma membrane can modulate ASIC3 function, the most well studied being stomatin and stomatin-like proteins. In vitro co-expression of stomatin with mASIC3 leads to reduced transient current amplitude without altering the sustained phase or expression level, compared to cells only expressing mASIC3 [<xref rid="cit0231" ref-type="bibr">231</xref>]. Equally, in vitro transfection of stomatin-like protein 3 (STOML3) with ASIC3 results in reduced current amplitude and sustained currents (at pH 5 and 6) compared to when ASIC3 is expressed alone [<xref rid="cit0232" ref-type="bibr">232</xref>]. The in vivo implications of this have been studied in mice, STOML3<sup>&#x02212;/-</sup> mice showing an exacerbated reduction in mechanosensitivity of certain sensory neurones compared to ASIC3<sup>&#x02212;/-</sup> mice [<xref rid="cit0233" ref-type="bibr">233</xref>]. Lastly, coexpression of STOML1 with ASIC3 leads to faster inactivation of mASIC3 currents (pH 4 and 6) [<xref rid="cit0234" ref-type="bibr">234</xref>]. Investigation of how stomatin might interact with ASIC3 demonstrated that the C terminus of ASIC3 is important, in particular Leu488+&#x000a0;Leu489, mutation of which causes larger ASIC3-mediated currents and diminished inhibition by stomatin at pH 4.0 [<xref rid="cit0235" ref-type="bibr">235</xref>]. Further analysis has shown that the C terminus of ASIC3 is important for ASIC3-stomatin to physically interact and that transmembrane domain 1 of ASIC3 is critical for the modulation of ASIC3 function by stomatin, as demonstrated by chimera experiments with ASIC1a, which is not inhibited by stomatin [<xref rid="cit0236" ref-type="bibr">236</xref>].</p></sec></sec><sec id="s0006" disp-level="1"><title>Areas of interest and gaps in research</title><p>One of the drawbacks with the crystal structures that have been employed for in silico virtual screening is that they only represent a snapshot of a fluid channel; moreover, currently only the structure of cASIC1a is available. Due to only the cASIC1a structure being available, any virtual screening protocol against an ASIC other than cASIC1a must employ a homology model and will thus be less accurate compared to when using the actual crystal structure. The amino acid homogeneity between cASIC1a and rASIC3 is 52%, and the two proteins have similar sequence lengths, 527 and 533 residues, and molecular weights of 60.0 and 59.2 kDa, respectively [<xref rid="cit0237" ref-type="bibr">237</xref>]. The amino acid differences may lead to a greater degree of structural differences than predicted by the homology models used in silico, with the regions showing the greatest disparities being 1&#x02013;85 and 472&#x02013;542 (the transmembrane regions, which can affect the ability to produce a biphasic current) and 110&#x02013;161 (finger region, which has yet to be implicated in modulation).</p><p>Whilst studies show that in response to an acid stimulus ASIC3 produces a biphasic current and that the sustained element could be linked to prolonged pain sensation, there have not been studies to deduce if this sustained element is directly involved in nociception during chronic pain conditions (constituting &#x0003e;3&#x000a0;months of pain), and unfortunately there do not currently exist any compounds that effectively inhibit only the sustained phased to enable such investigation. There has also to date not yet been an investigation of the contribution of ASIC3 to a chronic pain condition, for example, what is the phenotype of ASIC3<sup>&#x02212;/-</sup> mice undergoing destabilization of the medial meniscus model of OA, which develops and is sustained over many weeks. Conducting such a long-term study would enable assessment of whether or not ASIC3 expression changes at different time points and perhaps enable it to be determined as to whether or not the sustained phase plays a role in chronic pain? Also, in humans, is there a role for ASIC3 in chronic pain? At least for acute acid-evoked pain in humans, recent data suggest no role for ASICs [<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0238" ref-type="bibr">238</xref>], which contrasts with older literature [<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0023" ref-type="bibr">23</xref>], but how this scenario is altered in chronic pain states associated with prolonged tissue acidosis and the presence of multiple inflammatory mediators, many of which sensitize ASIC3, remains unknown.</p><p>Finally, hASIC3 has 3 splice variants; thus, greater understanding of how each variant functions and any differential tissue expression are required to determine what, if any, differential roles these variants have. One potential way to investigate this would be to investigate different pain models (both acute and chronic) in transgenic mice expressing the different human splice variants to determine what impact they may have on neuronal excitability and pain.</p><p>Fundamentally, what the field really lacks is a selective ASIC3 antagonist that effectively blocks both transient and sustained phases of the current (as well as those derived from ASIC3 heteromers), which could be used in an interventional way to determine the true contribution of ASIC3 to pain and other physiology, and the quest for such a compound remains.</p></sec></body><back><ack><title>Acknowledgments</title><p>Work in the Smith Lab is supported by Versus Arthritis Research Grant (RG21973) and Biotechnology and Biological Sciences Research Council grant (BB/R006210/1).</p></ack><sec id="s0007" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><sec id="s0008" disp-level="1"><title>Disclosure of Interest</title><p>The authors report no conflict of interest.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hutchings</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Colussi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>TG.</given-names></name></person-group>
<article-title>Ion channels as therapeutic antibody targets</article-title>. <source>MAbs [Internet]</source>. <year>2019</year>;<volume>11</volume>(<issue>2</issue>):<fpage>265</fpage>&#x02013;<lpage>296</lpage>.</mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ursu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Gaulton</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>A comprehensive map of molecular drug targets</article-title>. <source>Nat Rev Drug Discov</source>. <year>2016</year>;<volume>16</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02013;<lpage>34</lpage>. .<pub-id pub-id-type="pmid">27910877</pub-id></mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmer</surname><given-names>LG</given-names></name></person-group>
<article-title>Ion selectivity of the apical membrane Na channel in the toad urinary bladder</article-title>. <source>J Membr Biol</source>. <year>1982</year>;<volume>67</volume>(<issue>1</issue>):<fpage>91</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">6284943</pub-id></mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wichmann</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Althaus</surname><given-names>M</given-names></name></person-group>
<article-title>Evolution of Epithelial Sodium Channels - current concepts and hypotheses</article-title>. <source>Am J Physiol Integr Comp Physiol</source>. <year>2020</year> DOI:<pub-id pub-id-type="doi">10.1152/ajpregu.00144.2020</pub-id></mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waldmann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Weille</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Champigny</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>Molecular Cloning of a Non-inactivating Proton-gated Na+Channel Specific for Sensory Neurons</article-title>. <source>J Biol Chem</source>. <year>1997</year>; (<issue>34</issue>):<fpage>20975</fpage>&#x02013;<lpage>20978</lpage>. DOI:<pub-id pub-id-type="doi">10.1074/jbc.272.34.20975</pub-id>.<pub-id pub-id-type="pmid">9261094</pub-id></mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benos</surname><given-names>DJ</given-names></name></person-group>
<article-title>Amiloride: a molecular probe of sodium transport in tissues and cells</article-title>. <source>Am J Physiol</source>. <year>1982</year>;<fpage>242(3):C131&#x02013;145</fpage>.</mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaefer</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sakai</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mattei</surname><given-names>MG</given-names></name>, et al</person-group>
<article-title>Molecular cloning, functional expression and chromosomal localization of an amiloride-sensitive Na + channel from human small intestine.</article-title>. <source>FEBS Lett</source>. <year>2000</year>; (<issue>2&#x02013;3</issue>):<page-range>p. 205&#x02013;210</page-range> DOI:<pub-id pub-id-type="doi">10.1016/S0014-5793(00)01403-4</pub-id>.</mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoagland</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Sherwood</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>KG</given-names></name>, et al</person-group>
<article-title>Identification of a calcium permeable human acid-sensing ion channel 1 transcript variant</article-title>. <source>J Biol Chem</source>. <year>2010</year>;<volume>285</volume>(<issue>53</issue>):<fpage>41852</fpage>&#x02013;<lpage>41862</lpage>. .<pub-id pub-id-type="pmid">21036899</pub-id></mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babinski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Catarsi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Biagini</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>Mammalian ASIC2a and ASIC3 Subunits Co-assemble into Heteromeric Proton-gated Channels Sensitive to Gd3+.</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>37</issue>):<fpage>28519</fpage>&#x02013;<lpage>28525</lpage>. .<pub-id pub-id-type="pmid">10842183</pub-id></mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gr&#x000fc;nder</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Geissler</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>B&#x000e4;ssler</surname><given-names>EL</given-names></name>, et al</person-group>
<article-title>A new member of acid-sensing ion channels from pituitary gland</article-title>. <source>Neuroreport.</source>
<year>2000</year>;<volume>11</volume>(<issue>8</issue>):<fpage>1607</fpage>&#x02013;<lpage>1611</lpage>. .<pub-id pub-id-type="pmid">10852210</pub-id></mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Babinski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>L&#x000ea;</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>S&#x000e9;gu&#x000e9;la</surname><given-names>P</given-names></name></person-group>
<article-title>Molecular cloning and regional distribution of a human proton receptor subunit with biphasic functional properties</article-title>. <source>J Neurochem</source>. <year>1999</year>;<volume>72</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">9886053</pub-id></mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jasti</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Furukawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>EB</given-names></name>, et al</person-group>
<article-title>Structure of acid-sensing ion channel 1 at 1.9 &#x000c5; resolution and low pH</article-title>. <source>Nature.</source>
<year>2007</year>;<volume>449</volume>(<issue>7160</issue>):<fpage>316</fpage>&#x02013;<lpage>323</lpage>. .<pub-id pub-id-type="pmid">17882215</pub-id></mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carnally</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Dev</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>AP</given-names></name>, et al</person-group>
<article-title>Direct visualization of the trimeric structure of the ASIC1a channel, using AFM imaging</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2008</year>;<volume>372</volume>(<issue>4</issue>):<fpage>752</fpage>&#x02013;<lpage>755</lpage>. .<pub-id pub-id-type="pmid">18514062</pub-id></mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lingueglia</surname><given-names>E</given-names></name>, <name name-style="western"><surname>De Weille</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Bassilana</surname><given-names>F</given-names></name>, et al</person-group>
<article-title>A modulatory subunit of acid sensing ion channels in brain and dorsal root ganglion cells</article-title>. <source>J Biol Chem</source>. <year>1997</year>;<volume>272</volume>(<issue>47</issue>):<fpage>29778</fpage>&#x02013;<lpage>29783</lpage>. .<pub-id pub-id-type="pmid">9368048</pub-id></mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akopian</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name>, et al</person-group>
<article-title>A new member of the acid-sensing ion channel family</article-title>. <source>Neuroreport.</source>
<year>2000</year>;<volume>11</volume>(<issue>10</issue>):<fpage>2217</fpage>&#x02013;<lpage>2222</lpage>. .<pub-id pub-id-type="pmid">10923674</pub-id></mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>ESJ</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Cadiou</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Proton binding sites involved in the activation of acid-sensing ion channel ASIC2a</article-title>. <source>Neurosci Lett</source>. <year>2007</year>;<volume>426</volume>(<issue>1</issue>):<fpage>12</fpage>&#x02013;<lpage>17</lpage>. .<pub-id pub-id-type="pmid">17881127</pub-id></mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donier</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rugiero</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Jacob</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Regulation of ASIC activity by ASIC4 - New insights into ASIC channel function revealed by a yeast two-hybrid assay</article-title>. <source>Eur J Neurosci</source>. <year>2008</year>;<volume>28</volume>(<issue>1</issue>):<fpage>74</fpage>&#x02013;<lpage>86</lpage>. .<pub-id pub-id-type="pmid">18662336</pub-id></mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hesselager</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Timmermann</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Ahring</surname><given-names>PK</given-names></name></person-group>
<article-title>pH Dependency and Desensitization Kinetics of Heterologously Expressed Combinations of Acid-sensing Ion Channel Subunits</article-title>. <source>J Biol Chem</source>. <year>2004</year>;<volume>279</volume>(<issue>12</issue>):<fpage>11006</fpage>&#x02013;<lpage>11015</lpage>.<pub-id pub-id-type="pmid">14701823</pub-id></mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Weille</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Bassilana</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lazdunski</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Identification, functional expression and chromosomal localisation of a sustained human proton-gated cation channel</article-title>. <source>FEBS Lett</source>. <year>1998</year>; (<issue>3</issue>):<page-range>p. 257&#x02013;260</page-range> DOI:<pub-id pub-id-type="doi">10.1016/S0014-5793(98)00916-8</pub-id>.</mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishtal</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Pidoplichko</surname><given-names>VI</given-names></name></person-group>
<article-title>A receptor for protons in the nerve cell membrane</article-title>. <source>Neuroscience.</source>
<year>1980</year>;<volume>5</volume>(<issue>12</issue>):<fpage>2325</fpage>&#x02013;<lpage>2327</lpage>.<pub-id pub-id-type="pmid">6970348</pub-id></mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Slater</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cadiou</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Acid-induced pain and its modulation in humans</article-title>. <source>J Neurosci</source>. <year>2004</year>;<volume>24</volume>(<issue>48</issue>):<fpage>10974</fpage>&#x02013;<lpage>10979</lpage>. .<pub-id pub-id-type="pmid">15574747</pub-id></mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heber</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ciotu</surname><given-names>CI</given-names></name>, <name name-style="western"><surname>Hartner</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>TRPV1 antagonist BCTC inhibits pH 60-induced pain in human skin..</article-title>
<source>Pain.</source>
<year>2020</year>;<volume>00</volume>:<fpage>1</fpage>.</mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugawa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ishida</surname><given-names>Y</given-names></name>, et al</person-group>
<article-title>Amiloride-blockable acid-sensing ion channels are leading acid sensors expressed in human nociceptors</article-title>. <source>J Clin Invest</source>. <year>2002</year>;<volume>110</volume>(<issue>8</issue>):<fpage>1185</fpage>&#x02013;<lpage>1190</lpage>. .<pub-id pub-id-type="pmid">12393854</pub-id></mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pattison</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Callejo</surname><given-names>G</given-names></name></person-group>
<article-title>St John Smith E. Evolution of acid nociception: ion channels and receptors for detecting acid</article-title>. <source>Philos Trans R Soc B Biol Sci</source>. <year>2019</year>;<volume>374</volume>(<issue>1785</issue>):<fpage>20190291</fpage>.</mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeisel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hochgerner</surname><given-names>H</given-names></name>, <name name-style="western"><surname>L&#x000f6;nnerberg</surname><given-names>P</given-names></name>, et al</person-group>
<article-title>Molecular Architecture of the Mouse Nervous System</article-title>. <source>Cell</source>. <year>2018</year>;<volume>174</volume>(<issue>4</issue>):<fpage>e22</fpage>. .</mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hockley</surname><given-names>JRF</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Callejo</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>Single-cell RNAseq reveals seven classes of colonic sensory neuron</article-title>. <source>Gut.</source>
<year>2019</year>;<volume>68</volume>:<fpage>633</fpage>&#x02013;<lpage>644</lpage>.<pub-id pub-id-type="pmid">29483303</pub-id></mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waldmann</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Champigny</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bassilana</surname><given-names>F</given-names></name>, et al</person-group>
<article-title>A proton-gated cation channel involved in acid-sensing</article-title>. <source>Nature.</source>
<year>1997</year>; (<issue>6621</issue>):<page-range>p. 173&#x02013;177</page-range> DOI:<pub-id pub-id-type="doi">10.1038/386173a0</pub-id>.</mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>St. John Smith</surname><given-names>E</given-names></name></person-group>
<article-title>Advances in understanding nociception and neuropathic pain</article-title>. <source>J Neurol</source>. <year>2018</year>;<volume>265</volume>(<issue>2</issue>):<fpage>231</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">29032407</pub-id></mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paukert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Polleichtner</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>Candidate Amino Acids Involved in H+ Gating of Acid-sensing Ion Channel 1a</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>1</issue>):<fpage>572</fpage>&#x02013;<lpage>581</lpage>. .<pub-id pub-id-type="pmid">17981796</pub-id></mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tianbo</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Youshan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Canessa</surname><given-names>CM</given-names></name></person-group>
<article-title>Interaction of the aromatics Tyr-72/Trp-288 in the interface of the extracellular and transmembrane domains is essential for proton gating of acid-sensing ion channels</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>(<issue>7</issue>):<fpage>4689</fpage>&#x02013;<lpage>4694</lpage>.<pub-id pub-id-type="pmid">19074149</pub-id></mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuhmacher</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Srivats</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>ESJ</given-names></name></person-group>
<article-title>Structural domains underlying the activation of acid-sensing ion channel 2a</article-title>. <source>Mol Pharmacol</source>. <year>2015</year>;<volume>87</volume>(<issue>4</issue>):<fpage>561</fpage>&#x02013;<lpage>571</lpage>.<pub-id pub-id-type="pmid">25583083</pub-id></mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liechti</surname><given-names>LAL</given-names></name>, <name name-style="western"><surname>Bern&#x000e8;che</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bargeton</surname><given-names>B</given-names></name>, et al</person-group>
<article-title>A combined computational and functional approach identifies new residues involved in pH-dependent gating of ASIC1a</article-title>. <source>J Biol Chem</source>. <year>2010</year>;<volume>285</volume>(<issue>21</issue>):<fpage>16315</fpage>&#x02013;<lpage>16329</lpage>. .<pub-id pub-id-type="pmid">20299463</pub-id></mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vecchia</surname><given-names>MCD</given-names></name>, <name name-style="western"><surname>Rued</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Carattino</surname><given-names>MD</given-names></name></person-group>
<article-title>Gating transitions in the palm domain of ASIC1a</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>8</issue>):<fpage>5487</fpage>&#x02013;<lpage>5495</lpage>.<pub-id pub-id-type="pmid">23300086</pub-id></mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutherland</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Adelman</surname><given-names>JP</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channel 3 matches the acid-gated current in cardiac ischemia-sensing neurons</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2001</year>;<volume>98</volume>(<issue>2</issue>):<fpage>711</fpage>&#x02013;<lpage>716</lpage>. .<pub-id pub-id-type="pmid">11120882</pub-id></mixed-citation></ref><ref id="cit0035"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuhmacher</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Callejo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Srivats</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>Naked mole-rat Acid-sensing ion channel 3 forms nonfunctional homomers, but functional heteromers</article-title>. <source>J Biol Chem</source>. <year>2018</year>;<volume>293</volume>(<issue>5</issue>):<fpage>1756</fpage>&#x02013;<lpage>1766</lpage>. .<pub-id pub-id-type="pmid">29237731</pub-id></mixed-citation></ref><ref id="cit0036"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delaunay</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gasull</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Salinas</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Human ASIC3 channel dynamically adapts its activity to sense the extracellular pH in both acidic and alkaline directions</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2012</year>;<volume>109</volume>(<issue>32</issue>):<fpage>13124</fpage>&#x02013;<lpage>13129</lpage>. .<pub-id pub-id-type="pmid">22829666</pub-id></mixed-citation></ref><ref id="cit0037"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bisson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Younker</surname><given-names>J</given-names></name></person-group>
<article-title>Correcting arterial blood gases for temperature: (when) is it clinically significant?</article-title>
<source>Nurs Crit Care</source>. <year>2006</year>;<volume>11</volume>(<issue>5</issue>):<fpage>232</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">16983854</pub-id></mixed-citation></ref><ref id="cit0038"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldie</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Nachemson</surname><given-names>A</given-names></name></person-group>
<article-title>Synovial ph in rheumatoid knee-joints I. The effect of synovectomy</article-title>. <source>Acta Orthop</source>. <year>1969;40(5):634&#x02013;641</year>.</mixed-citation></ref><ref id="cit0039"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shishkin</surname><given-names>VI</given-names></name>, <name name-style="western"><surname>Kudryavtseva</surname><given-names>GV</given-names></name>, <name name-style="western"><surname>Ryabkov</surname><given-names>AB</given-names></name></person-group>
<article-title>A pH-dependent mechanism of energy transformation in joint fluid cells in osteoarthrosis of the knee joint and benefits of chondroitinsulfate</article-title>. <source>Ter Arkh</source>. <year>2005;77(10):79&#x02013;82</year>.</mixed-citation></ref><ref id="cit0040"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pakpoy</surname><given-names>RK</given-names></name></person-group>
<article-title>Urinary Ph in Gout</article-title>. <source>Australas Ann Med</source>. <year>1965</year>;<volume>14</volume>(<issue>1</issue>):<fpage>35</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">14271788</pub-id></mixed-citation></ref><ref id="cit0041"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howell</surname><given-names>DS</given-names></name></person-group>
<article-title>Preliminary Observations on Local pH in Gouty Tophi and Synovial Fluid</article-title>. <source>Arthritis Rheum</source>. <year>1965</year>;<volume>8</volume>(<issue>4</issue>):<fpage>736</fpage>&#x02013;<lpage>740</lpage>.<pub-id pub-id-type="pmid">5859546</pub-id></mixed-citation></ref><ref id="cit0042"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaidya</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bhochhibhoya</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakarmi</surname><given-names>S</given-names></name></person-group>
<article-title>Synovial fluid uric acid level aids diagnosis of gout</article-title>. <source>Biomed Reports</source>. <year>2018</year>;<volume>9</volume>:<fpage>60</fpage>&#x02013;<lpage>64</lpage>.</mixed-citation></ref><ref id="cit0043"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ngamtrakulpanit</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Adjei</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>Identification of Intrinsic Airway Acidification in Pulmonary Tuberculosis</article-title>. <source>Glob J Health Sci</source>. <year>2010</year>;<volume>2</volume>(<issue>1</issue>):<fpage>106</fpage>&#x02013;<lpage>110</lpage>. .<pub-id pub-id-type="pmid">21197384</pub-id></mixed-citation></ref><ref id="cit0044"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>XX</given-names></name>, <name name-style="western"><surname>Ostedgaard</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Hoegger</surname><given-names>MJ</given-names></name>, et al</person-group>
<article-title>Acidic pH increases airway surface liquid viscosity in cystic fibrosis</article-title>. <source>J Clin Invest</source>. <year>2016</year>;<volume>126</volume>(<issue>3</issue>):<fpage>879</fpage>&#x02013;<lpage>891</lpage>. .<pub-id pub-id-type="pmid">26808501</pub-id></mixed-citation></ref><ref id="cit0045"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kostikas</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Papatheodorou</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ganas</surname><given-names>K</given-names></name>, et al</person-group>
<article-title>pH in expired breath condensate of patients with inflammatory airway diseases</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2002</year>;<volume>165</volume>(<issue>10</issue>):<fpage>1364</fpage>&#x02013;<lpage>1370</lpage>. .<pub-id pub-id-type="pmid">12016097</pub-id></mixed-citation></ref><ref id="cit0046"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gessner</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hammerschmidt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kuhn</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Exhaled breath condensate acidification in acute lung injury</article-title>. <source>Respir Med</source>. <year>2003</year>;<volume>97</volume>(<issue>11</issue>):<fpage>1188</fpage>&#x02013;<lpage>1194</lpage>. .<pub-id pub-id-type="pmid">14635972</pub-id></mixed-citation></ref><ref id="cit0047"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Banani</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bernard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Baetz</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine: comparison between low- and zero-flow ischaemia</article-title>. <source>Cardiovasc Res</source>. <year>2000</year> DOI:<pub-id pub-id-type="doi">10.1016/S0008-6363(00)00136-X</pub-id>.</mixed-citation></ref><ref id="cit0048"><label>[48]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Silver</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Erecinska</surname><given-names>M</given-names></name></person-group>
<source>Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-</source>. <publisher-loc>and hyperglycemic animals. J Neurosci</publisher-loc>: <publisher-name>hypo-</publisher-name>; <year>1994</year>.</mixed-citation></ref><ref id="cit0049"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuhmacher</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>ESJ</given-names></name></person-group>
<article-title>Expression of acid-sensing ion channels and selection of reference genes in mouse and naked mole rat.</article-title>. <source>Mol Brain [Internet]</source>. <year>2016</year>;<volume>9</volume>:<fpage>1</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="cit0050"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>England</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Akopian</surname><given-names>AN</given-names></name>, et al</person-group>
<article-title>A sensory neuron-specific, proton-gated ion channel</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1998</year>;<volume>95</volume>(<issue>17</issue>):<fpage>10240</fpage>&#x02013;<lpage>10245</lpage>. .<pub-id pub-id-type="pmid">9707631</pub-id></mixed-citation></ref><ref id="cit0051"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>QY</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>XN</given-names></name>, et al</person-group>
<article-title>Distribution of acid-sensing ion channel 3 in the rat hypothalamus.</article-title>. <source>Neurosci</source>. <year>2009</year>;<volume>159</volume>(<issue>3</issue>):<fpage>1126</fpage>&#x02013;<lpage>1134</lpage>.</mixed-citation></ref><ref id="cit0052"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cha</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>I</given-names></name>, et al</person-group>
<article-title>Abnormal hippocampal structure and function in clinical anxiety and comorbid depression</article-title>. <source>Hippocampus.</source>
<year>2016</year> DOI:<pub-id pub-id-type="doi">10.1002/hipo.22566</pub-id>.</mixed-citation></ref><ref id="cit0053"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feij&#x000f3; de Mello</surname><given-names>ADA</given-names></name>, <name name-style="western"><surname>De Mello</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Carpenter</surname><given-names>LL</given-names></name>, et al</person-group>
<article-title>Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis</article-title>. <source>Rev Bras Psiquiatr</source>. <year>2003</year>;<volume>25</volume>(<issue>4</issue>):<fpage>231</fpage>&#x02013;<lpage>238</lpage>. .<pub-id pub-id-type="pmid">15328550</pub-id></mixed-citation></ref><ref id="cit0054"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>MY</given-names></name>, et al</person-group>
<article-title>Mice lacking Asic3 show reduced anxiety-like behavior on the elevated plus maze and reduced aggression</article-title>. <source>Genes, Brain Behav</source>. <year>2010</year>;9(6):<fpage>603</fpage>&#x02013;<lpage>614</lpage>.<pub-id pub-id-type="pmid">20497234</pub-id></mixed-citation></ref><ref id="cit0055"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Elevated Expression of Acid-Sensing Ion Channel 3 Inhibits Epilepsy via Activation of Interneurons</article-title>. <source>Mol Neurobiol</source>. <year>2016</year>;<volume>53</volume>(<issue>1</issue>):<fpage>485</fpage>&#x02013;<lpage>498</lpage>. .<pub-id pub-id-type="pmid">25476599</pub-id></mixed-citation></ref><ref id="cit0056"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Bischoff</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators</article-title>. <source>Headache [Internet]</source>. <year>2013</year>;<volume>53</volume>(<issue>8</issue>):<fpage>1250</fpage>&#x02013;<lpage>1261</lpage>. <ext-link ext-link-type="uri" xlink:href="http://Available&#x000a0;from:&#x000a0;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf">Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf</ext-link>.. .</mixed-citation></ref><ref id="cit0057"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deval</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lingueglia</surname><given-names>E</given-names></name></person-group>
<article-title>Acid-Sensing Ion Channels and nociception in the peripheral and central nervous systems.</article-title>. <source>Neuropharmacol</source>. <year>2015</year>;<volume>94</volume>:<fpage>49</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="cit0058"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deval</surname><given-names>E</given-names></name>, <name name-style="western"><surname>No&#x000eb;l</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lay</surname><given-names>N</given-names></name>, et al</person-group>
<article-title>ASIC3, a sensor of acidic and primary inflammatory pain</article-title>. <source>Embo J</source>. <year>2008</year>;<volume>27</volume>(<issue>22</issue>):<fpage>3047</fpage>&#x02013;<lpage>3055</lpage>. .<pub-id pub-id-type="pmid">18923424</pub-id></mixed-citation></ref><ref id="cit0059"><label>[59]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deval</surname><given-names>E</given-names></name>, <name name-style="western"><surname>No&#x000eb;l</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gasull</surname><given-names>X</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channels in postoperative pain</article-title>. <source>J Neurosci</source>. <year>2011</year>;<volume>31</volume>(<issue>16</issue>):<fpage>6059</fpage>&#x02013;<lpage>6066</lpage>. .<pub-id pub-id-type="pmid">21508231</pub-id></mixed-citation></ref><ref id="cit0060"><label>[60]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Zimmer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>WH</given-names></name>, et al</person-group>
<article-title>A role for ASIC3 in the modulation of high-intensity pain stimuli</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2002</year>;<volume>99</volume>(<issue>13</issue>):<fpage>8992</fpage>&#x02013;<lpage>8997</lpage>. .<pub-id pub-id-type="pmid">12060708</pub-id></mixed-citation></ref><ref id="cit0061"><label>[61]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>ASIC3 Mediates Itch Sensation in Response to Coincident Stimulation by Acid and Nonproton Ligand</article-title>. <source>Cell Rep [Internet]</source>. <year>2015</year>;<volume>13</volume>(<issue>2</issue>):<fpage>387</fpage>&#x02013;<lpage>398</lpage>.</mixed-citation></ref><ref id="cit0062"><label>[62]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mogil</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Breese</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Witty</surname><given-names>MF</given-names></name>, et al</person-group>
<article-title>Transgenic expression of a dominant-negative ASIC3 subunit leads to increased sensitivity to mechanical and inflammatory stimuli</article-title>. <source>J Neurosci</source>. <year>2005</year>;<volume>25</volume>(<issue>43</issue>):<fpage>9893</fpage>&#x02013;<lpage>9901</lpage>. .<pub-id pub-id-type="pmid">16251436</pub-id></mixed-citation></ref><ref id="cit0063"><label>[63]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staniland</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>McMahon</surname><given-names>SB</given-names></name></person-group>
<article-title>Mice lacking acid-sensing ion channels (ASIC) 1 or 2, but not ASIC3, show increased pain behaviour in the formalin test</article-title>. <source>Eur J Pain [Internet]</source>. <year>2009</year>;<volume>13</volume>(<issue>6</issue>):<fpage>554</fpage>&#x02013;<lpage>563</lpage>.</mixed-citation></ref><ref id="cit0064"><label>[64]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arendt-Nielsen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fern&#x000e1;ndez-de-las-Pe&#x000f1;as</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Graven-Nielsen</surname><given-names>T</given-names></name></person-group>
<article-title>Basic aspects of musculoskeletal pain: from acute to chronic pain</article-title>. <source>J Man Manip Ther</source>. <year>2011</year>;<volume>19</volume>(<issue>4</issue>):<fpage>186</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">23115471</pub-id></mixed-citation></ref><ref id="cit0065"><label>[65]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Issberner</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Reeh</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Steen</surname><given-names>KH</given-names></name></person-group>
<article-title>Pain due to tissue acidosis: A mechanism for inflammatory and ischemic myalgia?</article-title>
<source>Neurosci Lett</source>. <year>1996</year>;<volume>208</volume>:<fpage>191</fpage>&#x02013;<lpage>194</lpage>.<pub-id pub-id-type="pmid">8733302</pub-id></mixed-citation></ref><ref id="cit0066"><label>[66]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Egelius</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Jonsson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sunblad</surname><given-names>L</given-names></name></person-group>
<article-title>Studies of hyaluronic acid in rheumatoid arthritis</article-title>. <source>Ann Rheum Dis</source>. <year>1956</year>;<volume>15</volume>(<issue>4</issue>):<fpage>357</fpage>&#x02013;<lpage>363</lpage>.<pub-id pub-id-type="pmid">13395270</pub-id></mixed-citation></ref><ref id="cit0067"><label>[67]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikeuchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kolker</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Burnes</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice</article-title>. <source>J Pain</source>. <year>2009</year>;<volume>137</volume>(<issue>3</issue>):<fpage>662</fpage>&#x02013;<lpage>669</lpage>. .</mixed-citation></ref><ref id="cit0068"><label>[68]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikeuchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kolker</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Sluka</surname><given-names>KA</given-names></name></person-group>
<article-title>Acid-Sensing Ion Channel 3 Expression in Mouse Knee Joint Afferents and Effects of Carrageenan-Induced Arthritis</article-title>. <source>J Pain</source>. <year>2009</year> DOI:<pub-id pub-id-type="doi">10.1016/j.jpain.2008.10.010</pub-id></mixed-citation></ref><ref id="cit0069"><label>[69]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolker</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Walder</surname><given-names>RY</given-names></name>, <name name-style="western"><surname>Usachev</surname><given-names>Y</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channel 3 expressed in type B synoviocytes and chondrocytes modulates hyaluronan expression and release.</article-title>. <source>Ann Rheum Dis [Internet]</source>. <year>2010</year>;<volume>69</volume>(<issue>5</issue>):<fpage>903</fpage>&#x02013;<lpage>909</lpage>. <ext-link ext-link-type="uri" xlink:href="http://Available&#x000a0;from:&#x000a0;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf">Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf</ext-link>.</mixed-citation></ref><ref id="cit0070"><label>[70]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kolker</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Usachev</surname><given-names>Y</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channel 3 decreases phosphorylation of extracellular signal-regulated kinases and induces synoviocyte cell death by increasing intracellular calcium</article-title>. <source>Arthritis Res Ther</source>. <year>2014</year>;<volume>16</volume>(<issue>3</issue>):<fpage>1</fpage>&#x02013;<lpage>12</lpage>. .</mixed-citation></ref><ref id="cit0071"><label>[71]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Queme</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>ER</given-names></name>, et al</person-group>
<article-title>Muscle IL1&#x003b2; drives ischemic myalgia via ASIC3-mediated sensory neuron sensitization</article-title>. <source>J Neurosci</source>. <year>2016</year>;<volume>36</volume>(<issue>26</issue>):<fpage>6857</fpage>&#x02013;<lpage>6871</lpage>. .<pub-id pub-id-type="pmid">27358445</pub-id></mixed-citation></ref><ref id="cit0072"><label>[72]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>National Institute for Health and Clinical Excellence).</collab></person-group>
<article-title>Osteoarthritis: the care and management of Osteoarthritis [Internet]</article-title>. <year>2012</year>
<ext-link ext-link-type="uri" xlink:href="http://Available&#x000a0;from:&#x000a0;https://www.nice.org.uk/guidance/cg177/resources/osteoarthritis-update-final-scope2">Available from: https://www.nice.org.uk/guidance/cg177/resources/osteoarthritis-update-final-scope2</ext-link>.</mixed-citation></ref><ref id="cit0073"><label>[73]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izumi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ikeuchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>Q</given-names></name>, et al</person-group>
<article-title>Local ASIC3 modulates pain and disease progression in a rat model of osteoarthritis</article-title>. <source>J Biomed Sci</source>. <year>2012</year>;<volume>19</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">22212150</pub-id></mixed-citation></ref><ref id="cit0074"><label>[74]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stills</surname><given-names>HF</given-names></name></person-group>
<article-title>Adjuvants and antibody production: dispelling the myths associated with Freund&#x02019;s complete and other adjuvants</article-title>. <source>Ilar J</source>. <year>2005</year>;<volume>46</volume>(<issue>3</issue>):<fpage>280</fpage>&#x02013;<lpage>293</lpage>.<pub-id pub-id-type="pmid">15953835</pub-id></mixed-citation></ref><ref id="cit0075"><label>[75]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winter</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Risley</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Nuss</surname><given-names>GW</given-names></name></person-group>
<article-title>Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Anti-inflammatory Drugs</article-title>. <source>Exp Biol Med</source>. <year>1962</year>;<volume>111</volume>(<issue>3</issue>):<fpage>544</fpage>&#x02013;<lpage>547</lpage>.</mixed-citation></ref><ref id="cit0076"><label>[76]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frasnelli</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Tarussio</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chobaz-P&#x000e9;clat</surname><given-names>V</given-names></name>, et al</person-group>
<article-title>TLR2 modulates inflammation in zymosan-induced arthritis in mice</article-title>. <source>Arthritis Res Ther</source>. <year>2005</year>;<volume>7</volume>(<issue>2</issue>):<fpage>370</fpage>&#x02013;<lpage>379</lpage>. .</mixed-citation></ref><ref id="cit0077"><label>[77]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Role of acid-sensing ion channel 3 in sub-acute-phase inflammation</article-title>. <source>Mol Pain</source>. <year>2009</year>;<volume>5</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">19126241</pub-id></mixed-citation></ref><ref id="cit0078"><label>[78]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walder</surname><given-names>RY</given-names></name>, <name name-style="western"><surname>Rasmussen</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Rainier</surname><given-names>JD</given-names></name>, et al</person-group>
<article-title>ASIC1 and ASIC3 Play Different Roles in the Development of Hyperalgesia After Inflammatory Muscle Injury</article-title>. <source>J Pain</source>. <year>2010</year>;<volume>11</volume>(<issue>3</issue>):<fpage>210</fpage>&#x02013;<lpage>218</lpage>. .<pub-id pub-id-type="pmid">20015700</pub-id></mixed-citation></ref><ref id="cit0079"><label>[79]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sluka</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Breese</surname><given-names>NM</given-names></name>, et al</person-group>
<article-title>Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1</article-title>. <source>Pain.</source>
<year>2003</year>;<volume>106</volume>(<issue>3</issue>):<fpage>229</fpage>&#x02013;<lpage>239</lpage>.<pub-id pub-id-type="pmid">14659506</pub-id></mixed-citation></ref><ref id="cit0080"><label>[80]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sluka</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Radhakrishnan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>CJ</given-names></name>, et al</person-group>
<article-title>ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation</article-title>. <source>Pain.</source>
<year>2007</year>;<volume>129</volume>(<issue>1</issue>):<fpage>102</fpage>&#x02013;<lpage>112</lpage>. .<pub-id pub-id-type="pmid">17134831</pub-id></mixed-citation></ref><ref id="cit0081"><label>[81]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borzan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>RA</given-names></name>, et al</person-group>
<article-title>A role for acid-sensing ion channel 3, but not acid-sensing ion channel 2, in sensing dynamic mechanical stimuli</article-title>. <source>Anesthesiology.</source>
<year>2010</year>;<volume>113</volume>(<issue>3</issue>):<fpage>647</fpage>&#x02013;<lpage>654</lpage>. .<pub-id pub-id-type="pmid">20693874</pub-id></mixed-citation></ref><ref id="cit0082"><label>[82]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Authier</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gillet</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Fialip</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections</article-title>. <source>Exp Neurol</source>. <year>2003</year>;<volume>182</volume>(<issue>1</issue>):<fpage>12</fpage>&#x02013;<lpage>20</lpage>. .<pub-id pub-id-type="pmid">12821373</pub-id></mixed-citation></ref><ref id="cit0083"><label>[83]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hori</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ozaki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>Upregulations of P2X3 and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats</article-title>. <source>Pain.</source>
<year>2010</year>;<volume>149</volume>(<issue>2</issue>):<fpage>393</fpage>&#x02013;<lpage>405</lpage>. .<pub-id pub-id-type="pmid">20378247</pub-id></mixed-citation></ref><ref id="cit0084"><label>[84]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walder</surname><given-names>RY</given-names></name>, <name name-style="western"><surname>Gautam</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>SP</given-names></name>, et al</person-group>
<article-title>Selective targeting of ASIC3 using artificial miRNAs inhibits primary and secondary hyperalgesia after muscle inflammation</article-title>. <source>Pain.</source>
<year>2011</year> DOI:<pub-id pub-id-type="doi">10.1016/j.pain.2011.06.027</pub-id>.</mixed-citation></ref><ref id="cit0085"><label>[85]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Light</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>White</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Hughen</surname><given-names>RW</given-names></name>, et al</person-group>
<article-title>Moderate exercise increases expression for sensory, adrenergic and immune genes in chronic fatigue syndrome patients, but not in normal subjects</article-title>. <source>Pain.</source>
<year>2009</year>;<volume>10</volume>(<issue>10</issue>):<fpage>1099</fpage>&#x02013;<lpage>1112</lpage>. .</mixed-citation></ref><ref id="cit0086"><label>[86]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gregory</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Gibson-Corley</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Frey-Law</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>Fatigue-enhanced hyperalgesia in response to muscle insult: induction and development occur in a sex-dependent manner</article-title>. <source>Pain.</source>
<year>2013</year>;<volume>154</volume>(<issue>12</issue>):<fpage>2668</fpage>&#x02013;<lpage>2676</lpage>. .<pub-id pub-id-type="pmid">23906552</pub-id></mixed-citation></ref><ref id="cit0087"><label>[87]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collaborators</surname><given-names>G</given-names></name></person-group>
<article-title>D and II and P. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990 &#x02013; 2017: a systematic analysis for the Global Burden of Disease Study 2017</article-title>. <source>Lancet</source>. <year>2017</year>;<volume>392:</volume>:<fpage>1789</fpage>&#x02013;<lpage>1858</lpage>. <comment>2018</comment>.</mixed-citation></ref><ref id="cit0088"><label>[88]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>CZ</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>YQ</given-names></name>, et al</person-group>
<article-title>The relationship between low pH in intervertebral discs and low back pain: A systematic review</article-title>. <source>Arch Med Sci</source>. <year>2012</year>;<volume>6</volume>:<fpage>952</fpage>&#x02013;<lpage>956</lpage>.</mixed-citation></ref><ref id="cit0089"><label>[89]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brand</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Forouzandeh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kaur</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Acidification changes affect the inflammasome in human nucleus pulposus cells.</article-title>. <source>J Inflamm (United Kingdom) [Internet]</source>. <year>2016</year>;<volume>13</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="cit0090"><label>[90]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uchiyama</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Danielson</surname><given-names>KG</given-names></name>, et al</person-group>
<article-title>Expression of Acid-Sensing Ion Channel 3 (ASIC3) in nucleus pulposus cells of the intervertebral disc is regulated by p75NTR and ERK signaling</article-title>. <source>J Bone Miner Res</source>. <year>2007</year>;<volume>22</volume>(<issue>12</issue>):<page-range>p. 1996&#x02013;2006</page-range>. .</mixed-citation></ref><ref id="cit0091"><label>[91]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Katsura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sakurai</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Suppression of the p75 Neurotrophin Receptor in Uninjured Sensory Neurons Reduces Neuropathic Pain after Nerve Injury. J Neurosci</article-title>. <year>2006</year>;<volume>26</volume>:<fpage>11974</fpage>&#x02013;<lpage>11986</lpage>.</mixed-citation></ref><ref id="cit0092"><label>[92]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uchiyama</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guttapalli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gajghate</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>SMAD3 functions as a transcriptional repressor of acid-sensing ion channel 3 (ASIC3) in nucleus pulposus cells of the intervertebral disc</article-title>. <source>J Bone Miner Res</source>. <year>2008</year>;<volume>23</volume>:<fpage>1619</fpage>&#x02013;<lpage>1628</lpage>.<pub-id pub-id-type="pmid">18466073</pub-id></mixed-citation></ref><ref id="cit0093"><label>[93]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Biological behavior of human nucleus pulposus mesenchymal stem cells in response to changes in the acidic environment during intervertebral disc degeneration</article-title>. <source>Stem Cells Dev</source>. <year>2017</year>;<volume>26</volume>(<issue>12</issue>):<fpage>901</fpage>&#x02013;<lpage>911</lpage>. .<pub-id pub-id-type="pmid">28298159</pub-id></mixed-citation></ref><ref id="cit0094"><label>[94]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>HTJ</given-names></name>, <name name-style="western"><surname>Hodson</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Baird</surname><given-names>P</given-names></name>, et al</person-group>
<article-title>Acidic pH promotes intervertebral disc degeneration: acid-sensing ion channel-3 as a potential therapeutic target</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>12</lpage>. .<pub-id pub-id-type="pmid">28442746</pub-id></mixed-citation></ref><ref id="cit0095"><label>[95]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molliver</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Immke</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Fierro</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>ASIC3, an acid-sensing ion channel, is expressed in metaboreceptive sensory neurons</article-title>. <source>Mol Pain</source>. <year>2005</year>;<volume>1</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">15813987</pub-id></mixed-citation></ref><ref id="cit0096"><label>[96]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group>
<article-title>Femoral artery occlusion increases expression of ASIC3 in dorsal root ganglion neurons</article-title>. <source>Am J Physiol - Hear Circ Physiol</source>. <year>2010</year>;<volume>299</volume>(<issue>5</issue>):<fpage>1357</fpage>&#x02013;<lpage>1364</lpage>.</mixed-citation></ref><ref id="cit0097"><label>[97]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hattori</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Harding</surname><given-names>AMS</given-names></name>, et al</person-group>
<article-title>ASIC2a and ASIC3 heteromultimerize to form pH-sensitive channels in mouse cardiac DRG neurons</article-title>. <source>Circ Res</source>. <year>2009</year>;<volume>105</volume>(<issue>3</issue>):<fpage>279</fpage>&#x02013;<lpage>286</lpage>. .<pub-id pub-id-type="pmid">19590043</pub-id></mixed-citation></ref><ref id="cit0098"><label>[98]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Immke</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>McCleskey</surname><given-names>EW</given-names></name></person-group>
<article-title>Lactate enhances the acid-sensing NA+ channel on ischemia-sensing neurons</article-title>. <source>Nat Neurosci</source>. <year>2001</year>;<volume>4</volume>(<issue>9</issue>):<fpage>869</fpage>&#x02013;<lpage>870</lpage>.<pub-id pub-id-type="pmid">11528414</pub-id></mixed-citation></ref><ref id="cit0099"><label>[99]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yagi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wenk</surname><given-names>HN</given-names></name>, <name name-style="western"><surname>Naves</surname><given-names>LA</given-names></name>, et al</person-group>
<article-title>Sustained currents through ASIC3 ion channels at the modest pH changes that occur during myocardial ischemia</article-title>. <source>Circ Res</source>. <year>2006</year>;<volume>99</volume>(<issue>5</issue>):<fpage>501</fpage>&#x02013;<lpage>509</lpage>. .<pub-id pub-id-type="pmid">16873722</pub-id></mixed-citation></ref><ref id="cit0100"><label>[100]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birdsong</surname><given-names>WT</given-names></name>, <name name-style="western"><surname>Fierro</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>FG</given-names></name>, et al</person-group>
<article-title>Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels</article-title>. <source>Neuron.</source>
<year>2010</year> DOI:<pub-id pub-id-type="doi">10.1016/j.neuron.2010.09.029</pub-id>.</mixed-citation></ref><ref id="cit0101"><label>[101]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Light</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Hughen</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Dorsal root ganglion neurons innervating skeletal muscle respond to physiological combinations of protons, ATP, and lactate mediated by ASIC, P2X, and TRPV1</article-title>. <source>J Neurophysiol</source>. <year>2008</year>;<volume>100</volume>(<issue>3</issue>):<fpage>1184</fpage>&#x02013;<lpage>1201</lpage>. .<pub-id pub-id-type="pmid">18509077</pub-id></mixed-citation></ref><ref id="cit0102"><label>[102]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>ZY</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Whiteis</surname><given-names>CA</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channels contribute to transduction of extracellular acidosis in rat carotid body glomus cells</article-title>. <source>Circ Res</source>. <year>2007</year>;<volume>101</volume>(<issue>10</issue>):<fpage>1009</fpage>&#x02013;<lpage>1019</lpage>. .<pub-id pub-id-type="pmid">17872465</pub-id></mixed-citation></ref><ref id="cit0103"><label>[103]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abboud</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>CJ</given-names></name></person-group>
<article-title>ASICs and cardiovascular homeostasis</article-title>. <source>Neuropharmacol</source>. <year>2015</year>;<volume>94</volume>:<fpage>87</fpage>&#x02013;<lpage>98</lpage>.</mixed-citation></ref><ref id="cit0104"><label>[104]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>TBJ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>WN</given-names></name>, et al</person-group>
<article-title>Abnormal cardiac autonomic regulation in mice lacking ASIC3</article-title>. <source>Biomed Res Int</source>. <year>2014</year>;<fpage>2014:709159</fpage>.</mixed-citation></ref><ref id="cit0105"><label>[105]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>Genetic variation in the ASIC3 gene influences blood pressure levels in Taiwanese</article-title>. <source>J Hypertens</source>. <year>2008</year>;<volume>26</volume>(<issue>11</issue>):<fpage>2154</fpage>&#x02013;<lpage>2160</lpage>. .<pub-id pub-id-type="pmid">18854755</pub-id></mixed-citation></ref><ref id="cit0106"><label>[106]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>SH</given-names></name>, et al</person-group>
<article-title>Role of the acid-sensing ion channel 3 in blood volume control</article-title>. <source>Circ J</source>. <year>2011</year>;<volume>75</volume>(<issue>4</issue>):<fpage>874</fpage>&#x02013;<lpage>883</lpage>. .<pub-id pub-id-type="pmid">21304211</pub-id></mixed-citation></ref><ref id="cit0107"><label>[107]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Napoli</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Guardasole</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Zarra</surname><given-names>E</given-names></name>, et al</person-group>
<article-title>Migraine attack restores the response of vascular smooth muscle cells to nitric oxide but not to norepinephrine</article-title>. <source>World J Cardiol</source>. <year>2013</year>;<volume>5</volume>(<issue>10</issue>):<fpage>375</fpage>. .<pub-id pub-id-type="pmid">24198907</pub-id></mixed-citation></ref><ref id="cit0108"><label>[108]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Farley</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Swenson</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>Extracellular acidosis activates ASIC-like channels in freshly isolated cerebral artery smooth muscle cells</article-title>. <source>Am J Physiol - Cell Physiol</source>. <year>2010</year>;<volume>298</volume>(<issue>5</issue>):<fpage>1198</fpage>&#x02013;<lpage>1208</lpage>. .</mixed-citation></ref><ref id="cit0109"><label>[109]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grifoni</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Jernigan</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>ASIC proteins regulate smooth muscle cell migration</article-title>. <source>Microvasc Res</source>. <year>2008</year>;<volume>75</volume>(<issue>2</issue>):<fpage>202</fpage>&#x02013;<lpage>210</lpage>. .<pub-id pub-id-type="pmid">17936312</pub-id></mixed-citation></ref><ref id="cit0110"><label>[110]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fromy</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lingueglia</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sigaudo-Roussel</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>Asic3 is a neuronal mechanosensor for pressure-induced vasodilation that protects against pressure ulcers</article-title>. <source>Nat Med</source>. <year>2012</year>;<volume>18</volume>(<issue>8</issue>):<fpage>1205</fpage>&#x02013;<lpage>1207</lpage>. .<pub-id pub-id-type="pmid">22842475</pub-id></mixed-citation></ref><ref id="cit0111"><label>[111]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukuda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ichikawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Terayama</surname><given-names>R</given-names></name>, et al</person-group>
<article-title>ASIC3-immunoreactive neurons in the rat vagal and glossopharyngeal sensory ganglia</article-title>. <source>Brain Res</source>. <year>2006</year>;<volume>1081</volume>(<issue>1</issue>):<fpage>150</fpage>&#x02013;<lpage>155</lpage>. .<pub-id pub-id-type="pmid">16510130</pub-id></mixed-citation></ref><ref id="cit0112"><label>[112]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Brierley</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>CM</given-names></name>, et al</person-group>
<article-title>Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function</article-title>. <source>Gut.</source>
<year>2005</year>;<volume>54</volume>(<issue>10</issue>):<fpage>1408</fpage>&#x02013;<lpage>1415</lpage>. .<pub-id pub-id-type="pmid">15987792</pub-id></mixed-citation></ref><ref id="cit0113"><label>[113]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Brierley</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>RL</given-names></name>, et al</person-group>
<article-title>Localization and comparative analysis of acid-sensing ion channel (ASIC1, 2, and 3) mRNA expression in mouse colonic sensory neurons within thoracolumbar dorsal root ganglia</article-title>. <source>J Comp Neurol</source>. <year>2007</year>;<volume>500</volume>(<issue>5</issue>):<page-range>p. p. 863&#x02013;875</page-range>. .</mixed-citation></ref><ref id="cit0114"><label>[114]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dusenkova</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ru</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Surdenikova</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>The expression profile of acid-sensing ion channel (ASIC) subunits ASIC1a, ASIC1b, ASIC2a, ASIC2b, and ASIC3 in the esophageal vagal afferent nerve subtypes</article-title>. <source>Am J Physiol - Gastrointest Liver Physiol</source>. <year>2014</year>;<volume>307</volume>(<issue>9</issue>):<fpage>G922</fpage>&#x02013;<lpage>G930</lpage>. .<pub-id pub-id-type="pmid">25190475</pub-id></mixed-citation></ref><ref id="cit0115"><label>[115]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sugiura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Dang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lamb</surname><given-names>K</given-names></name>, et al</person-group>
<article-title>Acid-sensing properties in rat gastric sensory neurons from normal and ulcerated stomach</article-title>. <source>J Neurosci</source>. <year>2005</year>;<volume>25</volume>(<issue>10</issue>):<fpage>2617</fpage>&#x02013;<lpage>2627</lpage>. .<pub-id pub-id-type="pmid">15758172</pub-id></mixed-citation></ref><ref id="cit0116"><label>[116]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wultsch</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Painsipp</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Shahbazian</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>Deletion of the acid-sensing ion channel ASIC3 prevents gastritis-induced acid hyperresponsiveness of the stomach &#x02013; brainstem axis</article-title>. <source>Pain.</source>
<year>2015</year>;<volume>134</volume>(<issue>3</issue>):<fpage>245</fpage>&#x02013;<lpage>253</lpage>. .</mixed-citation></ref><ref id="cit0117"><label>[117]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bielefeldt</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>BM</given-names></name></person-group>
<article-title>Differential effects of ASIC3 and TRPV1 deletion on gastroesophageal sensation in mice</article-title>. <source>Am J Physiol - Gastrointest Liver Physiol</source>. <year>2007</year>;<volume>294</volume>:<fpage>130</fpage>&#x02013;<lpage>138</lpage>.</mixed-citation></ref><ref id="cit0118"><label>[118]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yiangou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Facer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>JAM</given-names></name>, et al</person-group>
<article-title>Increased acid-sensing ion channel ASIC-3 in inflamed human intestine</article-title>. <source>Eur J Gastroenterol Hepatol</source>. <year>2001</year>;<volume>13</volume>(<issue>8</issue>):<fpage>891</fpage>&#x02013;<lpage>896</lpage>. .<pub-id pub-id-type="pmid">11507351</pub-id></mixed-citation></ref><ref id="cit0119"><label>[119]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>RCW</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gebhart</surname><given-names>GF</given-names></name></person-group>
<article-title>The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3</article-title>. <source>J Neurosci</source>. <year>2005</year>;<volume>25</volume>(<issue>47</issue>):<page-range>p. 10981&#x02013;10989</page-range>.</mixed-citation></ref><ref id="cit0120"><label>[120]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>RCW</given-names></name>, <name name-style="western"><surname>Otsuka</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wagstrom</surname><given-names>E</given-names></name>, et al</person-group>
<article-title>Short-Term Sensitization of Colon Mechanoreceptors Is Associated With Long-Term Hypersensitivity to Colon Distention in the Mouse</article-title>. <source>Gastroenterology.</source>
<year>2007</year>;<volume>133</volume>(<issue>1</issue>):<fpage>184</fpage>&#x02013;<lpage>194</lpage>. .<pub-id pub-id-type="pmid">17553498</pub-id></mixed-citation></ref><ref id="cit0121"><label>[121]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groth</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Helbig</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Grau</surname><given-names>V</given-names></name>, et al</person-group>
<article-title>Spinal afferent neurons projecting to the rat lung and pleura express acid sensitive channels</article-title>. <source>Respir Res</source>. <year>2006</year>;<volume>7</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>16</lpage>. .<pub-id pub-id-type="pmid">16390543</pub-id></mixed-citation></ref><ref id="cit0122"><label>[122]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>LY</given-names></name></person-group>
<article-title>Characterization of acid signaling in rat vagal pulmonary sensory neurons</article-title>. <source>Am J Physiol - Lung Cell Mol Physiol</source>. <year>2006</year>;<volume>291</volume>(<issue>1</issue>):<fpage>58</fpage>&#x02013;<lpage>65</lpage>.</mixed-citation></ref><ref id="cit0123"><label>[123]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Shrestha</surname><given-names>K</given-names></name>, et al</person-group>
<article-title>Interregulation of Proton-gated Na+ Channel 3 and Cystic Fibrosis Transmembrane Conductance Regulator.</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>48</issue>):<fpage>36960</fpage>&#x02013;<lpage>36968</lpage>. .<pub-id pub-id-type="pmid">17012229</pub-id></mixed-citation></ref><ref id="cit0124"><label>[124]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labaki</surname><given-names>WW</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>MK</given-names></name></person-group>
<article-title>Chronic respiratory diseases: a global view</article-title>. <source>Lancet Respir [Internet]</source>. <year>2020</year>;<volume>8</volume>(<issue>6</issue>):<fpage>531</fpage>&#x02013;<lpage>533</lpage>.</mixed-citation></ref><ref id="cit0125"><label>[125]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>LY</given-names></name></person-group>
<article-title>Airway irritation and cough evoked by acid: from human to ion channel</article-title>. <source>Curr Opin Pharmacol</source>. <year>2011</year>;<volume>11</volume>(<issue>3</issue>):<fpage>238</fpage>&#x02013;<lpage>247</lpage>.<pub-id pub-id-type="pmid">21543258</pub-id></mixed-citation></ref><ref id="cit0126"><label>[126]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ricciardolo</surname><given-names>FLM</given-names></name></person-group>
<article-title>Mechanisms of Citric Acid &#x02013; induced bronchoconstriction</article-title>. Am J Med. <year>2001;11(8):18&#x02013;24</year>.</mixed-citation></ref><ref id="cit0127"><label>[127]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spathis</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Booth</surname><given-names>S</given-names></name></person-group>
<article-title>End of life care in chronic obstructive pulmonary disease: in search of a good death</article-title>. <source>Int J COPD</source>. <year>2008</year>;<volume>3</volume>:<fpage>11</fpage>&#x02013;<lpage>29</lpage>.</mixed-citation></ref><ref id="cit0128"><label>[128]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Dinger</surname><given-names>B</given-names></name>, et al</person-group>
<article-title>Chronic hypoxia-induced acid-sensitive ion channel expression in chemoafferent neurons contributes to chemoreceptor hypersensitivity</article-title>. <source>Am J Physiol - Lung Cell Mol Physiol</source>. <year>2011</year>;<volume>301</volume>(<issue>6</issue>):<fpage>985</fpage>&#x02013;<lpage>992</lpage>. .</mixed-citation></ref><ref id="cit0129"><label>[129]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voilley</surname><given-names>N</given-names></name>, <name name-style="western"><surname>De Weille</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mamet</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors</article-title>. <source>J Neurosci</source>. <year>2001</year>;<volume>21</volume>(<issue>20</issue>):<fpage>8026</fpage>&#x02013;<lpage>8033</lpage>. .<pub-id pub-id-type="pmid">11588175</pub-id></mixed-citation></ref><ref id="cit0130"><label>[130]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishibashi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Marumo</surname><given-names>F</given-names></name></person-group>
<article-title>Molecular cloning of a DEG/ENaC sodium channel cDNA from human testis</article-title>. <source>Biochem Biophys Res Commun</source>. <year>1998</year>;<volume>245</volume>(<issue>2</issue>):<fpage>589</fpage>&#x02013;<lpage>593</lpage>.<pub-id pub-id-type="pmid">9571199</pub-id></mixed-citation></ref><ref id="cit0131"><label>[131]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Payne</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Brzezinski</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>AV</given-names></name>, et al</person-group>
<article-title>Lessons Learned from a Middle-Aged Man with Testicular Pain: exercises in Clinical Reasoning</article-title>. <source>J Gen Intern Med</source>. <year>2017</year>;<volume>32</volume>(<issue>3</issue>):<fpage>355</fpage>&#x02013;<lpage>359</lpage>. .<pub-id pub-id-type="pmid">27778213</pub-id></mixed-citation></ref><ref id="cit0132"><label>[132]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ditting</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tiegs</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rodionova</surname><given-names>K</given-names></name>, et al</person-group>
<article-title>Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney?</article-title>
<source>Am J Physiol - Ren Physiol</source>. <year>2009</year>;<volume>297</volume>(<issue>5</issue>):<fpage>1427</fpage>&#x02013;<lpage>1434</lpage>. .</mixed-citation></ref><ref id="cit0133"><label>[133]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bielefeldt</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gebhart</surname><given-names>GF</given-names></name></person-group>
<article-title>Differential responses of bladder lumbosacral and thoracolumbar dorsal root ganglion neurons to purinergic agonists, protons, and capsaicin</article-title>. <source>J Neurosci</source>. <year>2005</year>;<volume>25</volume>(<issue>15</issue>):<fpage>3973</fpage>&#x02013;<lpage>3984</lpage>.<pub-id pub-id-type="pmid">15829649</pub-id></mixed-citation></ref><ref id="cit0134"><label>[134]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montalbetti</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Rooney</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Marciszyn</surname><given-names>AL</given-names></name>, et al</person-group>
<article-title>ASIC3 fine-tunes bladder sensory signaling</article-title>. <source>Am J Physiol - Ren Physiol</source>. <year>2018</year>;<volume>315</volume>(<issue>4</issue>):<fpage>F870</fpage>&#x02013;<lpage>F879</lpage>. .</mixed-citation></ref><ref id="cit0135"><label>[135]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corrow</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Girard</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Vizzard</surname><given-names>MA</given-names></name></person-group>
<article-title>Expression and response of acid-sensing ion channels in urinary bladder to cyclophosphamide-induced cystitis</article-title>. <source>Am J Physiol - Ren Physiol</source>. <year>2010</year>;<volume>298</volume>(<issue>5</issue>):<fpage>1130</fpage>&#x02013;<lpage>1139</lpage>.</mixed-citation></ref><ref id="cit0136"><label>[136]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#x000e1;nchez-Freire</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Blanchard</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Burkhard</surname><given-names>FC</given-names></name>, et al</person-group>
<article-title>Acid-sensing channels in human bladder: expression, function and alterations during bladder pain syndrome.</article-title>. <source>J Urol [Internet]</source>. <year>2011</year>;<volume>186</volume>(<issue>4</issue>):<fpage>1509</fpage>&#x02013;<lpage>1516</lpage>.</mixed-citation></ref><ref id="cit0137"><label>[137]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Welch</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mulligan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bingham</surname><given-names>S</given-names></name>, &#x00026; <name name-style="western"><surname>Khaw</surname><given-names>K</given-names></name></person-group> Urine pH is an indicator of dietary acid&#x02013;base load, fruit and vegetables and meat intakes: results from the European Prospective Investigation into Cancer and Nutrition (<publisher-loc>EPIC)-Norfolk population study, fruit and vegetables and meat intakes</publisher-loc>: <publisher-name>Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk population study</publisher-name>Br J Nutr. <year>2008</year>;99(6):1335&#x02013;1343. doi:<pub-id pub-id-type="doi">10.1017/S0007114507862350</pub-id>
<issue>6</issue>
<volume>99</volume>
<fpage>S33</fpage>-<lpage>1343</lpage></mixed-citation></ref><ref id="cit0138"><label>[138]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>HC</given-names></name>, et al</person-group>
<article-title>Association between urine pH and common uropathogens in children with urinary tract infections</article-title>. <source>J Microbiol Immunol Infect [Internet]</source>. <year>2019</year>
<pub-id pub-id-type="doi">10.1016/j.jmii.2019.08.002</pub-id></mixed-citation></ref><ref id="cit0139"><label>[139]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gautam</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Kaur</surname><given-names>IR</given-names></name></person-group>
<article-title>Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: a randomized placebo-controlled clinical research study</article-title>. <source>Int Urol Nephrol</source>. <year>2016</year>. doi:<pub-id pub-id-type="doi">10.1007/s11255-016-1342-8</pub-id></mixed-citation></ref><ref id="cit0140"><label>[140]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#x000e1;lez-Garrido</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vega</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mercado</surname><given-names>F</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channels expression, identity and role in the excitability of the cochlear afferent neurons</article-title>. <source>Front Cell Neurosci</source>. <year>2015</year>;<volume>9</volume>:<fpage>1</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">25667569</pub-id></mixed-citation></ref><ref id="cit0141"><label>[141]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hildebrand</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>De Silva</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Klockars</surname><given-names>T</given-names></name>, et al</person-group>
<article-title>Characterisation of DRASIC in the mouse inner ear</article-title>. <source>Hear Res</source>. <year>2004</year>;<volume>190</volume>(<issue>1&#x02013;2</issue>):<fpage>149</fpage>&#x02013;<lpage>160</lpage>. .<pub-id pub-id-type="pmid">15051137</pub-id></mixed-citation></ref><ref id="cit0142"><label>[142]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mercado</surname><given-names>F</given-names></name>, <name name-style="western"><surname>L&#x000f3;pez</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Acuna</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>Acid-sensing ionic channels in the rat vestibular endorgans and ganglia</article-title>. <source>J Neurophysiol</source>. <year>2006</year>;<volume>96</volume>(<issue>3</issue>):<fpage>1615</fpage>&#x02013;<lpage>1624</lpage>. .<pub-id pub-id-type="pmid">16790596</pub-id></mixed-citation></ref><ref id="cit0143"><label>[143]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>EYK</given-names></name>, et al</person-group>
<article-title>Asic3 -/- female mice with hearing deficit affects social development of pups</article-title>. <source>PLoS One</source>. <year>2009</year>;<fpage>4:e6508</fpage>.</mixed-citation></ref><ref id="cit0144"><label>[144]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ettaiche</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Deval</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pagnotta</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channel 3 in retinal function and survival</article-title>. <source>Investig Ophthalmol Vis Sci</source>. <year>2009</year>;<volume>50</volume>(<issue>5</issue>):<fpage>2417</fpage>&#x02013;<lpage>2426</lpage>. .<pub-id pub-id-type="pmid">19117938</pub-id></mixed-citation></ref><ref id="cit0145"><label>[145]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lilley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>LeTissier</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>J</given-names></name></person-group>
<article-title>The Discovery and Characterization of a Proton-Gated Sodium Current in Rat Retinal Ganglion Cells</article-title>. <source>J Neurosci</source>. <year>2004</year>;<volume>24</volume>(<issue>5</issue>):<fpage>1013</fpage>&#x02013;<lpage>1022</lpage>.<pub-id pub-id-type="pmid">14762119</pub-id></mixed-citation></ref><ref id="cit0146"><label>[146]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>JN</given-names></name></person-group>
<article-title>The changes of vitreous pH values in an acute glaucoma rabbit model</article-title>. <source>J Ocul Pharmacol Ther</source>. <year>2001</year>;<volume>17</volume>(<issue>4</issue>):<fpage>343</fpage>&#x02013;<lpage>350</lpage>.<pub-id pub-id-type="pmid">11572465</pub-id></mixed-citation></ref><ref id="cit0147"><label>[147]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sol&#x000e9;-Magdalena</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Revuelta</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Men&#x000e9;nez-D&#x000ed;az</surname><given-names>I</given-names></name>, et al</person-group>
<article-title>Human odontoblasts express transient receptor protein and acid-sensing ion channel mechanosensor proteins</article-title>. <source>Microsc Res Tech</source>. <year>2011</year>;<volume>74</volume>(<issue>5</issue>):<page-range>p. p. 457&#x02013;463</page-range>. .</mixed-citation></ref><ref id="cit0148"><label>[148]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carda</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Peydr&#x000f3;</surname><given-names>A</given-names></name></person-group>
<article-title>Ultrastructural patterns of human dentinal tubules, odontoblasts processes and nerve fibres</article-title>. <source>Tissue Cell</source>. <year>2006</year>;<volume>38</volume>(<issue>2</issue>):<fpage>141</fpage>&#x02013;<lpage>150</lpage>.<pub-id pub-id-type="pmid">16546231</pub-id></mixed-citation></ref><ref id="cit0149"><label>[149]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichikawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sugimoto</surname><given-names>T</given-names></name></person-group>
<article-title>The co-expression of ASIC3 with calcitonin gene-related peptide and parvalbumin in the rat trigeminal ganglion</article-title>. <source>Brain Res</source>. <year>2002</year>;<volume>943</volume>(<issue>2</issue>):<fpage>287</fpage>&#x02013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">12101052</pub-id></mixed-citation></ref><ref id="cit0150"><label>[150]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Harada</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>I</given-names></name>, et al</person-group>
<article-title>Detection of acid-sensing ion channel 3 (ASIC3) in periodontal Ruffini endings of mouse incisors.</article-title>. <source>Neurosci Lett [Internet]</source>. <year>2011</year>;<volume>488</volume>(<issue>2</issue>):<fpage>173</fpage>&#x02013;<lpage>177</lpage>.</mixed-citation></ref><ref id="cit0151"><label>[151]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huque</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cowart</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Dankulich-Nagrudny</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>Sour ageusia in two individuals implicates ion channels of the ASIC and PKD families in human sour taste perception at the anterior tongue</article-title>. <source>PLoS One</source>. <year>2009</year>;<fpage>4:e7347</fpage>.</mixed-citation></ref><ref id="cit0152"><label>[152]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ogura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kinnamon</surname><given-names>SC</given-names></name></person-group>
<article-title>Acid-activated cation currents in rat vallate taste receptor cells</article-title>. <source>J Neurophysiol</source>. <year>2002</year>;<volume>88</volume>(<issue>1</issue>):<fpage>133</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">12091539</pub-id></mixed-citation></ref><ref id="cit0153"><label>[153]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnett</surname><given-names>T</given-names></name></person-group>
<article-title>Regulation of bone cell function by acid&#x02013;base balance</article-title>. <source>Proc Nutr Soc [Internet]</source>. <year>2003</year>;<volume>62</volume>(<issue>2</issue>):<fpage>511</fpage>&#x02013;<lpage>520</lpage>. <ext-link ext-link-type="uri" xlink:href="http://Available&#x000a0;from:&#x000a0;https://www.cambridge.org/core/product/identifier/S0029665103000673/type/journal_article">Available from: https://www.cambridge.org/core/product/identifier/S0029665103000673/type/journal_article</ext-link>. .</mixed-citation></ref><ref id="cit0154"><label>[154]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jahr</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Van Driel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Van Osch</surname><given-names>GJVM</given-names></name>, et al</person-group>
<article-title>Identification of acid-sensing ion channels in bone</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2005</year>;<volume>337</volume>(<issue>1</issue>):<fpage>349</fpage>&#x02013;<lpage>354</lpage>.<pub-id pub-id-type="pmid">16185661</pub-id></mixed-citation></ref><ref id="cit0155"><label>[155]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoneda</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hiasa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nagata</surname><given-names>Y</given-names></name>, et al</person-group>
<article-title>Acidic microenvironment and bone pain in cancer-colonized bone.</article-title>. <source>Bonekey Rep [Internet]</source>. <year>2015</year>;<volume>4</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="cit0156"><label>[156]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W-N</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>X</given-names></name>, et al</person-group>
<article-title>Acid-Sensing Ion Channels Contribute to the Effect of Acidosis on the Function of Dendritic Cells</article-title>. <source>J Immunol</source>. <year>2011</year>;<volume>186</volume>(<issue>6</issue>):<fpage>3686</fpage>&#x02013;<lpage>3692</lpage>. .<pub-id pub-id-type="pmid">21321108</pub-id></mixed-citation></ref><ref id="cit0157"><label>[157]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>XW</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Ni</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Acid-sensing ion channels promote the inflammation and migration of cultured rat microglia</article-title>. <source>Glia.</source>
<year>2015</year>;<volume>63</volume>(<issue>3</issue>):<page-range>p. p. 483&#x02013;496</page-range>. .</mixed-citation></ref><ref id="cit0158"><label>[158]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>WN</given-names></name>, et al</person-group>
<article-title>Existence and distinction of acid-evoked currents in rat astrocytes</article-title>. <source>Glia.</source>
<year>2010</year>;<volume>58</volume>(<issue>12</issue>):<fpage>1415</fpage>&#x02013;<lpage>1424</lpage>. .<pub-id pub-id-type="pmid">20549751</pub-id></mixed-citation></ref><ref id="cit0159"><label>[159]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Chou</surname><given-names>HH</given-names></name>, et al</person-group>
<article-title>Association between an ASIC3 gene variant and insulin resistance in Taiwanese.</article-title>. <source>Clin Chim Acta [Internet]</source>. <year>2010</year>;<volume>411</volume>(<issue>15&#x02013;16</issue>):<fpage>1132</fpage>&#x02013;<lpage>1136</lpage>.</mixed-citation></ref><ref id="cit0160"><label>[160]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>YW</given-names></name>, et al</person-group>
<article-title>Increase of insulin sensitivity and reversal of age-dependent glucose intolerance with inhibition of ASIC3</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2008</year>;<volume>371</volume>(<issue>4</issue>):<fpage>729</fpage>&#x02013;<lpage>734</lpage>.<pub-id pub-id-type="pmid">18466760</pub-id></mixed-citation></ref><ref id="cit0161"><label>[161]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khawaja</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Abu-Shennar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Saleh</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; The case of Jordan</article-title>. <source>Diabetol Metab Syndr [Internet]</source>. <year>2018</year>;<volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="cit0162"><label>[162]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hicks</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Selvin</surname><given-names>E</given-names></name></person-group>
<article-title>Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes</article-title>. <source>Curr Diab Rep</source>. <year>2019</year>;<fpage>19:86</fpage>.<pub-id pub-id-type="pmid">30887399</pub-id></mixed-citation></ref><ref id="cit0163"><label>[163]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Digirolamo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Newby</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Lovejoy</surname><given-names>J</given-names></name></person-group>
<article-title>Lactate production in adipose tissue; a regulated function with extra&#x02010;adipose implications</article-title>. <source>Faseb J</source>. <year>1992</year> DOI:<pub-id pub-id-type="doi">10.1096/fasebj.6.7.1563593</pub-id></mixed-citation></ref><ref id="cit0164"><label>[164]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mamet</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Baron</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lazdunski</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Proinflammatory mediators, stimulators of sensory neuron excitability via the expression of acid-sensing ion channels</article-title>. <source>J Neurosci</source>. <year>2002</year>;<volume>22</volume>(<issue>24</issue>):<fpage>10662</fpage>&#x02013;<lpage>10670</lpage>.<pub-id pub-id-type="pmid">12486159</pub-id></mixed-citation></ref><ref id="cit0165"><label>[165]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deval</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Salinas</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Baron</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>ASIC2b-dependent Regulation of ASIC3, an Essential Acid-sensing Ion Channel Subunit in Sensory Neurons via the Partner Protein PICK-1</article-title>. <source>J Biol Chem</source>. <year>2004</year> DOI:<pub-id pub-id-type="doi">10.1074/jbc.M313078200</pub-id>.</mixed-citation></ref><ref id="cit0166"><label>[166]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Cadiou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>McNaughton</surname><given-names>PA</given-names></name></person-group>
<article-title>Arachidonic acid potentiates acid-sensing ion channels in rat sensory neurons by a direct action</article-title>. <source>Neuroscience.</source>
<year>2007</year>;<volume>145</volume>(<issue>2</issue>):<fpage>686</fpage>&#x02013;<lpage>698</lpage>.<pub-id pub-id-type="pmid">17258862</pub-id></mixed-citation></ref><ref id="cit0167"><label>[167]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marra</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ferru-cl&#x000e9;ment</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Breuil</surname><given-names>V</given-names></name>, et al</person-group>
<article-title>Non-acidic activation of pain-related Acid-Sensing Ion Channel 3 by lipids</article-title>. EMBO J. <year>2016</year>;<volume>35</volume>:<fpage>414</fpage>&#x02013;<lpage>428</lpage>.</mixed-citation></ref><ref id="cit0168"><label>[168]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cadiou</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Studer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>NG</given-names></name>, et al</person-group>
<article-title>Modulation of acid-sensing ion channel activity by nitric oxide</article-title>. <source>J Neurosci</source>. <year>2007</year>;<volume>27</volume>(<issue>48</issue>):<fpage>13251</fpage>&#x02013;<lpage>13260</lpage>. .<pub-id pub-id-type="pmid">18045919</pub-id></mixed-citation></ref><ref id="cit0169"><label>[169]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Askwith</surname><given-names>CC</given-names></name></person-group>
<article-title>Potentiation of acid-sensing ion channels by sulfhydryl compounds</article-title>. <source>Am J Physiol - Cell Physiol</source>. <year>2007</year>;<fpage>292:C2161&#x02013;174</fpage>.</mixed-citation></ref><ref id="cit0170"><label>[170]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osafo</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Agyare</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Obiri</surname><given-names>DD</given-names></name>, et al</person-group>
<article-title>Mechanism of Action of Nonsteroidal Anti-Inflammatory Drugs, Nonsteroidal Anti-Inflammatory Drugs</article-title>. <source>IntechOpen.</source>. <year>2017</year>;<page-range>p. 13</page-range>. InTech.</mixed-citation></ref><ref id="cit0171"><label>[171]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lynagh</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Romero-Rojo</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Lund</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Molecular Basis for Allosteric Inhibition of Acid-Sensing Ion Channel 1a by Ibuprofen</article-title>. <source>J Med Chem</source>. <year>2017</year>;<volume>60</volume>(<issue>19</issue>):<fpage>8192</fpage>&#x02013;<lpage>8200</lpage>. .<pub-id pub-id-type="pmid">28949138</pub-id></mixed-citation></ref><ref id="cit0172"><label>[172]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CC</given-names></name>, et al</person-group>
<article-title>Identification and characterization of a subset of mouse sensory neurons that express acid-sensing ion channel 3</article-title>. <source>Neuroscience.</source>
<year>2008</year>;<volume>151</volume>(<issue>2</issue>):<fpage>544</fpage>&#x02013;<lpage>557</lpage>. .<pub-id pub-id-type="pmid">18082972</pub-id></mixed-citation></ref><ref id="cit0173"><label>[173]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leng</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cottrell</surname><given-names>JE</given-names></name>, et al</person-group>
<article-title>Subunit and frequency-dependent inhibition of Acid Sensing Ion Channels by local anesthetic tetracaine.</article-title>. <source>Mol Pain [Internet]</source>. <year>2013</year>;<volume>9</volume>:<fpage>1</fpage>
<comment>Available from: Molecular Pain</comment></mixed-citation></ref><ref id="cit0174"><label>[174]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>Inhibition of acid-sensing ion channel currents by propofol in rat dorsal root ganglion neurons</article-title>. <source>Clin Exp Pharmacol Physiol</source>. <year>2014</year>;<volume>41</volume>(<issue>4</issue>):<page-range>p. p. 295&#x02013;300</page-range>. .</mixed-citation></ref><ref id="cit0175"><label>[175]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Koshelev</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Andreev</surname><given-names>YA</given-names></name>, et al</person-group>
<article-title>Endogenous isoquinoline alkaloids agonists of acid-sensing ion channel type 3</article-title>. <source>Front Mol Neurosci</source>. <year>2017</year>;<volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">28167898</pub-id></mixed-citation></ref><ref id="cit0176"><label>[176]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farrag</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Drobish</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Puhl</surname><given-names>HL</given-names></name>, et al</person-group>
<article-title>Endomorphins potentiate acid-sensing ion channel currents and enhance the lactic acid-mediated increase in arterial blood pressure: effects amplified in hindlimb ischaemia</article-title>. <source>J Physiol</source>. <year>2017</year>;<volume>595</volume>(<issue>23</issue>):<page-range>p. p. 7167&#x02013;7183</page-range>. .</mixed-citation></ref><ref id="cit0177"><label>[177]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Askwith</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Welsh</surname><given-names>MJ</given-names></name>, et al</person-group>
<article-title>DEG/ENaC ion channels involved in sensory transduction are modulated by cold temperature</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2001</year>;<volume>98</volume>(<issue>11</issue>):<fpage>6459</fpage>&#x02013;<lpage>6463</lpage>. .<pub-id pub-id-type="pmid">11353858</pub-id></mixed-citation></ref><ref id="cit0178"><label>[178]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neelands</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Mcdonald</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Differential effects of temperature on acid-activated currents mediated by TRPV1 and ASIC channels in rat dorsal root ganglion neurons</article-title>. <source>Brain Res [Internet]</source>. <year>2010</year>;<volume>1329</volume>:<fpage>55</fpage>&#x02013;<lpage>66</lpage>.</mixed-citation></ref><ref id="cit0179"><label>[179]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanchard</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Kellenberger</surname><given-names>S</given-names></name></person-group>
<article-title>Effect of a temperature increase in the non-noxious range on proton-evoked ASIC and TRPV1 activity. Pflugers&#x000a0;Arch</article-title>. <year>2011</year>;461:<fpage>123</fpage>&#x02013;<lpage>139</lpage>.</mixed-citation></ref><ref id="cit0180"><label>[180]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roush</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Kostis</surname><given-names>JB</given-names></name>, et al</person-group>
<article-title>Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses</article-title>. <source>J Hypertens</source>. <year>2016</year>;<volume>34</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>19</lpage>. .<pub-id pub-id-type="pmid">26556568</pub-id></mixed-citation></ref><ref id="cit0181"><label>[181]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleyman</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Cragoe</surname><given-names>EJ</given-names></name></person-group>
<article-title>Amiloride and its analogs as tools in the study of ion transport</article-title>. <source>J Membr Biol [Internet]</source>. <year>1988</year>;<volume>105</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>21</lpage>. <ext-link ext-link-type="uri" xlink:href="http://Available&#x000a0;from:&#x000a0;http://www.ncbi.nlm.nih.gov/pubmed/2852254">Available from: http://www.ncbi.nlm.nih.gov/pubmed/2852254</ext-link>. .</mixed-citation></ref><ref id="cit0182"><label>[182]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frelin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Barbry</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vigne</surname><given-names>P</given-names></name>, et al</person-group>
<article-title>Amiloride and its analogs as tools to inhibit Na+ transport via the Na+ channel, the Na+/H+ antiport and the Na+/Ca2+ exchanger</article-title>. <source>Biochimie.</source>
<year>1988</year> DOI:<pub-id pub-id-type="doi">10.1016/0300-9084(88)90196-4</pub-id>.</mixed-citation></ref><ref id="cit0183"><label>[183]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manev</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bertolino</surname><given-names>M</given-names></name>, <name name-style="western"><surname>DeErausquin</surname><given-names>G</given-names></name></person-group>
<article-title>Amiloride blocks glutamate-operated cationic channels and protects neurons in culture from glutamate-induced death</article-title>. <source>Neuropharmacology.</source>
<year>1990</year>;<volume>29</volume>(<issue>12</issue>):<fpage>1103</fpage>&#x02013;<lpage>1110</lpage>.<pub-id pub-id-type="pmid">1963475</pub-id></mixed-citation></ref><ref id="cit0184"><label>[184]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baconguis</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bohlen</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Goehring</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>X-ray structure of acid-sensing ion channel 1-snake toxin complex reveals open state of a Na+-selective channel.</article-title>. <source>Cell</source>. <year>2014</year>;<volume>156</volume>(<issue>4</issue>):<fpage>717</fpage>&#x02013;<lpage>729</lpage>.<pub-id pub-id-type="pmid">24507937</pub-id></mixed-citation></ref><ref id="cit0185"><label>[185]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Nonproton ligand sensing domain is required for paradoxical stimulation of Acid-sensing Ion Channel 3 (ASIC3) channels by amiloride</article-title>. <source>J Biol Chem</source>. <year>2011</year>;<volume>286</volume>(<issue>49</issue>):<fpage>42635</fpage>&#x02013;<lpage>42646</lpage>. .<pub-id pub-id-type="pmid">21998313</pub-id></mixed-citation></ref><ref id="cit0186"><label>[186]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dub&#x000e9;</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Lehto</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Breese</surname><given-names>NM</given-names></name>, et al</person-group>
<article-title>Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels</article-title>. <source>Pain.</source>
<year>2005</year>;<volume>117</volume>(<issue>1</issue>):<fpage>88</fpage>&#x02013;<lpage>96</lpage>. .<pub-id pub-id-type="pmid">16061325</pub-id></mixed-citation></ref><ref id="cit0187"><label>[187]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dwyer</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Rizzo</surname><given-names>SJS</given-names></name>, <name name-style="western"><surname>Neal</surname><given-names>SJ</given-names></name>, et al</person-group>
<article-title>Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models</article-title>. <source>Psychopharmacol (Berl)</source>. <year>2009</year>;<volume>203</volume>(<issue>1</issue>):<fpage>41</fpage>&#x02013;<lpage>52</lpage>. .</mixed-citation></ref><ref id="cit0188"><label>[188]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuduk</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Di Marco</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>RK</given-names></name>, et al</person-group>
<article-title>Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3).</article-title>. <source>Bioorganic Med Chem Lett [Internet]</source>. <year>2009</year>;<volume>19</volume>(<issue>9</issue>):<fpage>2514</fpage>&#x02013;<lpage>2518</lpage>.</mixed-citation></ref><ref id="cit0189"><label>[189]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuduk</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Di Marco</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Bodmer-Narkevitch</surname><given-names>V</given-names></name>, et al</person-group>
<article-title>Synthesis, structure-activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567</article-title>. <source>ACS Chem Neurosci</source>. <year>2010</year>;<volume>1</volume>(<issue>1</issue>):<page-range>p. p. 19&#x02013;24</page-range>. .</mixed-citation></ref><ref id="cit0190"><label>[190]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolkenberg</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Mulhearn</surname><given-names>JJ</given-names></name>, et al</person-group>
<article-title>High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors</article-title>. <source>Bioorganic Med Chem Lett [Internet]</source>. <year>2011</year>;<volume>21</volume>(<issue>9</issue>):<fpage>2646</fpage>&#x02013;<lpage>2649</lpage>.</mixed-citation></ref><ref id="cit0191"><label>[191]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>WG</given-names></name>, et al</person-group>
<article-title>A nonproton ligand sensor in the acid-sensing ion channel</article-title>. <source>Neuron.</source>
<year>2010</year>;<volume>68</volume>(<issue>1</issue>):<fpage>61</fpage>&#x02013;<lpage>72</lpage>. .<pub-id pub-id-type="pmid">20920791</pub-id></mixed-citation></ref><ref id="cit0192"><label>[192]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Callejo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pattison</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Greenhalgh</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Chakrabarti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Andreopoulou</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hockley</surname><given-names>James R.F.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>Ewan St. John.</given-names></name>, <name name-style="western"><surname>Rahman</surname><given-names>T</given-names></name></person-group>
<article-title>In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3</article-title>. <source>Biochem Pharmacol</source>. <year>2020</year>;<volume>174</volume>:<fpage>113834</fpage> doi:<pub-id pub-id-type="doi">10.1016/j.bcp.2020.113834</pub-id><pub-id pub-id-type="pmid">32027884</pub-id></mixed-citation></ref><ref id="cit0193"><label>[193]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agharkar</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>EB</given-names></name></person-group>
<article-title>4-Chlorophenylguanidine is an ASIC3 agonist and positive allosteric modulator.</article-title>. <source>J Pharmacol Sci [Internet]</source>. <year>2017</year>;<volume>133</volume>(<issue>3</issue>):<fpage>184</fpage>&#x02013;<lpage>186</lpage>.</mixed-citation></ref><ref id="cit0194"><label>[194]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Sami Shaikh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>W</given-names></name>, et al</person-group>
<article-title>Non-proton ligand-sensing domain of acid-sensing ion channel 3 is required for itch sensation</article-title>. <source>J Neurochem</source>. <year>2016</year>;<volume>139</volume>(<issue>6</issue>):<page-range>p. p. 1093&#x02013;1101</page-range>. .</mixed-citation></ref><ref id="cit0195"><label>[195]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>ZD</given-names></name>, et al</person-group>
<article-title>ASIC3 Channels Integrate Agmatine and Multiple Inflammatory Signals through the Nonproton Ligand Sensing Domain</article-title>. <source>Mol Pain</source>. <year>2010</year>;<volume>6</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">20089138</pub-id></mixed-citation></ref><ref id="cit0196"><label>[196]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sastre</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Galea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Feinstein</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines</article-title>. <source>J Biochem</source>. <year>1998</year>;<volume>330</volume>(<issue>3</issue>):<fpage>1405</fpage>&#x02013;<lpage>1409</lpage>. .</mixed-citation></ref><ref id="cit0197"><label>[197]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, et al</person-group>
<article-title>Serotonin facilitates peripheral pain sensitivity in a manner that depends on the nonproton ligand sensing domain of ASIC3 channel</article-title>. <source>J Neurosci</source>. <year>2013</year>;<volume>33</volume>(<issue>10</issue>):<fpage>4265</fpage>&#x02013;<lpage>4279</lpage>. .<pub-id pub-id-type="pmid">23467344</pub-id></mixed-citation></ref><ref id="cit0198"><label>[198]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diochot</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Baron</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rash</surname><given-names>LD</given-names></name>, et al</person-group>
<article-title>A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons</article-title>. <source>Embo J</source>. <year>2004</year>;<volume>23</volume>:<fpage>1516</fpage>&#x02013;<lpage>1525</lpage>.<pub-id pub-id-type="pmid">15044953</pub-id></mixed-citation></ref><ref id="cit0199"><label>[199]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanchard</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Rash</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Kellenberger</surname><given-names>S</given-names></name></person-group>
<article-title>Inhibition of voltage-gated Na + currents in sensory neurones by the sea anemone toxin APETx2</article-title>. <source>Br J Pharmacol</source>. <year>2012</year>;<volume>165</volume>(<issue>7</issue>):<fpage>2167</fpage>&#x02013;<lpage>2177</lpage>.<pub-id pub-id-type="pmid">21943094</pub-id></mixed-citation></ref><ref id="cit0200"><label>[200]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>ESJ</given-names></name></person-group>
<article-title>In silico assessment of interaction of sea anemone toxin APETx2 and acid sensing ion channel 3</article-title>. <source>Biochem Biophys Res Commun [Internet]</source>. <year>2014</year>;<volume>450</volume>(<issue>1</issue>):<fpage>384</fpage>&#x02013;<lpage>389</lpage>.</mixed-citation></ref><ref id="cit0201"><label>[201]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozlov</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Andreev</surname><given-names>YA</given-names></name>, et al</person-group>
<article-title>A sea anemone polypeptide toxin inhibiting the ASIC3 acid-sensitive channel</article-title>. <source>Russ J Bioorganic Chem</source>. <year>2012</year>;<volume>38</volume>(<issue>6</issue>):<fpage>578</fpage>&#x02013;<lpage>583</lpage>. .</mixed-citation></ref><ref id="cit0202"><label>[202]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodr&#x000ed;guez</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Salceda</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Garateix</surname><given-names>AG</given-names></name>, et al</person-group>
<article-title>A novel sea anemone peptide that inhibits acid-sensing ion channels Dedicated to professor L&#x000e1;szlo B&#x000e9;ress, a pioneer in the research on sea anemone toxins, for his contributions to this field</article-title>. <source>Peptides [Internet]</source>. <year>2014</year>;<volume>53</volume>:<fpage>3</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="cit0203"><label>[203]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Koshelev</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Andreev</surname><given-names>YA</given-names></name>, et al</person-group>
<article-title>Conversed mutagenesis of an inactive peptide to ASIC3 inhibitor for active sites determination</article-title>. <source>Toxicon [Internet]</source>. <year>2016</year>;<volume>116</volume>:<fpage>11</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="cit0204"><label>[204]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Kozlov</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Andreev</surname><given-names>YA</given-names></name>, et al</person-group>
<article-title>Sea anemone peptide with uncommon &#x003b2;-hairpin structure inhibits acid-sensing ion channel 3 (ASIC3) and reveals analgesic activity</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>32</issue>):<page-range>p. p. 23116&#x02013;23127</page-range>. .</mixed-citation></ref><ref id="cit0205"><label>[205]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bohlen</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Chesler</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Sharif-Naeini</surname><given-names>R</given-names></name>, et al</person-group>
<article-title>A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain</article-title>. <source>Nature.</source>
<year>2011</year> DOI:<pub-id pub-id-type="doi">10.1038/nature10607</pub-id>.</mixed-citation></ref><ref id="cit0206"><label>[206]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#x000e1;ez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Salceda</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fl&#x000f3;</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>&#x003b1;-Dendrotoxin inhibits the ASIC current in dorsal root ganglion neurons from rat</article-title>. <source>Neurosci Lett</source>. <year>2015</year>;<volume>606</volume>:<page-range>p. p. 42&#x02013;47</page-range>.</mixed-citation></ref><ref id="cit0207"><label>[207]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Askwith</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ikuma</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Neuropeptide FF and FMRFamide Potentiate Acid-Evoked Currents from Sensory Neurons and Proton-Gated DEG/ENaC Channels</article-title>. <source>Neuron [Internet]</source>. <year>2000</year>;<volume>26</volume>(<issue>1</issue>):<fpage>133</fpage>&#x02013;<lpage>141</lpage>. <ext-link ext-link-type="uri" xlink:href="http://Available&#x000a0;from:&#x000a0;https://www.cell.com/action/showPdf?pii=S0896-6273%2800%2981144&#x02013;7">Available from: https://www.cell.com/action/showPdf?pii=S0896-6273%2800%2981144&#x02013;7</ext-link>. .</mixed-citation></ref><ref id="cit0208"><label>[208]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deval</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Baron</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lingueglia</surname><given-names>E</given-names></name>, et al</person-group>
<article-title>Effects of neuropeptide SF and related peptides on acid sensing ion channel 3 and sensory neuron excitability</article-title>. <source>Neuropharmacology.</source>
<year>2003</year>;<volume>44</volume>(<issue>5</issue>):<fpage>662</fpage>&#x02013;<lpage>671</lpage>. .<pub-id pub-id-type="pmid">12668052</pub-id></mixed-citation></ref><ref id="cit0209"><label>[209]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reimers</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>C-H</given-names></name>, <name name-style="western"><surname>Kalbacher</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Identification of a cono-RFamide from the venom of Conus textile that targets ASIC3 and enhances muscle pain</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2017</year>;<volume>114</volume>(<issue>17</issue>):<fpage>E3507</fpage>&#x02013;<lpage>E3515</lpage>. .</mixed-citation></ref><ref id="cit0210"><label>[210]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reiners</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Margreiter</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Oslender-Bujotzek</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>The conorfamide RPRFA stabilizes the open conformation of acid-sensing ion channel 3 via the nonproton ligand&#x02013;sensing domain</article-title>. <source>Mol Pharmacol</source>. <year>2018</year>;<volume>94</volume>(<issue>4</issue>):<fpage>1114</fpage>&#x02013;<lpage>1124</lpage>. .<pub-id pub-id-type="pmid">30012583</pub-id></mixed-citation></ref><ref id="cit0211"><label>[211]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Koshelev</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Ivanov</surname><given-names>IA</given-names></name>, et al</person-group>
<article-title>Endogenous Neuropeptide Nocistatin Is a Direct Agonist of Acid-Sensing Ion Channels (ASIC1, ASIC2 and ASIC3)</article-title>. <source>Biomolecules.</source>
<year>2019</year>;<volume>9</volume>(<issue>9</issue>):<fpage>401</fpage>. .</mixed-citation></ref><ref id="cit0212"><label>[212]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinsbekk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rise</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Johnsen</surname><given-names>R</given-names></name></person-group>
<article-title>Changes among male and female visitors to practitioners of complementary and alternative medicine in a large adult Norwegian population from 1997 to 2008 (The HUNT studies)</article-title>. <source>BMC Complement Altern Med [Internet]</source>. <year>2011</year>;<volume>11</volume>(<issue>1</issue>):<fpage>61</fpage>
<ext-link ext-link-type="uri" xlink:href="http://Available&#x000a0;from:&#x000a0;http://www.biomedcentral.com/1472-6882/11/61">Available from: http://www.biomedcentral.com/1472-6882/11/61</ext-link>. .</mixed-citation></ref><ref id="cit0213"><label>[213]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubinnyi</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Koshelev</surname><given-names>SG</given-names></name>, et al</person-group>
<article-title>Lignan from thyme possesses inhibitory effect on ASIC3 channel current</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>(<issue>39</issue>):<fpage>32993</fpage>&#x02013;<lpage>33000</lpage>. .<pub-id pub-id-type="pmid">22854960</pub-id></mixed-citation></ref><ref id="cit0214"><label>[214]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Koshelev</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Belozerova</surname><given-names>OA</given-names></name>, et al</person-group>
<article-title>Biological activity of sevanol and its analogues</article-title>. <source>Russ J Bioorganic Chem</source>. <year>2015</year>;<volume>41</volume>(<issue>5</issue>):<fpage>543</fpage>&#x02013;<lpage>547</lpage>. .</mixed-citation></ref><ref id="cit0215"><label>[215]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>ZG</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XY</given-names></name>, et al</person-group>
<article-title>Inhibition of acid sensing ion channel by ligustrazine on angina model in rat</article-title>. <source>Am J Transl Res</source>. <year>2015</year>;<volume>7</volume>:<fpage>1798</fpage>&#x02013;<lpage>1811</lpage>.<pub-id pub-id-type="pmid">26692925</pub-id></mixed-citation></ref><ref id="cit0216"><label>[216]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>XG</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>X</given-names></name>, et al</person-group>
<article-title>Subtype-selective inhibition of acid-sensing ion channel 3 by a natural flavonoid</article-title>. <source>CNS Neurosci Ther</source>. <year>2019</year>;<volume>25</volume>(<issue>1</issue>):<page-range>p. p. 47&#x02013;56</page-range>. .</mixed-citation></ref><ref id="cit0217"><label>[217]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Qu</surname><given-names>ZW</given-names></name>, et al</person-group>
<article-title>Gastrodin inhibits the activity of acid-sensing ion channels in rat primary sensory neurons.</article-title>. <source>Eur J Pharmacol [Internet]</source>. <year>2014</year>;<volume>731</volume>:<fpage>50</fpage>&#x02013;<lpage>57</lpage>.</mixed-citation></ref><ref id="cit0218"><label>[218]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>YB</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>LF</given-names></name>, et al</person-group>
<article-title>ASICs mediate the modulatory effect by paeoniflorin on alpha-synuclein autophagic degradation</article-title>. <source>Brain Res [Internet]</source>. <year>2011</year>;<volume>1396</volume>:<fpage>77</fpage>&#x02013;<lpage>87</lpage>.</mixed-citation></ref><ref id="cit0219"><label>[219]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garateix</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Salceda</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Men&#x000e9;ndez</surname><given-names>R</given-names></name>, et al</person-group>
<article-title>Antinociception produced by Thalassia testudinum extract BM-21 is mediated by the inhibition of acid sensing ionic channels by the phenolic compound thalassiolin B</article-title>. <source>Mol Pain</source>. <year>2011</year>;<volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">21205324</pub-id></mixed-citation></ref><ref id="cit0220"><label>[220]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Neuroscience Letters Inhibition of acid-sensing ion channels by chlorogenic acid in rat dorsal root ganglion neurons.</article-title>. <source>Neurosci Lett [Internet]</source>. <year>2014</year>;<volume>567</volume>:<fpage>35</fpage>&#x02013;<lpage>39</lpage>.</mixed-citation></ref><ref id="cit0221"><label>[221]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagdas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cinkilic</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yucel</surname><given-names>H</given-names></name></person-group>
<article-title>Antihyperalgesic activity of chlorogenic acid in experimental neuropathic pain. J Nat Med</article-title>. <year>2013</year>;67:<fpage>698</fpage>&#x02013;<lpage>704</lpage>.</mixed-citation></ref><ref id="cit0222"><label>[222]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osmakov</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Koshelev</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Andreev</surname><given-names>YA</given-names></name>, et al</person-group>
<article-title>Proton-independent activation of acid-sensing ion channel 3 by an alkaloid, lindoldhamine, from Laurus nobilis.</article-title>. <source>Br J Pharmacol</source>. <year>2018</year>;<volume>175</volume>(<issue>6</issue>):<page-range>p. p. 924&#x02013;937</page-range>. .</mixed-citation></ref><ref id="cit0223"><label>[223]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Calcium-permeable acid-sensing ion channel is a molecular target of the neurotoxic metal ion lead</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>5</issue>):<fpage>2497</fpage>&#x02013;<lpage>2505</lpage>. .<pub-id pub-id-type="pmid">16319075</pub-id></mixed-citation></ref><ref id="cit0224"><label>[224]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staruschenko</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dorofeeva</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Bolshakov</surname><given-names>KV</given-names></name>, et al</person-group>
<article-title>Subunit-dependent cadmium and nickel inhibition of acid-sensing ion channels</article-title>. <source>Dev Neurobiol</source>. <year>2007</year>;67:<page-range>p. 97&#x02013;107</page-range>.</mixed-citation></ref><ref id="cit0225"><label>[225]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>TL</given-names></name></person-group>
<article-title>Modulation of acid-sensing ion channels by Cu2+ in cultured hypothalamic neurons of the rat</article-title>. <source>Neuroscience.</source>
<year>2007</year>;<volume>145</volume>(<issue>2</issue>):<fpage>631</fpage>&#x02013;<lpage>641</lpage>.<pub-id pub-id-type="pmid">17224241</pub-id></mixed-citation></ref><ref id="cit0226"><label>[226]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Papasian</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>JQ</given-names></name>, et al</person-group>
<article-title>Inhibitory regulation of acid-sensing ion channel 3 by zinc</article-title>. <source>Neurosci</source>. <year>2010</year>;<volume>169</volume>(<issue>2</issue>):<fpage>574</fpage>&#x02013;<lpage>583</lpage>.</mixed-citation></ref><ref id="cit0227"><label>[227]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Diarylamidines: high potency inhibitors of acid-sensing ion channels</article-title>. <source>Neuropharmacology.</source>
<year>2010</year>;<volume>58</volume>(<issue>7</issue>):<fpage>1045</fpage>&#x02013;<lpage>1053</lpage>. .<pub-id pub-id-type="pmid">20114056</pub-id></mixed-citation></ref><ref id="cit0228"><label>[228]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugawa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ishida</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ueda</surname><given-names>T</given-names></name>, et al</person-group>
<article-title>Nafamostat mesilate reversibly blocks acid-sensing ion channel currents</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2007</year>;<volume>363</volume>(<issue>1</issue>):<fpage>203</fpage>&#x02013;<lpage>208</lpage>. .<pub-id pub-id-type="pmid">17826743</pub-id></mixed-citation></ref><ref id="cit0229"><label>[229]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boiko</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kucher</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Eaton</surname><given-names>BA</given-names></name>, et al</person-group>
<article-title>Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>13</issue>):<fpage>9418</fpage>&#x02013;<lpage>9427</lpage>. .<pub-id pub-id-type="pmid">23404498</pub-id></mixed-citation></ref><ref id="cit0230"><label>[230]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munro</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Erichsen</surname><given-names>HK</given-names></name>, et al</person-group>
<article-title>NS383 Selectively Inhibits Acid-Sensing Ion Channels Containing 1a and 3 Subunits to Reverse Inflammatory and Neuropathic Hyperalgesia in Rats</article-title>. <source>CNS Neurosci Ther</source>. <year>2016</year>;<volume>22</volume>(<issue>2</issue>):<fpage>135</fpage>&#x02013;<lpage>145</lpage>. .<pub-id pub-id-type="pmid">26663905</pub-id></mixed-citation></ref><ref id="cit0231"><label>[231]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Eshcol</surname><given-names>JO</given-names></name>, et al</person-group>
<article-title>Stomatin modulates gating of acid-sensing ion channels</article-title>. <source>J Biol Chem</source>. <year>2004</year>;<volume>279</volume>(<issue>51</issue>):<fpage>53886</fpage>&#x02013;<lpage>53891</lpage>. .<pub-id pub-id-type="pmid">15471860</pub-id></mixed-citation></ref><ref id="cit0232"><label>[232]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wetzel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Riethmacher</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>A stomatin-domain protein essential for touch sensation in the mouse</article-title>. <source>Nature.</source>
<year>2007</year>;<volume>445</volume>(<issue>7124</issue>):<fpage>206</fpage>&#x02013;<lpage>209</lpage>. .<pub-id pub-id-type="pmid">17167420</pub-id></mixed-citation></ref><ref id="cit0233"><label>[233]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moshourab</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Wetzel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Martinez-Salgado</surname><given-names>C</given-names></name>, et al</person-group>
<article-title>Stomatin-domain protein interactions with acid-sensing ion channels modulate nociceptor mechanosensitivity</article-title>. <source>J Physiol</source>. <year>2013</year>;<volume>591</volume>(<issue>22</issue>):<fpage>5555</fpage>&#x02013;<lpage>5574</lpage>. .<pub-id pub-id-type="pmid">23959680</pub-id></mixed-citation></ref><ref id="cit0234"><label>[234]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kozlenkov</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lapatsina</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lewin</surname><given-names>GR</given-names></name>, et al</person-group>
<article-title>Subunit-specific inhibition of acid sensing ion channels by stomatin-like protein 1</article-title>. <source>J Physiol</source>. <year>2014</year> DOI:<pub-id pub-id-type="doi">10.1113/jphysiol.2013.258657</pub-id>.</mixed-citation></ref><ref id="cit0235"><label>[235]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brand</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>ESJ</given-names></name>, <name name-style="western"><surname>Schwefel</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>A stomatin dimer modulates the activity of acid-sensing ion channels</article-title>. <source>Embo J</source>. <year>2012</year>;<volume>31</volume>(<issue>17</issue>):<fpage>3635</fpage>&#x02013;<lpage>3646</lpage>. .<pub-id pub-id-type="pmid">22850675</pub-id></mixed-citation></ref><ref id="cit0236"><label>[236]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klipp</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Cullinan</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Bankston</surname><given-names>JR</given-names></name></person-group>
<article-title>Insights into the molecular mechanisms underlying the inhibition of acid-sensing ion channel 3 gating by stomatin</article-title>. <source>J Gen Physiol</source>. <year>2020</year>;<volume>152</volume>(<issue>3</issue>):<fpage>1</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="cit0237"><label>[237]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name></person-group>
<article-title>UniProt:A worldwide hub of protein knowledge</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>;<volume>47</volume>:<fpage>D506</fpage>&#x02013;<lpage>D515</lpage>.<pub-id pub-id-type="pmid">30395287</pub-id></mixed-citation></ref><ref id="cit0238"><label>[238]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarz</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Namer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Reeh</surname><given-names>PW</given-names></name>, et al</person-group>
<article-title>TRPA1 and TRPV1 Antagonists Do Not Inhibit Human Acidosis-Induced Pain.</article-title>. <source>J Pain [Internet]</source>. <year>2017</year>;<volume>18</volume>(<issue>5</issue>):<fpage>526</fpage>&#x02013;<lpage>534</lpage>.</mixed-citation></ref></ref-list></back></article>